BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Goldsmith DR, Rapaport MH, Miller BJ. A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression. Mol Psychiatry 2016;21:1696-709. [PMID: 26903267 DOI: 10.1038/mp.2016.3] [Cited by in Crossref: 808] [Cited by in F6Publishing: 693] [Article Influence: 134.7] [Reference Citation Analysis]
Number Citing Articles
1 Hartwig FP, Borges MC, Horta BL, Bowden J, Davey Smith G. Inflammatory Biomarkers and Risk of Schizophrenia: A 2-Sample Mendelian Randomization Study. JAMA Psychiatry 2017;74:1226-33. [PMID: 29094161 DOI: 10.1001/jamapsychiatry.2017.3191] [Cited by in Crossref: 90] [Cited by in F6Publishing: 73] [Article Influence: 18.0] [Reference Citation Analysis]
2 Minamino H, Katsushima M, Hashimoto M, Fujita Y, Torii M, Ikeda K, Isomura N, Oguri Y, Yamamoto W, Watanabe R, Murakami K, Murata K, Nishitani K, Tanaka M, Ito H, Uda M, Nin K, Arai H, Matsuda S, Morinobu A, Inagaki N. Influence of dietary habits on depression among patients with rheumatoid arthritis: A cross-sectional study using KURAMA cohort database. PLoS One 2021;16:e0255526. [PMID: 34351967 DOI: 10.1371/journal.pone.0255526] [Reference Citation Analysis]
3 Hadian Y, Fregoso D, Nguyen C, Bagood MD, Dahle SE, Gareau MG, Isseroff RR. Microbiome-skin-brain axis: A novel paradigm for cutaneous wounds. Wound Repair Regen 2020;28:282-92. [PMID: 32034844 DOI: 10.1111/wrr.12800] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
4 Lluch E, Miller BJ. Rates of hepatitis B and C in patients with schizophrenia: A meta-analysis. Gen Hosp Psychiatry 2019;61:41-6. [PMID: 31710857 DOI: 10.1016/j.genhosppsych.2019.10.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
5 Linnaranta O, Trontti KT, Honkanen J, Hovatta I, Keinänen J, Suvisaari J. Peripheral metabolic state and immune system in first-episode psychosis - A gene expression study with a prospective one-year follow-up. J Psychiatr Res 2021;137:383-92. [PMID: 33765450 DOI: 10.1016/j.jpsychires.2021.03.013] [Reference Citation Analysis]
6 Harrison PJ, Geddes JR, Tunbridge EM. The Emerging Neurobiology of Bipolar Disorder. Trends Neurosci 2018;41:18-30. [PMID: 29169634 DOI: 10.1016/j.tins.2017.10.006] [Cited by in Crossref: 85] [Cited by in F6Publishing: 65] [Article Influence: 17.0] [Reference Citation Analysis]
7 Murphy CE, Walker AK, O'Donnell M, Galletly C, Lloyd AR, Liu D, Weickert CS, Weickert TW. Peripheral NF-κB dysregulation in people with schizophrenia drives inflammation: putative anti-inflammatory functions of NF-κB kinases. Transl Psychiatry 2022;12:21. [PMID: 35027554 DOI: 10.1038/s41398-021-01764-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Cheng W, Frei O, van der Meer D, Wang Y, O'Connell KS, Chu Y, Bahrami S, Shadrin AA, Alnæs D, Hindley GFL, Lin A, Karadag N, Fan CC, Westlye LT, Kaufmann T, Molden E, Dale AM, Djurovic S, Smeland OB, Andreassen OA. Genetic Association Between Schizophrenia and Cortical Brain Surface Area and Thickness. JAMA Psychiatry 2021;78:1020-30. [PMID: 34160554 DOI: 10.1001/jamapsychiatry.2021.1435] [Reference Citation Analysis]
9 Sneeboer MAM, Snijders GJLJ, Berdowski WM, Fernández-Andreu A, van Mierlo HC, Berdenis van Berlekom A, Litjens M, Kahn RS, Hol EM, de Witte LD; Psychiatric Donor Program of the Netherlands Brain Bank (NBB-Psy). Microglia in post-mortem brain tissue of patients with bipolar disorder are not immune activated. Transl Psychiatry 2019;9:153. [PMID: 31127084 DOI: 10.1038/s41398-019-0490-x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 8.7] [Reference Citation Analysis]
10 li Y, jinxiang T, shu Y, yadong P, ying L, meng Y, Ping Z, xiao H, xiao F. Childhood trauma and the plasma levels of IL-6, TNF-α are risk factors for major depressive disorder and schizophrenia in adolescents: a cross-sectional and case-control study. Journal of Affective Disorders 2022. [DOI: 10.1016/j.jad.2022.02.020] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Köhler CA, Freitas TH, Stubbs B, Maes M, Solmi M, Veronese N, de Andrade NQ, Morris G, Fernandes BS, Brunoni AR, Herrmann N, Raison CL, Miller BJ, Lanctôt KL, Carvalho AF. Peripheral Alterations in Cytokine and Chemokine Levels After Antidepressant Drug Treatment for Major Depressive Disorder: Systematic Review and Meta-Analysis. Mol Neurobiol 2018;55:4195-206. [PMID: 28612257 DOI: 10.1007/s12035-017-0632-1] [Cited by in Crossref: 76] [Cited by in F6Publishing: 111] [Article Influence: 15.2] [Reference Citation Analysis]
12 Atkinson LZ, Colbourne L, Smith A, Harmer CH, Nobre AC, Rendell J, Jones H, Hinds C, Mould A, Tunbridge EM, Cipriani A, Geddes JR, Saunders KEA, Harrison PJ. The Oxford study of Calcium channel Antagonism, Cognition, Mood instability and Sleep (OxCaMS): study protocol for a randomised controlled, experimental medicine study. Trials 2019;20:120. [PMID: 30755265 DOI: 10.1186/s13063-019-3175-0] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 4.7] [Reference Citation Analysis]
13 Morozova A, Zorkina Y, Pavlov K, Pavlova O, Abramova O, Ushakova V, Mudrak AV, Zozulya S, Otman I, Sarmanova Z, Klyushnik T, Reznik A, Kostyuk G, Chekhonin V. Associations of Genetic Polymorphisms and Neuroimmune Markers With Some Parameters of Frontal Lobe Dysfunction in Schizophrenia. Front Psychiatry 2021;12:655178. [PMID: 34025476 DOI: 10.3389/fpsyt.2021.655178] [Reference Citation Analysis]
14 Shvartsur R, Agam G, Uzzan S, Azab AN. Low-Dose Aspirin Augments the Anti-Inflammatory Effects of Low-Dose Lithium in Lipopolysaccharide-Treated Rats. Pharmaceutics 2022;14:901. [DOI: 10.3390/pharmaceutics14050901] [Reference Citation Analysis]
15 Hoekstra PJ. Attention-deficit/hyperactivity disorder: is there a connection with the immune system? Eur Child Adolesc Psychiatry 2019;28:601-2. [DOI: 10.1007/s00787-019-01344-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
16 Pinto JV, Passos IC, Librenza-Garcia D, Marcon G, Schneider MA, Conte JH, da Silva JPA, Lima LP, Quincozes-Santos A, Kauer-Sant Anna M, Kapczinski F. Neuron-glia Interaction as a Possible Pathophysiological Mechanism of Bipolar Disorder. Curr Neuropharmacol 2018;16:519-32. [PMID: 28847296 DOI: 10.2174/1570159X15666170828170921] [Cited by in Crossref: 28] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
17 Evrensel A, Tarhan N. Inflammation Biomarkers in Psychiatry. CPRR 2020;16:78-85. [DOI: 10.2174/2666082216999200625115701] [Reference Citation Analysis]
18 Lei Y, Du M, Zhang G, Chen L, Fu Y, Zhong Y, Zhang E. Bioinformatics and Network Pharmacology-Based Approaches to Explore the Potential Mechanism of the Antidepressant Effect of Cyperi Rhizoma through Soothing the Liver. Evid Based Complement Alternat Med 2021;2021:8614963. [PMID: 35126596 DOI: 10.1155/2021/8614963] [Reference Citation Analysis]
19 Larsen JB, Reitan SK, Løberg EM, Rettenbacher M, Bruserud Ø, Larsen TK, Anda L, Bartz-Johannessen C, Johnsen E, Kroken RA. The association between cytokines and psychomotor speed in a spectrum of psychotic disorders: A longitudinal study. Brain Behav Immun Health 2021;18:100392. [PMID: 34877553 DOI: 10.1016/j.bbih.2021.100392] [Reference Citation Analysis]
20 Salagre E, Dodd S, Aedo A, Rosa A, Amoretti S, Pinzon J, Reinares M, Berk M, Kapczinski FP, Vieta E, Grande I. Toward Precision Psychiatry in Bipolar Disorder: Staging 2.0. Front Psychiatry 2018;9:641. [PMID: 30555363 DOI: 10.3389/fpsyt.2018.00641] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 9.0] [Reference Citation Analysis]
21 Shi J, Guo H, Liu S, Xue W, Fan F, Li H, Fan H, An H, Wang Z, Tan S, Yang F, Tan Y. Subcortical Brain Volumes Relate to Neurocognition in First-Episode Schizophrenia, Bipolar Disorder, Major Depression Disorder, and Healthy Controls. Front Psychiatry 2022;12:747386. [DOI: 10.3389/fpsyt.2021.747386] [Reference Citation Analysis]
22 Ye G, Yin GZ, Tang Z, Fu JL, Chen J, Chen SS, Li J, Fu T, Yu X, Xu DW, Yao JK, Hui L. Association between increased serum interleukin-6 levels and sustained attention deficits in patients with major depressive disorder. Psychol Med 2018;48:2508-14. [DOI: 10.1017/s0033291718000090] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 4.3] [Reference Citation Analysis]
23 Zhu M, Liu Z, Guo Y, Sultana MS, Wu K, Lang X, Lv Q, Huang X, Yi Z, Li Z. Sex difference in the interrelationship between TNF-α and oxidative stress status in first-episode drug-naïve schizophrenia. J Neuroinflammation 2021;18:202. [PMID: 34526062 DOI: 10.1186/s12974-021-02261-5] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Jiang N, Jingwei L, Wang H, Huang H, Wang Q, Zeng G, Li S, Liu X. Ginsenoside 20(S)-protopanaxadiol attenuates depressive-like behaviour and neuroinflammation in chronic unpredictable mild stress-induced depressive rats. Behavioural Brain Research 2020;393:112710. [DOI: 10.1016/j.bbr.2020.112710] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
25 Misiak B, Stańczykiewicz B, Kotowicz K, Rybakowski JK, Samochowiec J, Frydecka D. Cytokines and C-reactive protein alterations with respect to cognitive impairment in schizophrenia and bipolar disorder: A systematic review. Schizophr Res 2018;192:16-29. [PMID: 28416092 DOI: 10.1016/j.schres.2017.04.015] [Cited by in Crossref: 79] [Cited by in F6Publishing: 75] [Article Influence: 15.8] [Reference Citation Analysis]
26 Panda TS, Lalremmawia H, Tiwary BK. Blood genomic biomarkers for early diagnosis of schizophrenia. Asian J Psychiatr 2021;59:102638. [PMID: 33823477 DOI: 10.1016/j.ajp.2021.102638] [Reference Citation Analysis]
27 Taniguchi K, Ikeda Y, Nagase N, Tsuji A, Kitagishi Y, Matsuda S; Department of Food Science and Nutrition, Nara Women's University, Kita-Uoya Nishimachi, Nara 630-8506, Japan. . AIMSBOA 2021;8:243-56. [DOI: 10.3934/bioeng.2021021] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Sowa-Kućma M, Styczeń K, Siwek M, Misztak P, Nowak RJ, Dudek D, Rybakowski JK, Nowak G, Maes M. Are there differences in lipid peroxidation and immune biomarkers between major depression and bipolar disorder: Effects of melancholia, atypical depression, severity of illness, episode number, suicidal ideation and prior suicide attempts. Prog Neuropsychopharmacol Biol Psychiatry 2018;81:372-83. [PMID: 28867391 DOI: 10.1016/j.pnpbp.2017.08.024] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 7.2] [Reference Citation Analysis]
29 Melbourne JK, Rosen C, Feiner B, Sharma RP. C4A mRNA expression in PBMCs predicts the presence and severity of delusions in schizophrenia and bipolar disorder with psychosis. Schizophr Res 2018;197:321-7. [PMID: 29449061 DOI: 10.1016/j.schres.2018.01.018] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
30 Suvisaari J, Mantere O, Keinänen J, Mäntylä T, Rikandi E, Lindgren M, Kieseppä T, Raij TT. Is It Possible to Predict the Future in First-Episode Psychosis? Front Psychiatry 2018;9:580. [PMID: 30483163 DOI: 10.3389/fpsyt.2018.00580] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 7.0] [Reference Citation Analysis]
31 Kappelmann N, Czamara D, Rost N, Moser S, Schmoll V, Trastulla L, Stochl J, Lucae S, Binder EB, Khandaker GM, Arloth J; CHARGE inflammation working group. Polygenic risk for immuno-metabolic markers and specific depressive symptoms: A multi-sample network analysis study. Brain Behav Immun 2021;95:256-68. [PMID: 33794315 DOI: 10.1016/j.bbi.2021.03.024] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
32 Misiak B, Ricceri L, Sąsiadek MM. Transposable Elements and Their Epigenetic Regulation in Mental Disorders: Current Evidence in the Field. Front Genet 2019;10:580. [PMID: 31293617 DOI: 10.3389/fgene.2019.00580] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 7.3] [Reference Citation Analysis]
33 Kuwano N, Kato TA, Setoyama D, Sato-kasai M, Shimokawa N, Hayakawa K, Ohgidani M, Sagata N, Kubo H, Kishimoto J, Kang D, Kanba S. Tryptophan-kynurenine and lipid related metabolites as blood biomarkers for first-episode drug-naïve patients with major depressive disorder: An exploratory pilot case-control study. Journal of Affective Disorders 2018;231:74-82. [DOI: 10.1016/j.jad.2018.01.014] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 5.8] [Reference Citation Analysis]
34 Khandaker GM. Commentary: Causal associations between inflammation, cardiometabolic markers and schizophrenia: the known unknowns. Int J Epidemiol 2019;48:1516-8. [PMID: 31563954 DOI: 10.1093/ije/dyz201] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
35 Matison AP, Mather KA, Flood VM, Reppermund S. Associations between nutrition and the incidence of depression in middle-aged and older adults: A systematic review and meta-analysis of prospective observational population-based studies. Ageing Res Rev 2021;70:101403. [PMID: 34246793 DOI: 10.1016/j.arr.2021.101403] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
36 Larsen JB, Stunes AK, Iversen VC, Vaaler AE, Reitan SK. Cytokines in Relation to Motor Activity in an Acute Psychiatric Population. Front Psychiatry 2019;10:920. [PMID: 31920766 DOI: 10.3389/fpsyt.2019.00920] [Reference Citation Analysis]
37 Ge Y, Xu W, Zhang L, Liu M. Ginkgolide B attenuates myocardial infarction-induced depression-like behaviors via repressing IL-1β in central nervous system. Int Immunopharmacol 2020;85:106652. [PMID: 32521492 DOI: 10.1016/j.intimp.2020.106652] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
38 Ryan AE, Mowry BJ, Kesby JP, Scott JG, Greer JM. Is there a role for antibodies targeting muscarinic acetylcholine receptors in the pathogenesis of schizophrenia? Aust N Z J Psychiatry 2019;53:1059-69. [PMID: 31347380 DOI: 10.1177/0004867419864438] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
39 Izumi R, Hino M, Wada A, Nagaoka A, Kawamura T, Mori T, Sainouchi M, Kakita A, Kasai K, Kunii Y, Yabe H. Detailed Postmortem Profiling of Inflammatory Mediators Expression Revealed Post-inflammatory Alternation in the Superior Temporal Gyrus of Schizophrenia. Front Psychiatry 2021;12:653821. [PMID: 33815179 DOI: 10.3389/fpsyt.2021.653821] [Reference Citation Analysis]
40 Deng Z, Liu J, He S, Gao W. The Pyroptosis-Related Signature Predicts Diagnosis and Indicates Immune Characteristic in Major Depression Disease. Front Pharmacol 2022;13:848939. [DOI: 10.3389/fphar.2022.848939] [Reference Citation Analysis]
41 Goldsmith DR, Haroon E, Woolwine BJ, Jung MY, Wommack EC, Harvey PD, Treadway MT, Felger JC, Miller AH. Inflammatory markers are associated with decreased psychomotor speed in patients with major depressive disorder. Brain Behav Immun 2016;56:281-8. [PMID: 27040122 DOI: 10.1016/j.bbi.2016.03.025] [Cited by in Crossref: 61] [Cited by in F6Publishing: 54] [Article Influence: 10.2] [Reference Citation Analysis]
42 Husain MI, Cullen C, Umer M, Carvalho AF, Kloiber S, Meyer JH, Ortiz A, Knyahnytska Y, Husain MO, Giddens J, Diniz BS, Wang W, Young AH, Mulsant BH, Daskalakis ZJ. Minocycline as adjunctive treatment for treatment-resistant depression: study protocol for a double blind, placebo-controlled, randomized trial (MINDEP2). BMC Psychiatry 2020;20:173. [PMID: 32295565 DOI: 10.1186/s12888-020-02553-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
43 Rosenkranz MA, Esnault S, Gresham L, Davidson RJ, Christian BT, Jarjour NN, Busse WW. Role of amygdala in stress-induced upregulation of airway IL-1 signaling in asthma. Biol Psychol 2022;167:108226. [PMID: 34800561 DOI: 10.1016/j.biopsycho.2021.108226] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Stumper A, Moriarity DP, Coe CL, Ellman LM, Abramson LY, Alloy LB. Pubertal Status and Age are Differentially Associated with Inflammatory Biomarkers in Female and Male Adolescents. J Youth Adolesc 2020;49:1379-92. [PMID: 31410721 DOI: 10.1007/s10964-019-01101-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
45 Lang X, Trihn TH, Wu HE, Tong Y, Xiu M, Zhang XY. Association between TNF-alpha polymorphism and the age of first suicide attempt in chronic patients with schizophrenia. Aging (Albany NY) 2020;12:1433-45. [PMID: 31954374 DOI: 10.18632/aging.102692] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
46 van Mierlo HC, Schot A, Boks MP, de Witte LD. The association between schizophrenia and the immune system: Review of the evidence from unbiased ‘omic-studies’. Schizophrenia Research 2020;217:114-23. [DOI: 10.1016/j.schres.2019.05.028] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
47 Jung YJ, Tweedie D, Scerba MT, Kim DS, Palmas MF, Pisanu A, Carta AR, Greig NH. Repurposing Immunomodulatory Imide Drugs (IMiDs) in Neuropsychiatric and Neurodegenerative Disorders. Front Neurosci 2021;15:656921. [PMID: 33854417 DOI: 10.3389/fnins.2021.656921] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
48 Zhu S, Zhao L, Fan Y, Lv Q, Wu K, Lang X, Li Z, Yi Z, Geng D. Interaction between TNF-α and oxidative stress status in first-episode drug-naïve schizophrenia. Psychoneuroendocrinology 2020;114:104595. [DOI: 10.1016/j.psyneuen.2020.104595] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
49 Carratalá-Ros C, López-Cruz L, Martínez-Verdú A, Olivares-García R, Salamone JD, Correa M. Impact of Fluoxetine on Behavioral Invigoration of Appetitive and Aversively Motivated Responses: Interaction With Dopamine Depletion. Front Behav Neurosci 2021;15:700182. [PMID: 34305547 DOI: 10.3389/fnbeh.2021.700182] [Reference Citation Analysis]
50 Han KM, Ham BJ. How Inflammation Affects the Brain in Depression: A Review of Functional and Structural MRI Studies. J Clin Neurol 2021;17:503-15. [PMID: 34595858 DOI: 10.3988/jcn.2021.17.4.503] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
51 Fan Y, Gao Y, Ma Q, Yang Z, Zhao B, He X, Yang J, Yan B, Gao F, Qian L, Wang W, Zhu F, Ma X. Multi-Omics Analysis Reveals Aberrant Gut-Metabolome-Immune Network in Schizophrenia. Front Immunol 2022;13:812293. [PMID: 35309369 DOI: 10.3389/fimmu.2022.812293] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
52 Kotov R, Jonas KG, Carpenter WT, Dretsch MN, Eaton NR, Forbes MK, Forbush KT, Hobbs K, Reininghaus U, Slade T, South SC, Sunderland M, Waszczuk MA, Widiger TA, Wright AGC, Zald DH, Krueger RF, Watson D; HiTOP Utility Workgroup. Validity and utility of Hierarchical Taxonomy of Psychopathology (HiTOP): I. Psychosis superspectrum. World Psychiatry 2020;19:151-72. [PMID: 32394571 DOI: 10.1002/wps.20730] [Cited by in Crossref: 72] [Cited by in F6Publishing: 59] [Article Influence: 36.0] [Reference Citation Analysis]
53 Lu YR, Rao YB, Mou YJ, Chen Y, Lou HF, Zhang Y, Zhang DX, Xie HY, Hu LW, Fang P. High concentrations of serum interleukin-6 and interleukin-8 in patients with bipolar disorder. Medicine (Baltimore) 2019;98:e14419. [PMID: 30762747 DOI: 10.1097/MD.0000000000014419] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 2.7] [Reference Citation Analysis]
54 Wu C, Huang BE, Chen G, Lovenberg TW, Pocalyko DJ, Yao X. Integrative Analysis of DiseaseLand Omics Database for Disease Signatures and Treatments: A Bipolar Case Study. Front Genet 2019;10:396. [PMID: 31114610 DOI: 10.3389/fgene.2019.00396] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
55 Chang M, Womer FY, Gong X, Chen X, Tang L, Feng R, Dong S, Duan J, Chen Y, Zhang R, Wang Y, Ren S, Wang Y, Kang J, Yin Z, Wei Y, Wei S, Jiang X, Xu K, Cao B, Zhang Y, Zhang W, Tang Y, Zhang X, Wang F. Identifying and validating subtypes within major psychiatric disorders based on frontal-posterior functional imbalance via deep learning. Mol Psychiatry 2021;26:2991-3002. [PMID: 33005028 DOI: 10.1038/s41380-020-00892-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
56 Carta MG, Kalcev G, Fornaro M, Nardi AE. Novel experimental and early investigational drugs for the treatment of bipolar disorder. Expert Opin Investig Drugs 2021;30:1081-7. [PMID: 34844484 DOI: 10.1080/13543784.2021.2000965] [Reference Citation Analysis]
57 Del Colle A, Israelyan N, Gross Margolis K. Novel aspects of enteric serotonergic signaling in health and brain-gut disease. Am J Physiol Gastrointest Liver Physiol 2020;318:G130-43. [PMID: 31682158 DOI: 10.1152/ajpgi.00173.2019] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
58 Zhou S, Chen R, She Y, Liu X, Zhao H, Li C, Jia Y. A new perspective on depression and neuroinflammation: Non-coding RNA. Journal of Psychiatric Research 2022;148:293-306. [DOI: 10.1016/j.jpsychires.2022.02.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
59 Pereira CAC, Costa AC, Joaquim HPG, Talib LL, van de Bilt MT, Loch AA, Gattaz WF. COX-2 pathway is upregulated in ultra-high risk individuals for psychosis. World J Biol Psychiatry 2021;:1-6. [PMID: 34547958 DOI: 10.1080/15622975.2021.1961501] [Reference Citation Analysis]
60 Lee S, Lee KH, Park KM, Park SJ, Kim WJ, Lee J, Kronbichler A, Smith L, Solmi M, Stubbs B, Koyanagi A, Jacob L, Stickley A, Thompson T, Dragioti E, Oh H, Brunoni AR, Carvalho AF, Radua J, An SK, Namkoong K, Lee E, Shin JI, Fusar-Poli P. Impact of data extraction errors in meta-analyses on the association between depression and peripheral inflammatory biomarkers: an umbrella review. Psychol Med 2021;:1-14. [PMID: 34749836 DOI: 10.1017/S0033291721003767] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
61 Lai J, Zhang P, Jiang J, Mou T, Li Y, Xi C, Wu L, Gao X, Zhang D, Chen Y, Huang H, Li H, Cai X, Li M, Zheng P, Hu S. New Evidence of Gut Microbiota Involvement in the Neuropathogenesis of Bipolar Depression by TRANK1 Modulation: Joint Clinical and Animal Data. Front Immunol 2021;12:789647. [PMID: 34992606 DOI: 10.3389/fimmu.2021.789647] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
62 Traglia M, Croen LA, Jones KL, Heuer LS, Yolken R, Kharrazi M, DeLorenze GN, Ashwood P, Van de Water J, Weiss LA. Cross-genetic determination of maternal and neonatal immune mediators during pregnancy. Genome Med 2018;10:67. [PMID: 30134952 DOI: 10.1186/s13073-018-0576-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
63 Goerigk S, Cretaz E, Sampaio-junior B, Vieira ÉLM, Gattaz W, Klein I, Lafer B, Teixeira AL, Carvalho AF, Lotufo PA, Benseñor IM, Bühner M, Padberg F, Brunoni AR. Effects of tDCS on neuroplasticity and inflammatory biomarkers in bipolar depression: Results from a sham-controlled study. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2021;105:110119. [DOI: 10.1016/j.pnpbp.2020.110119] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
64 Liu L, Liu S, Guan W, Zhang L. Efficacy of tocilizumab for psychiatric symptoms associated with relapsing polychondritis: the first case report and review of the literature. Rheumatol Int 2016;36:1185-9. [PMID: 27260262 DOI: 10.1007/s00296-016-3509-0] [Cited by in Crossref: 3] [Article Influence: 0.5] [Reference Citation Analysis]
65 Leirer DJ, Iyegbe CO, Di Forti M, Patel H, Carra E, Fraietta S, Colizzi M, Mondelli V, Quattrone D, Lally J, Ajnakina O, Lee SH, Curtis CJ, Breen G, Pariante C, Aitchison K, Dazzan P, Murray RM, Dobson RJB, Newhouse SJ. Differential gene expression analysis in blood of first episode psychosis patients. Schizophr Res 2019;209:88-97. [PMID: 31113746 DOI: 10.1016/j.schres.2019.05.011] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
66 Tsai S, Gildengers AG, Hsu J, Chung K, Chen P, Huang Y. Inflammation associated with volume reduction in the gray matter and hippocampus of older patients with bipolar disorder. Journal of Affective Disorders 2019;244:60-6. [DOI: 10.1016/j.jad.2018.10.093] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
67 Wang Y, Meagher RB, Ambati S, Ma P, Phillips BG. Patients with obstructive sleep apnea have suppressed levels of soluble cytokine receptors involved in neurodegenerative disease, but normal levels with airways therapy. Sleep Breath 2021;25:1641-53. [PMID: 33037528 DOI: 10.1007/s11325-020-02205-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
68 Parkinson JT, Foley ÉM, Jadon DR, Khandaker GM. Depression in patients with spondyloarthritis: prevalence, incidence, risk factors, mechanisms and management. Ther Adv Musculoskelet Dis 2020;12:1759720X20970028. [PMID: 33224281 DOI: 10.1177/1759720X20970028] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
69 Li Z, Li X, Jin M, Liu Y, He Y, Jia N, Cui X, Liu Y, Hu G, Yu Q. Identification of potential blood biomarkers for early diagnosis of schizophrenia through RNA sequencing analysis. J Psychiatr Res 2022;147:39-49. [PMID: 35016150 DOI: 10.1016/j.jpsychires.2022.01.003] [Reference Citation Analysis]
70 Kim J, Cho H, Kim J, Kim A, Kang Y, Kang W, Choi KW, Ham BJ, Han KM, Tae WS. Changes in cortical thickness and volume of cerebellar subregions in patients with bipolar disorders. J Affect Disord 2020;271:74-80. [PMID: 32479334 DOI: 10.1016/j.jad.2020.03.087] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
71 Kanchanatawan B, Sirivichayakul S, Ruxrungtham K, Carvalho AF, Geffard M, Anderson G, Maes M. Deficit Schizophrenia Is Characterized by Defects in IgM-Mediated Responses to Tryptophan Catabolites (TRYCATs): a Paradigm Shift Towards Defects in Natural Self-Regulatory Immune Responses Coupled with Mucosa-Derived TRYCAT Pathway Activation. Mol Neurobiol 2018;55:2214-26. [PMID: 28290151 DOI: 10.1007/s12035-017-0465-y] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 4.4] [Reference Citation Analysis]
72 Borovcanin MM, Jovanovic I, Radosavljevic G, Pantic J, Minic Janicijevic S, Arsenijevic N, Lukic ML. Interleukin-6 in Schizophrenia-Is There a Therapeutic Relevance? Front Psychiatry 2017;8:221. [PMID: 29163240 DOI: 10.3389/fpsyt.2017.00221] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 4.2] [Reference Citation Analysis]
73 Korovaitseva GI, Gabaeva MV, Oleichik IV, Golimbet VE. The Effect of INDEL Polymorphism of the Human Leukocyte Antigen G (HLA-G) and the Season of Birth on the Risk of Schizophrenia and Its Clinical Features. Russ J Genet 2021;57:221-6. [DOI: 10.1134/s102279542102006x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
74 Tang M, Dang R, Liu S, Zhang M, Zheng Y, Yang R, Yin T. Ω-3 fatty acids-supplementary in gestation alleviates neuroinflammation and modulates neurochemistry in rats. Lipids Health Dis 2018;17:247. [PMID: 30390665 DOI: 10.1186/s12944-018-0894-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
75 Morris G, Puri BK, Walker AJ, Maes M, Carvalho AF, Bortolasci CC, Walder K, Berk M. Shared pathways for neuroprogression and somatoprogression in neuropsychiatric disorders. Neurosci Biobehav Rev 2019;107:862-82. [PMID: 31545987 DOI: 10.1016/j.neubiorev.2019.09.025] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 8.7] [Reference Citation Analysis]
76 Charoenngam N, Ponvilawan B, Ungprasert P. Patients with rheumatoid arthritis have a higher risk of bipolar disorder: A systematic review and meta-analysis. Psychiatry Research 2019;282:112484. [DOI: 10.1016/j.psychres.2019.112484] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
77 Momtazmanesh S, Zare-Shahabadi A, Rezaei N. Cytokine Alterations in Schizophrenia: An Updated Review. Front Psychiatry 2019;10:892. [PMID: 31908647 DOI: 10.3389/fpsyt.2019.00892] [Cited by in Crossref: 49] [Cited by in F6Publishing: 48] [Article Influence: 16.3] [Reference Citation Analysis]
78 Müller N. COX-2 Inhibitors, Aspirin, and Other Potential Anti-Inflammatory Treatments for Psychiatric Disorders. Front Psychiatry 2019;10:375. [PMID: 31214060 DOI: 10.3389/fpsyt.2019.00375] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 10.0] [Reference Citation Analysis]
79 Kocsis A, Gajwani R, Gross J, Gumley AI, Lawrie SM, Schwannauer M, Schultze-Lutter F, Grent-'t-Jong T, Uhlhaas PJ. Altered Autonomic Function in Individuals at Clinical High Risk for Psychosis. Front Psychiatry 2020;11:580503. [PMID: 33240132 DOI: 10.3389/fpsyt.2020.580503] [Reference Citation Analysis]
80 Zhang L, Zheng H, Wu R, Kosten TR, Zhang X, Zhao J. The effect of minocycline on amelioration of cognitive deficits and pro-inflammatory cytokines levels in patients with schizophrenia. Schizophrenia Research 2019;212:92-8. [DOI: 10.1016/j.schres.2019.08.005] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 5.7] [Reference Citation Analysis]
81 Raison CL, Miller AH. Pathogen-Host Defense in the Evolution of Depression: Insights into Epidemiology, Genetics, Bioregional Differences and Female Preponderance. Neuropsychopharmacology 2017;42:5-27. [PMID: 27629366 DOI: 10.1038/npp.2016.194] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 5.5] [Reference Citation Analysis]
82 Ferrari M, Godio M, Martini S, Callegari C, Cosentino M, Marino F. Effect of quetiapine on inflammation and immunity: a systematic review. Int J Psychiatry Clin Pract 2022;:1-12. [PMID: 35913757 DOI: 10.1080/13651501.2022.2101928] [Reference Citation Analysis]
83 Liu H, Lin Y, Tsai M, Wu Y, Lee M. Baicalein Exerts Therapeutic Effects against Endotoxin-Induced Depression-like Behavior in Mice by Decreasing Inflammatory Cytokines and Increasing Brain-Derived Neurotrophic Factor Levels. Antioxidants 2022;11:947. [DOI: 10.3390/antiox11050947] [Reference Citation Analysis]
84 Fourrier C, Sampson E, Mills NT, Baune BT. Anti-inflammatory treatment of depression: study protocol for a randomised controlled trial of vortioxetine augmented with celecoxib or placebo. Trials 2018;19:447. [PMID: 30126458 DOI: 10.1186/s13063-018-2829-7] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
85 Tripathy S, Singh N, Singh A, Kar SK. COVID-19 and Psychotic Symptoms: the View from Psychiatric Immunology. Curr Behav Neurosci Rep 2021;:1-7. [PMID: 34631364 DOI: 10.1007/s40473-021-00235-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
86 Hollander JA, Cory-Slechta DA, Jacka FN, Szabo ST, Guilarte TR, Bilbo SD, Mattingly CJ, Moy SS, Haroon E, Hornig M, Levin ED, Pletnikov MV, Zehr JL, McAllister KA, Dzierlenga AL, Garton AE, Lawler CP, Ladd-Acosta C. Beyond the looking glass: recent advances in understanding the impact of environmental exposures on neuropsychiatric disease. Neuropsychopharmacology 2020;45:1086-96. [PMID: 32109936 DOI: 10.1038/s41386-020-0648-5] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 13.5] [Reference Citation Analysis]
87 Klaus F, Mitchell K, Liou SC, Eyler LT, Nguyen TT. Chemokine MCP1 is associated with cognitive flexibility in schizophrenia: A preliminary analysis. J Psychiatr Res 2021;138:139-45. [PMID: 33852994 DOI: 10.1016/j.jpsychires.2021.04.007] [Reference Citation Analysis]
88 Giridharan VV, Sayana P, Pinjari OF, Ahmad N, da Rosa MI, Quevedo J, Barichello T. Postmortem evidence of brain inflammatory markers in bipolar disorder: a systematic review. Mol Psychiatry 2020;25:94-113. [DOI: 10.1038/s41380-019-0448-7] [Cited by in Crossref: 54] [Cited by in F6Publishing: 42] [Article Influence: 18.0] [Reference Citation Analysis]
89 Han KM, Choi KW, Kim A, Kang W, Kang Y, Tae WS, Han MR, Ham BJ. Association of DNA Methylation of the NLRP3 Gene with Changes in Cortical Thickness in Major Depressive Disorder. Int J Mol Sci 2022;23:5768. [PMID: 35628578 DOI: 10.3390/ijms23105768] [Reference Citation Analysis]
90 Martinuzzi E, Barbosa S, Courtet P, Olié E, Guillaume S, Ibrahim EC, Daoudlarian D, Davidovic L, Glaichenhaus N, Belzeaux R. Blood cytokines differentiate bipolar disorder and major depressive disorder during a major depressive episode: Initial discovery and independent sample replication. Brain Behav Immun Health 2021;13:100232. [PMID: 34589747 DOI: 10.1016/j.bbih.2021.100232] [Reference Citation Analysis]
91 Izuo N, Nitta A. New Insights Regarding Diagnosis and Medication for Schizophrenia Based on Neuronal Synapse-Microglia Interaction. J Pers Med 2021;11:371. [PMID: 34063598 DOI: 10.3390/jpm11050371] [Reference Citation Analysis]
92 Mehta ND, Stevens JS, Li Z, Gillespie CF, Fani N, Michopoulos V, Felger JC. Inflammation, reward circuitry and symptoms of anhedonia and PTSD in trauma-exposed women. Soc Cogn Affect Neurosci 2020;15:1046-55. [PMID: 32291455 DOI: 10.1093/scan/nsz100] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 12.0] [Reference Citation Analysis]
93 Felger JC, Treadway MT. Inflammation Effects on Motivation and Motor Activity: Role of Dopamine. Neuropsychopharmacology 2017;42:216-41. [PMID: 27480574 DOI: 10.1038/npp.2016.143] [Cited by in Crossref: 184] [Cited by in F6Publishing: 162] [Article Influence: 30.7] [Reference Citation Analysis]
94 Tosato S, Bonetto C, Tomassi S, Zanardini R, Faravelli C, Bruschi C, D’agostino A, Minelli A, Scocco P, Lasalvia A, Furlato K, Imbesi M, Preti A, Ruggeri M, Gennarelli M, Bocchio-chiavetto L. Childhood trauma and glucose metabolism in patients with first-episode psychosis. Psychoneuroendocrinology 2020;113:104536. [DOI: 10.1016/j.psyneuen.2019.104536] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
95 Tsai SY, Sajatovic M, Hsu JL, Chung KH, Chen PH, Huang YJ. Peripheral inflammatory markers associated with brain volume reduction in patients with bipolar I disorder. Acta Neuropsychiatr 2021;:1-10. [PMID: 34924065 DOI: 10.1017/neu.2021.39] [Reference Citation Analysis]
96 Romeo B, Brunet-Lecomte M, Martelli C, Benyamina A. Kinetics of Cytokine Levels during Antipsychotic Treatment in Schizophrenia: A Meta-Analysis. Int J Neuropsychopharmacol 2018;21:828-36. [PMID: 30016466 DOI: 10.1093/ijnp/pyy062] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 8.0] [Reference Citation Analysis]
97 Zou Z, Zhou B, Huang Y, Wang J, Min W, Li T. Differences in cytokines between patients with generalised anxiety disorder and panic disorder. J Psychosom Res 2020;133:109975. [PMID: 32220649 DOI: 10.1016/j.jpsychores.2020.109975] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
98 Hegvik TA, Instanes JT, Haavik J, Klungsøyr K, Engeland A. Associations between attention-deficit/hyperactivity disorder and autoimmune diseases are modified by sex: a population-based cross-sectional study. Eur Child Adolesc Psychiatry 2018;27:663-75. [PMID: 28983730 DOI: 10.1007/s00787-017-1056-1] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 5.8] [Reference Citation Analysis]
99 Reus GZ, de Moura AB, Silva RH, Resende WR, Quevedo J. Resilience Dysregulation in Major Depressive Disorder: Focus on Glutamatergic Imbalance and Microglial Activation. Curr Neuropharmacol 2018;16:297-307. [PMID: 28676011 DOI: 10.2174/1570159X15666170630164715] [Cited by in Crossref: 20] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
100 Pong S, Karmacharya R, Sofman M, Bishop JR, Lizano P. The Role of Brain Microvascular Endothelial Cell and Blood-Brain Barrier Dysfunction in Schizophrenia. Complex Psychiatry 2020;6:30-46. [PMID: 34883503 DOI: 10.1159/000511552] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
101 Bavato F, Cathomas F, Klaus F, Gütter K, Barro C, Maceski A, Seifritz E, Kuhle J, Kaiser S, Quednow BB. Altered neuroaxonal integrity in schizophrenia and major depressive disorder assessed with neurofilament light chain in serum. J Psychiatr Res 2021;140:141-8. [PMID: 34116440 DOI: 10.1016/j.jpsychires.2021.05.072] [Reference Citation Analysis]
102 Prestwood TR, Asgariroozbehani R, Wu S, Agarwal SM, Logan RW, Ballon JS, Hahn MK, Freyberg Z. Roles of inflammation in intrinsic pathophysiology and antipsychotic drug-induced metabolic disturbances of schizophrenia. Behav Brain Res 2021;402:113101. [PMID: 33453341 DOI: 10.1016/j.bbr.2020.113101] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
103 Aspesi D, Pinna G. Could a blood test for PTSD and depression be on the horizon? Expert Rev Proteomics 2018;15:983-1006. [PMID: 30394136 DOI: 10.1080/14789450.2018.1544894] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
104 Zhou X, Liao S, Qi L, Wang R. Physical activity and its association with cognitive function in middle- and older-aged Chinese: Evidence from China Health and Retirement Longitudinal Study, 2015. Eur J Sport Sci 2021;:1-11. [PMID: 33641627 DOI: 10.1080/17461391.2021.1897164] [Reference Citation Analysis]
105 Ghosh S, Dyer RA, Beasley CL. Evidence for altered cell membrane lipid composition in postmortem prefrontal white matter in bipolar disorder and schizophrenia. J Psychiatr Res 2017;95:135-42. [PMID: 28843843 DOI: 10.1016/j.jpsychires.2017.08.009] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
106 Jiang C, Dobrowolny H, Gescher DM, Meyer-Lotz G, Steiner J, Hoeschen C, Frodl T. Volatile organic compounds from exhaled breath in schizophrenia. World J Biol Psychiatry 2022;:1-25. [PMID: 35171077 DOI: 10.1080/15622975.2022.2040052] [Reference Citation Analysis]
107 Lauden A, Geishin A, Merzon E, Korobeinikov A, Green I, Golan-Cohen A, Vinker S, Manor I, Weizman A, Magen E. Higher rates of allergies, autoimmune diseases and low-grade inflammation markers in treatment-resistant major depression. Brain Behav Immun Health 2021;16:100313. [PMID: 34589804 DOI: 10.1016/j.bbih.2021.100313] [Reference Citation Analysis]
108 Meyer JH, Cervenka S, Kim MJ, Kreisl WC, Henter ID, Innis RB. Neuroinflammation in psychiatric disorders: PET imaging and promising new targets. Lancet Psychiatry 2020;7:1064-74. [PMID: 33098761 DOI: 10.1016/S2215-0366(20)30255-8] [Cited by in Crossref: 26] [Cited by in F6Publishing: 14] [Article Influence: 13.0] [Reference Citation Analysis]
109 Petralia MC, Ciurleo R, Bramanti A, Bramanti P, Saraceno A, Mangano K, Quattropani MC, Nicoletti F, Fagone P. Transcriptomic Data Analysis Reveals a Down-Expression of Galectin-8 in Schizophrenia Hippocampus. Brain Sci 2021;11:973. [PMID: 34439592 DOI: 10.3390/brainsci11080973] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
110 Klein-petersen AW, Köhler-forsberg O, Benros ME. Infections, antibiotic treatment and the Microbiome in relation to schizophrenia. Schizophrenia Research 2021;234:71-7. [DOI: 10.1016/j.schres.2019.11.033] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
111 Morrens M, Coppens V, Walther S. Do Immune Dysregulations and Oxidative Damage Drive Mood and Psychotic Disorders? Neuropsychobiology 2020;79:251-4. [PMID: 30991415 DOI: 10.1159/000496622] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
112 Michalczyk A, Tyburski E, Podwalski P, Waszczuk K, Rudkowski K, Kucharska-mazur J, Mak M, Rek-owodziń K, Plichta P, Bielecki M, Andrusewicz W, Cecerska-heryć E, Samochowiec A, Misiak B, Sagan L, Samochowiec J. Serum inflammatory markers and their associations with white matter integrity of the corpus callosum in schizophrenia patients and healthy controls. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2022. [DOI: 10.1016/j.pnpbp.2022.110510] [Reference Citation Analysis]
113 Valiati FE, Hizo GH, Pinto JV, Kauer-sant`anna M. The Possible Role of Telomere Length and Chemokines in the Aging Process: A Transdiagnostic Review in Psychiatry. CPRR 2019;15:171-92. [DOI: 10.2174/1573400515666190719155906] [Reference Citation Analysis]
114 Arabska J, Strzelecki D, Kozłowska E, Brzezińska-Błaszczyk E, Wysokiński A. The association between serum levels of TNF-α and IL-6 in schizophrenic patients and their metabolic status - A case control study. J Neuroimmunol 2020;347:577344. [PMID: 32777628 DOI: 10.1016/j.jneuroim.2020.577344] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
115 Morris G, Walder K, Berk M, Carvalho AF, Marx W, Bortolasci CC, Yung AR, Puri BK, Maes M. Intertwined associations between oxidative and nitrosative stress and endocannabinoid system pathways: Relevance for neuropsychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry 2022;114:110481. [PMID: 34826557 DOI: 10.1016/j.pnpbp.2021.110481] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
116 Chen P, Chen F, Chen G, Zhong S, Gong J, Zhong H, Ye T, Tang G, Wang J, Luo Z, Qi Z, Jia Y, Yang H, Yin Z, Huang L, Wang Y. Inflammation is associated with decreased functional connectivity of insula in unmedicated bipolar disorder. Brain Behav Immun 2020;89:615-22. [PMID: 32688026 DOI: 10.1016/j.bbi.2020.07.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
117 Savoy C, Van Lieshout RJ, Steiner M. Is plasminogen activator inhibitor-1 a physiological bottleneck bridging major depressive disorder and cardiovascular disease? Acta Physiol (Oxf) 2017;219:715-27. [PMID: 27246986 DOI: 10.1111/apha.12726] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 3.4] [Reference Citation Analysis]
118 Radu G, Luca C, Petrescu L, Bordejevic DA, Tomescu MC, Andor M, Cîtu I, Mavrea A, Buda V, Tomescu C, Borcan F, Dehelean L. The Predictive Value of Endothelial Inflammatory Markers in the Onset of Schizophrenia. Neuropsychiatr Dis Treat 2020;16:545-55. [PMID: 32158214 DOI: 10.2147/NDT.S240349] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
119 Tamura JK, Mcintyre RS. Current and Future Vistas in Bipolar Disorder. Curr Behav Neurosci Rep 2020;7:68-75. [DOI: 10.1007/s40473-020-00202-9] [Reference Citation Analysis]
120 Zhou X, Tian B, Han HB. Serum interleukin-6 in schizophrenia: A system review and meta-analysis. Cytokine 2021;141:155441. [PMID: 33529887 DOI: 10.1016/j.cyto.2021.155441] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
121 He X, Ma Q, Fan Y, Zhao B, Wang W, Zhu F, Ma X, Zhou L. The Role of Cytokines in Predicting the Efficacy of Acute Stage Treatment in Patients with Schizophrenia. Neuropsychiatr Dis Treat 2020;16:191-9. [PMID: 32021213 DOI: 10.2147/NDT.S218483] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
122 Nägele FL, Pasternak O, Bitzan LV, Mußmann M, Rauh J, Kubicki M, Leicht G, Shenton ME, Lyall AE, Mulert C. Cellular and extracellular white matter alterations indicate conversion to psychosis among individuals at clinical high-risk for psychosis. World J Biol Psychiatry 2021;22:214-27. [PMID: 32643526 DOI: 10.1080/15622975.2020.1775890] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
123 Karagüzel EÖ, Arslan FC, Uysal EK, Demir S, Aykut DS, Tat M, Karahan SC. Blood levels of interleukin-1 beta, interleukin-6 and tumor necrosis factor-alpha and cognitive functions in patients with obsessive compulsive disorder. Compr Psychiatry 2019;89:61-6. [PMID: 30594753 DOI: 10.1016/j.comppsych.2018.11.013] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
124 Ortelli P, Ferrazzoli D, Sebastianelli L, Engl M, Romanello R, Nardone R, Bonini I, Koch G, Saltuari L, Quartarone A, Oliviero A, Kofler M, Versace V. Neuropsychological and neurophysiological correlates of fatigue in post-acute patients with neurological manifestations of COVID-19: Insights into a challenging symptom. J Neurol Sci 2021;420:117271. [PMID: 33359928 DOI: 10.1016/j.jns.2020.117271] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 8.0] [Reference Citation Analysis]
125 Wei L, Syed Mortadza SA, Yan J, Zhang L, Wang L, Yin Y, Li C, Chalon S, Emond P, Belzung C, Li D, Lu C, Roger S, Jiang LH. ATP-activated P2X7 receptor in the pathophysiology of mood disorders and as an emerging target for the development of novel antidepressant therapeutics. Neurosci Biobehav Rev 2018;87:192-205. [PMID: 29453990 DOI: 10.1016/j.neubiorev.2018.02.005] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 4.5] [Reference Citation Analysis]
126 Misiak B, Beszłej JA, Kotowicz K, Szewczuk-Bogusławska M, Samochowiec J, Kucharska-Mazur J, Frydecka D. Cytokine alterations and cognitive impairment in major depressive disorder: From putative mechanisms to novel treatment targets. Prog Neuropsychopharmacol Biol Psychiatry 2018;80:177-88. [PMID: 28433456 DOI: 10.1016/j.pnpbp.2017.04.021] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 6.8] [Reference Citation Analysis]
127 Goldsmith DR, Bekhbat M, Le NA, Chen X, Woolwine BJ, Li Z, Haroon E, Felger JC. Protein and gene markers of metabolic dysfunction and inflammation together associate with functional connectivity in reward and motor circuits in depression. Brain Behav Immun 2020;88:193-202. [PMID: 32387344 DOI: 10.1016/j.bbi.2020.05.013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
128 Ashton MM, Dean OM, Walker AJ, Bortolasci CC, Ng CH, Hopwood M, Harvey BH, Möller M, McGrath JJ, Marx W, Turner A, Dodd S, Scott JG, Khoo JP, Walder K, Sarris J, Berk M. The Therapeutic Potential of Mangosteen Pericarp as an Adjunctive Therapy for Bipolar Disorder and Schizophrenia. Front Psychiatry 2019;10:115. [PMID: 30918489 DOI: 10.3389/fpsyt.2019.00115] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
129 Obermanns J, Krawczyk E, Juckel G, Emons B. Analysis of cytokine levels, T regulatory cells and serotonin content in patients with depression. Eur J Neurosci 2021;53:3476-89. [PMID: 33768559 DOI: 10.1111/ejn.15205] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
130 Kalinowski A, Liliental J, Anker LA, Linkovski O, Culbertson C, Hall JN, Pattni R, Sabatti C, Noordsy D, Hallmayer JF, Mellins ED, Ballon JS, O'Hara R, Levinson DF, Urban AE. Increased activation product of complement 4 protein in plasma of individuals with schizophrenia. Transl Psychiatry 2021;11:486. [PMID: 34552056 DOI: 10.1038/s41398-021-01583-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
131 Tsai SY, Kuo CJ, Sajatovic M, Huang YJ, Chen PH, Chung KH. Lithium exposure and chronic inflammation with activated macrophages and monocytes associated with atherosclerosis in bipolar disorder. J Affect Disord 2022;314:233-40. [PMID: 35878826 DOI: 10.1016/j.jad.2022.07.024] [Reference Citation Analysis]
132 Lestra V, Romeo B, Martelli C, Benyamina A, Hamdani N. Could CRP be a differential biomarker of illness stages in schizophrenia? A systematic review and meta-analysis. Schizophr Res 2022;246:175-86. [PMID: 35785580 DOI: 10.1016/j.schres.2022.06.026] [Reference Citation Analysis]
133 Lesh TA, Careaga M, Rose DR, McAllister AK, Van de Water J, Carter CS, Ashwood P. Cytokine alterations in first-episode schizophrenia and bipolar disorder: relationships to brain structure and symptoms. J Neuroinflammation 2018;15:165. [PMID: 29803226 DOI: 10.1186/s12974-018-1197-2] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 9.0] [Reference Citation Analysis]
134 Sun HL, Bai W, Li XH, Huang H, Cui XL, Cheung T, Su ZH, Yuan Z, Ng CH, Xiang YT. Schizophrenia and Inflammation Research: A Bibliometric Analysis. Front Immunol 2022;13:907851. [PMID: 35757702 DOI: 10.3389/fimmu.2022.907851] [Reference Citation Analysis]
135 Holzer P, Farzi A, Hassan AM, Zenz G, Jačan A, Reichmann F. Visceral Inflammation and Immune Activation Stress the Brain. Front Immunol 2017;8:1613. [PMID: 29213271 DOI: 10.3389/fimmu.2017.01613] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 6.0] [Reference Citation Analysis]
136 Al-hakeim HK, Twayej AJ, Al- Dujaili AH. Reduction in serum IL-1β, IL-6, and IL-18 levels and Beck Depression Inventory-II score by combined sertraline and ketoprofen administration in major depressive disorder: A clinical trial. Neurology, Psychiatry and Brain Research 2018;30:148-53. [DOI: 10.1016/j.npbr.2018.10.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
137 Papava I, Dehelean L, Romosan RS, Bondrescu M, Dimeny CZ, Domuta EM, Bratosin F, Bogdan I, Grigoras ML, Tigmeanu CV, Gherman A, Marincu I. The Impact of Hyper-Acute Inflammatory Response on Stress Adaptation and Psychological Symptoms of COVID-19 Patients. Int J Environ Res Public Health 2022;19:6501. [PMID: 35682084 DOI: 10.3390/ijerph19116501] [Reference Citation Analysis]
138 Deussing JM, Arzt E. P2X7 Receptor: A Potential Therapeutic Target for Depression? Trends Mol Med 2018;24:736-47. [PMID: 30093269 DOI: 10.1016/j.molmed.2018.07.005] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 6.3] [Reference Citation Analysis]
139 Li W, Ali T, He K, Liu Z, Shah FA, Ren Q, Liu Y, Jiang A, Li S. Ibrutinib alleviates LPS-induced neuroinflammation and synaptic defects in a mouse model of depression. Brain Behav Immun 2021;92:10-24. [PMID: 33181270 DOI: 10.1016/j.bbi.2020.11.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 3.5] [Reference Citation Analysis]
140 Tsai SY, Sajatovic M, Hsu JL, Chung KH, Chen PH, Huang YJ. Body mass index, residual psychotic symptoms, and inflammation associated with brain volume reduction in older patients with schizophrenia. Int J Geriatr Psychiatry 2020;35:728-36. [PMID: 32128879 DOI: 10.1002/gps.5291] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
141 Tonhajzerova I, Sekaninova N, Bona Olexova L, Visnovcova Z. Novel Insight into Neuroimmune Regulatory Mechanisms and Biomarkers Linking Major Depression and Vascular Diseases: The Dilemma Continues. Int J Mol Sci 2020;21:E2317. [PMID: 32230840 DOI: 10.3390/ijms21072317] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
142 Ansarey SH. Inflammation and JNK's Role in Niacin-GPR109A Diminished Flushed Effect in Microglial and Neuronal Cells With Relevance to Schizophrenia. Front Psychiatry 2021;12:771144. [DOI: 10.3389/fpsyt.2021.771144] [Reference Citation Analysis]
143 Kalmady SV, Shivakumar V, Jose D, Ravi V, Keshavan MS, Gangadhar BN, Venkatasubramanian G. Plasma cytokines in minimally treated schizophrenia. Schizophrenia Research 2018;199:292-6. [DOI: 10.1016/j.schres.2018.04.022] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
144 Langbein K, Schmidt U, Schack S, Biesel NJ, Rudzok M, Amminger GP, Berger M, Sauer H, Smesny S. State marker properties of niacin skin sensitivity in ultra-high risk groups for psychosis - An optical reflection spectroscopy study. Schizophr Res 2018;192:377-84. [PMID: 28602647 DOI: 10.1016/j.schres.2017.06.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
145 Kappelmann N, Lewis G, Dantzer R, Jones PB, Khandaker GM. Antidepressant activity of anti-cytokine treatment: a systematic review and meta-analysis of clinical trials of chronic inflammatory conditions. Mol Psychiatry 2018;23:335-43. [PMID: 27752078 DOI: 10.1038/mp.2016.167] [Cited by in Crossref: 291] [Cited by in F6Publishing: 258] [Article Influence: 48.5] [Reference Citation Analysis]
146 Park S, Miller BJ. Meta-analysis of cytokine and C-reactive protein levels in high-risk psychosis. Schizophrenia Research 2020;226:5-12. [DOI: 10.1016/j.schres.2019.03.012] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
147 Jeppesen R, Christensen RHB, Pedersen EMJ, Nordentoft M, Hjorthøj C, Köhler-Forsberg O, Benros ME. Efficacy and safety of anti-inflammatory agents in treatment of psychotic disorders - A comprehensive systematic review and meta-analysis. Brain Behav Immun 2020;90:364-80. [PMID: 32890697 DOI: 10.1016/j.bbi.2020.08.028] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
148 Yue Q, Yang J, Shu Q, Bai M, Shu K. Convolutional Neural Network Visualization for Identification of Risk Genes in Bipolar Disorder. Curr Mol Med 2020;20:429-41. [PMID: 31782363 DOI: 10.2174/1566524019666191129111753] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
149 Kos MZ, Duan J, Sanders AR, Blondell L, Drigalenko EI, Carless MA, Gejman PV, Göring HHH; MGS. Dopamine perturbation of gene co-expression networks reveals differential response in schizophrenia for translational machinery. Transl Psychiatry 2018;8:278. [PMID: 30546022 DOI: 10.1038/s41398-018-0325-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
150 Ushkalova EA, Zyryanov SK, Zatolochina KE. [Muramyldipeptide - based compounds in current medicine: focus on glucosaminylmuramyl dipeptide]. Ter Arkh 2019;91:122-7. [PMID: 32598599 DOI: 10.26442/00403660.2019.12.000471] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
151 Teixeira AL, Colpo GD, Fries GR, Bauer IE, Selvaraj S. Biomarkers for bipolar disorder: current status and challenges ahead. Expert Rev Neurother 2019;19:67-81. [PMID: 30451546 DOI: 10.1080/14737175.2019.1550361] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 5.5] [Reference Citation Analysis]
152 Guo X, Rao Y, Mao R, Cui L, Fang Y. Common cellular and molecular mechanisms and interactions between microglial activation and aberrant neuroplasticity in depression. Neuropharmacology 2020;181:108336. [DOI: 10.1016/j.neuropharm.2020.108336] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
153 Metcalf SA, Jones PB, Nordstrom T, Timonen M, Mäki P, Miettunen J, Jääskeläinen E, Järvelin MR, Stochl J, Murray GK, Veijola J, Khandaker GM. Serum C-reactive protein in adolescence and risk of schizophrenia in adulthood: A prospective birth cohort study. Brain Behav Immun 2017;59:253-9. [PMID: 27622678 DOI: 10.1016/j.bbi.2016.09.008] [Cited by in Crossref: 64] [Cited by in F6Publishing: 62] [Article Influence: 10.7] [Reference Citation Analysis]
154 Zhou FC, Lee JWY, Zhang QH, Sun ZL, Bo Q, He XX, Han T, Xiong M, Li C, Wang CY. Higher Serum C-Reactive Protein Levels in Catatonic Patients: A Comparison to Non-catatonic Patients and Healthy Controls. Schizophr Bull 2020:sbaa041. [PMID: 32219399 DOI: 10.1093/schbul/sbaa041] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
155 Auvinen P, Mäntyselkä P, Koponen H, Kautiainen H, Korniloff K, Ahonen T, Vanhala M. Elevation of tumor necrosis factor alpha levels is associated with restless legs symptoms in clinically depressed patients. Journal of Psychosomatic Research 2018;115:1-5. [DOI: 10.1016/j.jpsychores.2018.09.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
156 Dias ICS, de Campos-Carli SM, Vieira ELM, Mota APL, Azevedo PS, Anício VTDS, Guimarães FC, Mantovani LM, Cruz BF, Teixeira AL, Salgado JV. Adiponectin and Stnfr2 peripheral levels are associated with cardiovascular risk in patients with schizophrenia. J Psychiatr Res 2021:S0022-3956(21)00669-5. [PMID: 34785039 DOI: 10.1016/j.jpsychires.2021.11.020] [Reference Citation Analysis]
157 Poletti S, Mazza MG, Vai B, Lorenzi C, Colombo C, Benedetti F. Proinflammatory Cytokines Predict Brain Metabolite Concentrations in the Anterior Cingulate Cortex of Patients With Bipolar Disorder. Front Psychiatry 2020;11:590095. [PMID: 33363485 DOI: 10.3389/fpsyt.2020.590095] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
158 Al-Diwani AAJ, Pollak TA, Irani SR, Lennox BR. Psychosis: an autoimmune disease? Immunology 2017;152:388-401. [PMID: 28704576 DOI: 10.1111/imm.12795] [Cited by in Crossref: 49] [Cited by in F6Publishing: 37] [Article Influence: 9.8] [Reference Citation Analysis]
159 Hei G, Smith RC, Li R, Ou J, Song X, Zheng Y, He Y, Arriaza J, Fahey JW, Cornblatt B, Kang D, Yang Y, Huang J, Wang X, Cadenhead K, Zhang M, Davis JM, Zhao J, Jin H, Wu R. Sulforaphane Effects on Cognition and Symptoms in First and Early Episode Schizophrenia: A Randomized Double-Blind Trial. Schizophrenia Bulletin Open 2022;3:sgac024. [DOI: 10.1093/schizbullopen/sgac024] [Reference Citation Analysis]
160 Zheng W, Zhang QE, Cai DB, Yang XH, Qiu Y, Ungvari GS, Ng CH, Berk M, Ning YP, Xiang YT. N-acetylcysteine for major mental disorders: a systematic review and meta-analysis of randomized controlled trials. Acta Psychiatr Scand 2018;137:391-400. [PMID: 29457216 DOI: 10.1111/acps.12862] [Cited by in Crossref: 52] [Cited by in F6Publishing: 45] [Article Influence: 13.0] [Reference Citation Analysis]
161 Nascimento C, Nunes VP, Diehl Rodriguez R, Takada L, Suemoto CK, Grinberg LT, Nitrini R, Lafer B. A review on shared clinical and molecular mechanisms between bipolar disorder and frontotemporal dementia. Prog Neuropsychopharmacol Biol Psychiatry 2019;93:269-83. [PMID: 31014945 DOI: 10.1016/j.pnpbp.2019.04.008] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
162 Dash S, Syed YA, Khan MR. Understanding the Role of the Gut Microbiome in Brain Development and Its Association With Neurodevelopmental Psychiatric Disorders. Front Cell Dev Biol 2022;10:880544. [DOI: 10.3389/fcell.2022.880544] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
163 Kranaster L, Hoyer C, Aksay SS, Bumb JM, Müller N, Zill P, Schwarz MJ, Sartorius A. Antidepressant efficacy of electroconvulsive therapy is associated with a reduction of the innate cellular immune activity in the cerebrospinal fluid in patients with depression. World J Biol Psychiatry 2018;19:379-89. [PMID: 28714751 DOI: 10.1080/15622975.2017.1355473] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 4.6] [Reference Citation Analysis]
164 Zhang L, Zheng H, Wu R, Zhu F, Kosten TR, Zhang X, Zhao J. Minocycline adjunctive treatment to risperidone for negative symptoms in schizophrenia: Association with pro-inflammatory cytokine levels. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2018;85:69-76. [DOI: 10.1016/j.pnpbp.2018.04.004] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 6.0] [Reference Citation Analysis]
165 Morris G, Puri BK, Bortolasci CC, Carvalho A, Berk M, Walder K, Moreira EG, Maes M. The role of high-density lipoprotein cholesterol, apolipoprotein A and paraoxonase-1 in the pathophysiology of neuroprogressive disorders. Neurosci Biobehav Rev 2021;125:244-63. [PMID: 33657433 DOI: 10.1016/j.neubiorev.2021.02.037] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
166 Al-Hakeim HK, Almulla AF, Maes M. The Neuroimmune and Neurotoxic Fingerprint of Major Neurocognitive Psychosis or Deficit Schizophrenia: a Supervised Machine Learning Study. Neurotox Res 2020;37:753-71. [PMID: 31916129 DOI: 10.1007/s12640-019-00112-z] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
167 Rengasamy M, Zhong Y, Marsland A, Chen K, Douaihy A, Brent D, Melhem NM. Signaling networks in inflammatory pathways and risk for suicidal behavior. Brain Behav Immun Health 2020;7:100122. [PMID: 33791683 DOI: 10.1016/j.bbih.2020.100122] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
168 Maes M, Carvalho AF. The Compensatory Immune-Regulatory Reflex System (CIRS) in Depression and Bipolar Disorder. Mol Neurobiol 2018;55:8885-903. [DOI: 10.1007/s12035-018-1016-x] [Cited by in Crossref: 79] [Cited by in F6Publishing: 74] [Article Influence: 19.8] [Reference Citation Analysis]
169 Liu RT, Rowan-Nash AD, Sheehan AE, Walsh RFL, Sanzari CM, Korry BJ, Belenky P. Reductions in anti-inflammatory gut bacteria are associated with depression in a sample of young adults. Brain Behav Immun 2020;88:308-24. [PMID: 32229219 DOI: 10.1016/j.bbi.2020.03.026] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 9.0] [Reference Citation Analysis]
170 Miller BJ, Goldsmith DR. Inflammatory biomarkers in schizophrenia: Implications for heterogeneity and neurobiology. Biomarkers in Neuropsychiatry 2019;1:100006. [DOI: 10.1016/j.bionps.2019.100006] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
171 Morris G, Puri BK, Maes M, Olive L, Berk M, Carvalho AF. The role of microglia in neuroprogressive disorders: mechanisms and possible neurotherapeutic effects of induced ketosis. Prog Neuropsychopharmacol Biol Psychiatry 2020;99:109858. [PMID: 31923453 DOI: 10.1016/j.pnpbp.2020.109858] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
172 Duan F, Zhao S, Xia C, Ren Z, Yuan N, Xie L, Wang L, Xiong Y, Yu P, Chen Y, Tian J, Dai J, Lu J, Xia Y, Liu X, Chen C, Liu C. Changes of immune-related factors in the blood of schizophrenia and bipolar disorder patients receiving monotherapy. Transl Psychiatry 2022;12:212. [PMID: 35618730 DOI: 10.1038/s41398-022-01968-0] [Reference Citation Analysis]
173 Sahbaz C, Zibandey N, Kurtulmus A, Duran Y, Gokalp M, Kırpınar I, Sahin F, Guloksuz S, Akkoc T. Reduced regulatory T cells with increased proinflammatory response in patients with schizophrenia. Psychopharmacology (Berl) 2020;237:1861-71. [PMID: 32221694 DOI: 10.1007/s00213-020-05504-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
174 Sanchez-Autet M, Arranz B, Sierra P, Safont G, Garcia-Blanco A, de la Fuente L, Garriga M, Marín L, García-Portilla MP. Association between Neutrophil-Lymphocyte ratio, Platelet-Lymphocyte ratio, and C-Reactive Protein levels and metabolic status in patients with a bipolar disorder. World J Biol Psychiatry 2021;:1-27. [PMID: 34856870 DOI: 10.1080/15622975.2021.2013089] [Reference Citation Analysis]
175 Pillinger T, Osimo EF, Brugger S, Mondelli V, McCutcheon RA, Howes OD. A Meta-analysis of Immune Parameters, Variability, and Assessment of Modal Distribution in Psychosis and Test of the Immune Subgroup Hypothesis. Schizophr Bull 2019;45:1120-33. [PMID: 30407606 DOI: 10.1093/schbul/sby160] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 22.0] [Reference Citation Analysis]
176 Drepper C, Geißler J, Pastura G, Yilmaz R, Berg D, Romanos M, Gerlach M. Transcranial sonography in psychiatry as a potential tool in diagnosis and research. World J Biol Psychiatry 2018;19:484-96. [PMID: 28971725 DOI: 10.1080/15622975.2017.1386325] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
177 Vojvodic J, Mihajlovic G, Andonov A, Markovic M, Djordjevic J, Vojvodic P. Immunological Aspects of Depressive Disorder – The Review. Serbian Journal of Experimental and Clinical Research 2019;0:000010247820180076. [DOI: 10.2478/sjecr-2018-0076] [Reference Citation Analysis]
178 Su WJ, Zhang T, Jiang CL, Wang W. Clemastine Alleviates Depressive-Like Behavior Through Reversing the Imbalance of Microglia-Related Pro-inflammatory State in Mouse Hippocampus. Front Cell Neurosci 2018;12:412. [PMID: 30483062 DOI: 10.3389/fncel.2018.00412] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 5.5] [Reference Citation Analysis]
179 Fiorentino M, Sapone A, Senger S, Camhi SS, Kadzielski SM, Buie TM, Kelly DL, Cascella N, Fasano A. Blood-brain barrier and intestinal epithelial barrier alterations in autism spectrum disorders. Mol Autism 2016;7:49. [PMID: 27957319 DOI: 10.1186/s13229-016-0110-z] [Cited by in Crossref: 153] [Cited by in F6Publishing: 142] [Article Influence: 25.5] [Reference Citation Analysis]
180 Turner A, Baker A, Dean OM, Walker AJ, Dodd S, Cotton SM, Scott JG, Kavanagh BE, Ashton MM, Brown E, McGrath JJ, Berk M. Adjunctive Garcinia mangostana Linn. (Mangosteen) Pericarp for Schizophrenia: A 24-Week Double-blind, Randomized, Placebo Controlled Efficacy Trial: Péricarpe d'appoint Garcinia mangostana Linn (mangoustan) pour la schizophrénie : un essai d'efficacité de 24 semaines, à double insu, randomisé et contrôlé par placebo. Can J Psychiatry 2021;66:354-66. [PMID: 33355478 DOI: 10.1177/0706743720982437] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
181 Patas K, Willing A, Demiralay C, Engler JB, Lupu A, Ramien C, Schäfer T, Gach C, Stumm L, Chan K, Vignali M, Arck PC, Friese MA, Pless O, Wiedemann K, Agorastos A, Gold SM. T Cell Phenotype and T Cell Receptor Repertoire in Patients with Major Depressive Disorder. Front Immunol 2018;9:291. [PMID: 29515587 DOI: 10.3389/fimmu.2018.00291] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
182 Prakash J, Chatterjee K, Srivastava K, Chauhan VS. First-episode psychosis: How long does it last? A review of evolution and trajectory. Ind Psychiatry J 2021;30:198-206. [PMID: 35017801 DOI: 10.4103/ipj.ipj_38_21] [Reference Citation Analysis]
183 Sun Y, Wang D, Salvadore G, Hsu B, Curran M, Casper C, Vermeulen J, Kent JM, Singh J, Drevets WC, Wittenberg GM, Chen G. The effects of interleukin-6 neutralizing antibodies on symptoms of depressed mood and anhedonia in patients with rheumatoid arthritis and multicentric Castleman's disease. Brain Behav Immun 2017;66:156-64. [PMID: 28676350 DOI: 10.1016/j.bbi.2017.06.014] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 7.4] [Reference Citation Analysis]
184 Chaudhry IB, Husain MO, Khoso AB, Husain MI, Buch MH, Kiran T, Fu B, Bassett P, Qurashi I, Ur Rahman R, Baig S, Kazmi A, Corsi-Zuelli F, Haddad PM, Deakin B, Husain N. A randomised clinical trial of methotrexate points to possible efficacy and adaptive immune dysfunction in psychosis. Transl Psychiatry 2020;10:415. [PMID: 33257661 DOI: 10.1038/s41398-020-01095-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 6.5] [Reference Citation Analysis]
185 Ioannou M, Foiselle M, Mallet J, Stam EL, Godin O, Dubertret C, Terro E, Sommer IEC, Haarman BCM, Leboyer M, Schoevers RA. Towards precision medicine: What are the stratification hypotheses to identify homogeneous inflammatory subgroups. Eur Neuropsychopharmacol 2021;45:108-21. [PMID: 33189523 DOI: 10.1016/j.euroneuro.2020.11.001] [Reference Citation Analysis]
186 Klaus F, Guetter K, Schlegel R, Spiller TR, Seifritz E, Cathomas F, Kaiser S. Common and disorder-specific upregulation of the inflammatory markers TRAIL and CCL20 in depression and schizophrenia. Sci Rep 2021;11:19204. [PMID: 34584171 DOI: 10.1038/s41598-021-98769-0] [Reference Citation Analysis]
187 Marazziti D, Buccianelli B, Palermo S, Parra E, Arone A, Beatino MF, Massa L, Carpita B, Barberi FM, Mucci F. The Microbiota/Microbiome and the Gut-Brain Axis: How Much Do They Matter in Psychiatry? Life (Basel) 2021;11:760. [PMID: 34440503 DOI: 10.3390/life11080760] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
188 Aoki R, Kobayashi N, Suzuki G, Kuratsune H, Shimada K, Oka N, Takahashi M, Yamadera W, Iwashita M, Tokuno S, Nibuya M, Tanichi M, Mukai Y, Mitani K, Kondo K, Ito H, Nakayama K. Human herpesvirus 6 and 7 are biomarkers for fatigue, which distinguish between physiological fatigue and pathological fatigue. Biochem Biophys Res Commun 2016;478:424-30. [PMID: 27396623 DOI: 10.1016/j.bbrc.2016.07.010] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
189 Ionescu DF, Papakostas GI. Experimental medication treatment approaches for depression. Transl Psychiatry 2017;7:e1068. [PMID: 28323287 DOI: 10.1038/tp.2017.33] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 7.6] [Reference Citation Analysis]
190 Nakazawa K, Sapkota K. The origin of NMDA receptor hypofunction in schizophrenia. Pharmacol Ther 2020;205:107426. [PMID: 31629007 DOI: 10.1016/j.pharmthera.2019.107426] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 7.7] [Reference Citation Analysis]
191 Conen S, Gregory CJ, Hinz R, Smallman R, Corsi-zuelli F, Deakin B, Talbot PS. Neuroinflammation as measured by positron emission tomography in patients with recent onset and established schizophrenia: implications for immune pathogenesis. Mol Psychiatry. [DOI: 10.1038/s41380-020-0829-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
192 García-álvarez L, Caso J, García-portilla M, de la Fuente-tomás L, González-blanco L, Sáiz Martínez P, Leza J, Bobes J. Regulation of inflammatory pathways in schizophrenia: A comparative study with bipolar disorder and healthy controls. Eur psychiatr 2018;47:50-9. [DOI: 10.1016/j.eurpsy.2017.09.007] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 13.0] [Reference Citation Analysis]
193 Zheng W, Zhu X, Zhang Q, Cheng G, Cai D, He J, Ng CH, Ungvari GS, Peng X, Ning Y, Xiang Y. Adjunctive minocycline for major mental disorders: A systematic review. J Psychopharmacol 2019;33:1215-26. [DOI: 10.1177/0269881119858286] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 4.7] [Reference Citation Analysis]
194 Engh JA, Ueland T, Agartz I, Andreou D, Aukrust P, Boye B, Bøen E, Drange OK, Elvsåshagen T, Hope S, Høegh MC, Joa I, Johnsen E, Kroken RA, Lagerberg TV, Lekva T, Malt UF, Melle I, Morken G, Nærland T, Steen VM, Wedervang-Resell K, Weibell MA, Westlye LT, Djurovic S, Steen NE, Andreassen OA. Plasma Levels of the Cytokines B Cell-Activating Factor (BAFF) and A Proliferation-Inducing Ligand (APRIL) in Schizophrenia, Bipolar, and Major Depressive Disorder: A Cross Sectional, Multisite Study. Schizophr Bull 2021:sbab106. [PMID: 34499169 DOI: 10.1093/schbul/sbab106] [Reference Citation Analysis]
195 Ermakov EA, Melamud MM, Buneva VN, Ivanova SA. Immune System Abnormalities in Schizophrenia: An Integrative View and Translational Perspectives. Front Psychiatry 2022;13:880568. [PMID: 35546942 DOI: 10.3389/fpsyt.2022.880568] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
196 Corsi-Zuelli F, Marques L, da Roza DL, Loureiro CM, Shuhama R, Di Forti M, Menezes PR, Louzada-Junior P, Del-Ben CM. The independent and combined effects of cannabis use and systemic inflammation during the early stages of psychosis: exploring the two-hit hypothesis. Psychol Med 2021;:1-11. [PMID: 33736715 DOI: 10.1017/S0033291721000726] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
197 Miyamoto K, Funahashi Y, Yoshino Y, Kawabe K, Yamazaki K, Ozaki Y, Mori Y, Ochi S, Iga JI, Ueno SI. CTLA4 mRNA expression in blood is lower in schizophrenia, but not in affective disorders. Asian J Psychiatr 2020;52:102112. [PMID: 32371365 DOI: 10.1016/j.ajp.2020.102112] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
198 Wu D, Lv P, Li F, Zhang W, Fu G, Dai J, Hu N, Liu J, Xiao Y, Li S, Shah C, Tao B, Zhao Y, Gong Q, Lui S. Association of peripheral cytokine levels with cerebral structural abnormalities in schizophrenia. Brain Res 2019;1724:146463. [PMID: 31526800 DOI: 10.1016/j.brainres.2019.146463] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
199 Hagihara H, Horikawa T, Irino Y, Nakamura HK, Umemori J, Shoji H, Yoshida M, Kamitani Y, Miyakawa T. Peripheral blood metabolome predicts mood change-related activity in mouse model of bipolar disorder. Mol Brain 2019;12:107. [PMID: 31822292 DOI: 10.1186/s13041-019-0527-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
200 López-gonzález I, Pinacho R, Vila È, Escanilla A, Ferrer I, Ramos B. Neuroinflammation in the dorsolateral prefrontal cortex in elderly chronic schizophrenia. European Neuropsychopharmacology 2019;29:384-96. [DOI: 10.1016/j.euroneuro.2018.12.011] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
201 Auger N, Potter BJ, Healy-Profitós J, He S, Schnitzer ME, Paradis G. Mood disorders in pregnant women and future cardiovascular risk. J Affect Disord 2020;266:128-34. [PMID: 32056866 DOI: 10.1016/j.jad.2020.01.055] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
202 Xiu MH, Man LJ, Wang D, Du X, Yin G, Zhang Y, Tan YL, Chen N, Chen S, Teixeira AL, Cassidy RM, Soares JC, Zhang XY. Tumor necrosis factor-alpha -1031T/C polymorphism is associated with cognitive deficits in chronic schizophrenia patients versus healthy controls. Am J Med Genet B Neuropsychiatr Genet 2018;177:379-87. [PMID: 29633506 DOI: 10.1002/ajmg.b.32622] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
203 Malashenkova IK, Krynskiy SA, Ogurtsov DP, Mamoshina MV, Zakharova NV, Ushakov VL, Velichkovsky BM, Didkovsky NA. [A role of the immune system in the pathogenesis of schizophrenia]. Zh Nevrol Psikhiatr Im S S Korsakova 2018;118:72-80. [PMID: 30698566 DOI: 10.17116/jnevro201811812172] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
204 Atake K, Hori H, Kageyama Y, Koshikawa Y, Igata R, Tominaga H, Katsuki A, Bando H, Sakai S, Nishida K, Takekita Y, Kato T, Kinoshita T, Kato M. Pretreatment plasma cytokine levels as potential predictors of short-term remission of depression. World J Biol Psychiatry 2022;:1-25. [PMID: 35193470 DOI: 10.1080/15622975.2022.2045354] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
205 Wei Y, Wang T, Li G, Feng J, Deng L, Xu H, Yin L, Ma J, Chen D, Chen J. Investigation of systemic immune-inflammation index, neutrophil/high-density lipoprotein ratio, lymphocyte/high-density lipoprotein ratio, and monocyte/high-density lipoprotein ratio as indicators of inflammation in patients with schizophrenia and bipolar disorder. Front Psychiatry 2022;13:941728. [DOI: 10.3389/fpsyt.2022.941728] [Reference Citation Analysis]
206 Hughes HK, Mills-Ko E, Yang H, Lesh TA, Carter CS, Ashwood P. Differential Macrophage Responses in Affective Versus Non-Affective First-Episode Psychosis Patients. Front Cell Neurosci 2021;15:583351. [PMID: 33716670 DOI: 10.3389/fncel.2021.583351] [Reference Citation Analysis]
207 Squassina A, Pisanu C, Vanni R. Mood Disorders, Accelerated Aging, and Inflammation: Is the Link Hidden in Telomeres? Cells 2019;8:E52. [PMID: 30650526 DOI: 10.3390/cells8010052] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 6.7] [Reference Citation Analysis]
208 Ribeiro-santos R, de Campos-carli SM, Ferretjans R, Teixeira-carvalho A, Martins-filho OA, Teixeira AL, Salgado JV. The association of cognitive performance and IL-6 levels in schizophrenia is influenced by age and antipsychotic treatment. Nordic Journal of Psychiatry 2020;74:187-93. [DOI: 10.1080/08039488.2019.1688389] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
209 Melo MCA, Garcia RF, Linhares Neto VB, Sá MB, de Mesquita LMF, de Araújo CFC, de Bruin VMS. Sleep and circadian alterations in people at risk for bipolar disorder: A systematic review. Journal of Psychiatric Research 2016;83:211-9. [DOI: 10.1016/j.jpsychires.2016.09.005] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 6.7] [Reference Citation Analysis]
210 Volk DW. Role of microglia disturbances and immune-related marker abnormalities in cortical circuitry dysfunction in schizophrenia. Neurobiol Dis 2017;99:58-65. [PMID: 28007586 DOI: 10.1016/j.nbd.2016.12.019] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
211 Khalfallah O, Barbosa S, Martinuzzi E, Davidovic L, Yolken R, Glaichenhaus N. Monitoring inflammation in psychiatry: Caveats and advice. Eur Neuropsychopharmacol 2021:S0924-977X(21)00753-7. [PMID: 34607723 DOI: 10.1016/j.euroneuro.2021.09.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
212 Lan MJ, Rubin‐falcone H, Sublette ME, Oquendo MA, Stewart JW, Hellerstein DJ, Mcgrath PJ, Zanderigo F, Mann JJ. Deficits of white matter axial diffusivity in bipolar disorder relative to major depressive disorder: No relationship to cerebral perfusion or body mass index. Bipolar Disord 2020;22:296-302. [DOI: 10.1111/bdi.12845] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
213 Vallée A. Neuroinflammation in Schizophrenia: The Key Role of the WNT/β-Catenin Pathway. Int J Mol Sci 2022;23:2810. [PMID: 35269952 DOI: 10.3390/ijms23052810] [Reference Citation Analysis]
214 Rhoades R, Solomon S, Johnson C, Teng S. Impact of SARS-CoV-2 on Host Factors Involved in Mental Disorders. Front Microbiol 2022;13:845559. [PMID: 35444632 DOI: 10.3389/fmicb.2022.845559] [Reference Citation Analysis]
215 Trageser KJ, Sebastian-Valverde M, Naughton SX, Pasinetti GM. The Innate Immune System and Inflammatory Priming: Potential Mechanistic Factors in Mood Disorders and Gulf War Illness. Front Psychiatry 2020;11:704. [PMID: 32848904 DOI: 10.3389/fpsyt.2020.00704] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
216 García-Marchena N, Maza-Quiroga R, Serrano A, Barrios V, Requena-Ocaña N, Suárez J, Chowen JA, Argente J, Rubio G, Torrens M, López-Gallardo M, Marco EM, Castilla-Ortega E, Santín LJ, Rodríguez de Fonseca F, Pavón FJ, Araos P. Abstinent patients with alcohol use disorders show an altered plasma cytokine profile: Identification of both interleukin 6 and interleukin 17A as potential biomarkers of consumption and comorbid liver and pancreatic diseases. J Psychopharmacol 2020;34:1250-60. [PMID: 32536325 DOI: 10.1177/0269881120928176] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
217 Stilo SA, Murray RM. Non-Genetic Factors in Schizophrenia. Curr Psychiatry Rep 2019;21:100. [PMID: 31522306 DOI: 10.1007/s11920-019-1091-3] [Cited by in Crossref: 41] [Cited by in F6Publishing: 32] [Article Influence: 13.7] [Reference Citation Analysis]
218 Shi Y, Chen M, Zhao Z, Pan J, Huang S. Network Pharmacology and Molecular Docking Analyses of Mechanisms Underlying Effects of the Cyperi Rhizoma-Chuanxiong Rhizoma Herb Pair on Depression. Evid Based Complement Alternat Med 2021;2021:5704578. [PMID: 34976096 DOI: 10.1155/2021/5704578] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
219 Enache D, Nikkheslat N, Fathalla D, Morgan BP, Lewis S, Drake R, Deakin B, Walters J, Lawrie SM, Egerton A, MacCabe JH, Mondelli V. Peripheral immune markers and antipsychotic non-response in psychosis. Schizophr Res 2021;230:1-8. [PMID: 33667853 DOI: 10.1016/j.schres.2020.12.020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
220 Liu CH, Zhang GZ, Li B, Li M, Woelfer M, Walter M, Wang L. Role of inflammation in depression relapse. J Neuroinflammation 2019;16:90. [PMID: 30995920 DOI: 10.1186/s12974-019-1475-7] [Cited by in Crossref: 40] [Cited by in F6Publishing: 32] [Article Influence: 13.3] [Reference Citation Analysis]
221 Maes M, Landucci Bonifacio K, Morelli NR, Vargas HO, Barbosa DS, Carvalho AF, Nunes SOV. Major Differences in Neurooxidative and Neuronitrosative Stress Pathways Between Major Depressive Disorder and Types I and II Bipolar Disorder. Mol Neurobiol 2019;56:141-56. [DOI: 10.1007/s12035-018-1051-7] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 10.0] [Reference Citation Analysis]
222 Kwon W, Choi SK, Kim D, Kim HG, Park JK, Han JE, Cho GJ, Yun S, Yu W, Han SH, Ha YS, Lee JN, Kwon TG, Cho DH, Yi JK, Kim MO, Ryoo ZY, Park S. ZNF507 affects TGF-β signaling via TGFBR1 and MAP3K8 activation in the progression of prostate cancer to an aggressive state. J Exp Clin Cancer Res 2021;40:291. [PMID: 34537073 DOI: 10.1186/s13046-021-02094-3] [Reference Citation Analysis]
223 Chen L, Zeng X, Zhou S, Gu Z, Pan J. Correlation Between Serum High-Sensitivity C-Reactive Protein, Tumor Necrosis Factor-Alpha, Serum Interleukin-6 and White Matter Integrity Before and After the Treatment of Drug-Naïve Patients With Major Depressive Disorder. Front Neurosci 2022;16:948637. [DOI: 10.3389/fnins.2022.948637] [Reference Citation Analysis]
224 Yu S, Li W, Tang L, Fan X, Yao S, Zhang X, Bi Z, Cheng H. Depression in breast cancer patients: Immunopathogenesis and immunotherapy. Cancer Letters 2022;536:215648. [DOI: 10.1016/j.canlet.2022.215648] [Reference Citation Analysis]
225 Chaves Filho AJM, Mottin M, Soares MV, Jucá PM, Andrade CH, Macedo DS. Tetracyclines, a promise for neuropsychiatric disorders: from adjunctive therapy to the discovery of new targets for rational drug design in psychiatry. Behav Pharmacol 2021;32:123-41. [PMID: 33595954 DOI: 10.1097/FBP.0000000000000585] [Reference Citation Analysis]
226 Scola G, Duong A. Prenatal maternal immune activation and brain development with relevance to psychiatric disorders. Neuroscience 2017;346:403-8. [PMID: 28153689 DOI: 10.1016/j.neuroscience.2017.01.033] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 5.8] [Reference Citation Analysis]
227 Kaufmann FN, Costa AP, Ghisleni G, Diaz AP, Rodrigues ALS, Peluffo H, Kaster MP. NLRP3 inflammasome-driven pathways in depression: Clinical and preclinical findings. Brain Behav Immun 2017;64:367-83. [PMID: 28263786 DOI: 10.1016/j.bbi.2017.03.002] [Cited by in Crossref: 142] [Cited by in F6Publishing: 133] [Article Influence: 28.4] [Reference Citation Analysis]
228 Bekhbat M, Goldsmith DR, Woolwine BJ, Haroon E, Miller AH, Felger JC. Transcriptomic signatures of psychomotor slowing in peripheral blood of depressed patients: evidence for immunometabolic reprogramming. Mol Psychiatry 2021. [PMID: 34535767 DOI: 10.1038/s41380-021-01258-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
229 D'acunto G, Nageye F, Zhang J, Masi G, Cortese S. Inflammatory Cytokines in Children and Adolescents with Depressive Disorders: A Systematic Review and Meta-Analysis. Journal of Child and Adolescent Psychopharmacology 2019;29:362-9. [DOI: 10.1089/cap.2019.0015] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
230 Munsterhjelm C, Nordgreen J, Aae F, Heinonen M, Olstad K, Aasmundstad T, Janczak AM, Valros A. To be blamed or pitied? The effect of illness on social behavior, cytokine levels and feed intake in undocked boars. Physiol Behav 2017;179:298-307. [PMID: 28684135 DOI: 10.1016/j.physbeh.2017.06.024] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
231 Beyer DKE, Mattukat A, Freund N. Prefrontal dopamine D1 receptor manipulation influences anxiety behavior and induces neuroinflammation within the hippocampus. Int J Bipolar Disord 2021;9:9. [PMID: 33683478 DOI: 10.1186/s40345-020-00212-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
232 Malmqvist A, Schwieler L, Orhan F, Fatouros-bergman H, Bauer M, Flyckt L, Cervenka S, Engberg G, Piehl F, Erhardt S. Increased peripheral levels of TARC/CCL17 in first episode psychosis patients. Schizophrenia Research 2019;210:221-7. [DOI: 10.1016/j.schres.2018.12.033] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
233 Wedervang-Resell K, Friis S, Lonning V, Smelror RE, Johannessen C, Reponen EJ, Lyngstad SH, Lekva T, Aukrust P, Ueland T, Andreassen OA, Agartz I, Myhre AM. Increased interleukin 18 activity in adolescents with early-onset psychosis is associated with cortisol and depressive symptoms. Psychoneuroendocrinology 2020;112:104513. [PMID: 31761332 DOI: 10.1016/j.psyneuen.2019.104513] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
234 Pinto JV, Saraf G, Frysch C, Vigo D, Keramatian K, Chakrabarty T, Lam RW, Kauer-Sant'Anna M, Yatham LN. Cannabidiol as a Treatment for Mood Disorders: A Systematic Review. Can J Psychiatry 2020;65:213-27. [PMID: 31830820 DOI: 10.1177/0706743719895195] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 5.3] [Reference Citation Analysis]
235 Han FF, Wang HX, Wu JJ, Yao W, Hao CF, Pei JJ. Depressive symptoms and cognitive impairment: A 10-year follow-up study from the Survey of Health, Ageing and Retirement in Europe. Eur Psychiatry 2021;64:e55. [PMID: 34446123 DOI: 10.1192/j.eurpsy.2021.2230] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
236 Ancona A, Petito C, Iavarone I, Petito V, Galasso L, Leonetti A, Turchini L, Belella D, Ferrarrese D, Addolorato G, Armuzzi A, Gasbarrini A, Scaldaferri F. The gut-brain axis in irritable bowel syndrome and inflammatory bowel disease. Dig Liver Dis 2021;53:298-305. [PMID: 33303315 DOI: 10.1016/j.dld.2020.11.026] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
237 Schlaaff K, Dobrowolny H, Frodl T, Mawrin C, Gos T, Steiner J, Bogerts B. Increased densities of T and B lymphocytes indicate neuroinflammation in subgroups of schizophrenia and mood disorder patients. Brain, Behavior, and Immunity 2020;88:497-506. [DOI: 10.1016/j.bbi.2020.04.021] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
238 Fond G, Lançon C, Korchia T, Auquier P, Boyer L. The Role of Inflammation in the Treatment of Schizophrenia. Front Psychiatry 2020;11:160. [PMID: 32256401 DOI: 10.3389/fpsyt.2020.00160] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 11.0] [Reference Citation Analysis]
239 Notter T. Immunological Processes in Schizophrenia Pathology: Potential Biomarkers? In: Pratt J, Hall J, editors. Biomarkers in Psychiatry. Cham: Springer International Publishing; 2018. pp. 389-410. [DOI: 10.1007/7854_2018_43] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
240 Çakici N, Sutterland AL, Penninx BWJH, Dalm VA, de Haan L, van Beveren NJM. Altered peripheral blood compounds in drug-naïve first-episode patients with either schizophrenia or major depressive disorder: a meta-analysis. Brain Behav Immun 2020;88:547-58. [PMID: 32330592 DOI: 10.1016/j.bbi.2020.04.039] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 10.0] [Reference Citation Analysis]
241 Quidé Y, Bortolasci CC, Spolding B, Kidnapillai S, Watkeys OJ, Cohen-Woods S, Carr VJ, Berk M, Walder K, Green MJ. Systemic inflammation and grey matter volume in schizophrenia and bipolar disorder: Moderation by childhood trauma severity. Prog Neuropsychopharmacol Biol Psychiatry 2021;105:110013. [PMID: 32540496 DOI: 10.1016/j.pnpbp.2020.110013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
242 Yamashita Y, Makinodan M, Toritsuka M, Yamauchi T, Ikawa D, Kimoto S, Komori T, Takada R, Kayashima Y, Hamano-Iwasa K, Tsujii M, Matsuzaki H, Kishimoto T. Anti-inflammatory Effect of Ghrelin in Lymphoblastoid Cell Lines From Children With Autism Spectrum Disorder. Front Psychiatry 2019;10:152. [PMID: 30971960 DOI: 10.3389/fpsyt.2019.00152] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
243 Swardfager W, Hennebelle M, Yu D, Hammock BD, Levitt AJ, Hashimoto K, Taha AY. Metabolic/inflammatory/vascular comorbidity in psychiatric disorders; soluble epoxide hydrolase (sEH) as a possible new target. Neurosci Biobehav Rev 2018;87:56-66. [PMID: 29407524 DOI: 10.1016/j.neubiorev.2018.01.010] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 7.8] [Reference Citation Analysis]
244 Cotton SM, Berk M, Watson A, Wood S, Allott K, Bartholomeusz CF, Bortolasci CC, Walder K, O'Donoghue B, Dean OM, Chanen A, Amminger GP, McGorry PD, Burnside A, Uren J, Ratheesh A, Dodd S. ENACT: a protocol for a randomised placebo-controlled trial investigating the efficacy and mechanisms of action of adjunctive N-acetylcysteine for first-episode psychosis. Trials 2019;20:658. [PMID: 31779696 DOI: 10.1186/s13063-019-3786-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
245 Dunn GA, Loftis JM, Sullivan EL. Neuroinflammation in psychiatric disorders: An introductory primer. Pharmacol Biochem Behav 2020;196:172981. [PMID: 32621927 DOI: 10.1016/j.pbb.2020.172981] [Reference Citation Analysis]
246 Dawidowski B, Górniak A, Podwalski P, Lebiecka Z, Misiak B, Samochowiec J. The Role of Cytokines in the Pathogenesis of Schizophrenia. J Clin Med 2021;10:3849. [PMID: 34501305 DOI: 10.3390/jcm10173849] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
247 Quidé Y, Tozzi L, Corcoran M, Cannon DM, Dauvermann MR. The Impact of Childhood Trauma on Developing Bipolar Disorder: Current Understanding and Ensuring Continued Progress. Neuropsychiatr Dis Treat 2020;16:3095-115. [PMID: 33364762 DOI: 10.2147/NDT.S285540] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 5.5] [Reference Citation Analysis]
248 Goldsmith DR, Massa N, Pearce BD, Wommack EC, Alrohaibani A, Goel N, Cuthbert B, Fargotstein M, Felger JC, Haroon E, Miller AH, Duncan E. Inflammatory markers are associated with psychomotor slowing in patients with schizophrenia compared to healthy controls. NPJ Schizophr 2020;6:8. [PMID: 32238816 DOI: 10.1038/s41537-020-0098-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
249 Karthikeyan S, Dimick MK, Fiksenbaum L, Jeong H, Birmaher B, Kennedy JL, Lanctôt K, Levitt AJ, Miller GE, Schaffer A, Young LT, Youngstrom EA, Andreazza AC, Goldstein BI. Inflammatory markers, brain-derived neurotrophic factor, and the symptomatic course of adolescent bipolar disorder: A prospective repeated-measures study. Brain Behav Immun 2021;100:278-86. [PMID: 34896179 DOI: 10.1016/j.bbi.2021.11.020] [Reference Citation Analysis]
250 Ishii T, Hattori K, Miyakawa T, Watanabe K, Hidese S, Sasayama D, Ota M, Teraishi T, Hori H, Yoshida S, Nunomura A, Nakagome K, Kunugi H. Increased cerebrospinal fluid complement C5 levels in major depressive disorder and schizophrenia. Biochem Biophys Res Commun 2018;497:683-8. [PMID: 29454970 DOI: 10.1016/j.bbrc.2018.02.131] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
251 Khandaker GM, Stochl J, Zammit S, Goodyer I, Lewis G, Jones PB. Childhood inflammatory markers and intelligence as predictors of subsequent persistent depressive symptoms: a longitudinal cohort study. Psychol Med 2018;48:1514-22. [PMID: 29140226 DOI: 10.1017/S0033291717003038] [Cited by in Crossref: 37] [Cited by in F6Publishing: 26] [Article Influence: 7.4] [Reference Citation Analysis]
252 Qin XY, Wu HT, Cao C, Loh YP, Cheng Y. A meta-analysis of peripheral blood nerve growth factor levels in patients with schizophrenia. Mol Psychiatry 2017;22:1306-12. [PMID: 28070123 DOI: 10.1038/mp.2016.235] [Cited by in Crossref: 51] [Cited by in F6Publishing: 47] [Article Influence: 10.2] [Reference Citation Analysis]
253 Cyrino LAR, Delwing-de Lima D, Ullmann OM, Maia TP. Concepts of Neuroinflammation and Their Relationship With Impaired Mitochondrial Functions in Bipolar Disorder. Front Behav Neurosci 2021;15:609487. [PMID: 33732117 DOI: 10.3389/fnbeh.2021.609487] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
254 Sugimoto K, Kakeda S, Watanabe K, Katsuki A, Ueda I, Igata N, Igata R, Abe O, Yoshimura R, Korogi Y. Relationship between white matter integrity and serum inflammatory cytokine levels in drug-naive patients with major depressive disorder: diffusion tensor imaging study using tract-based spatial statistics. Transl Psychiatry 2018;8:141. [PMID: 30069019 DOI: 10.1038/s41398-018-0174-y] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 6.3] [Reference Citation Analysis]
255 Benros ME, Mortensen PB. Role of Infection, Autoimmunity, Atopic Disorders, and the Immune System in Schizophrenia: Evidence from Epidemiological and Genetic Studies. In: Khandaker GM, Meyer U, Jones PB, editors. Neuroinflammation and Schizophrenia. Cham: Springer International Publishing; 2020. pp. 141-59. [DOI: 10.1007/7854_2019_93] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
256 Amidfar M, Karami Z, Kheirabadi GR, Afshar H, Esmaeili A. Expression of Bcl-2 and Bax genes in peripheral blood lymphocytes of depressed and nondepressed individuals. J Res Med Sci 2019;24:41. [PMID: 31160908 DOI: 10.4103/jrms.JRMS_811_17] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
257 Hu SH, Han YQ, Mou TT, Huang ML, Lai JB, Ng CH, Lu J, Lu QQ, Lin QY, Zhang YZ, Hu JB, Wei N, Xu WJ, Zhou WH, Chen JK, Hu CC, Zhou XY, Lu SJ, Xu Y. Association of Genetic Polymorphisms with Age at Onset in Han Chinese Patients with Bipolar Disorder. Neurosci Bull 2019;35:591-4. [PMID: 30367335 DOI: 10.1007/s12264-018-0301-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
258 Szepesi Z, Manouchehrian O, Bachiller S, Deierborg T. Bidirectional Microglia-Neuron Communication in Health and Disease. Front Cell Neurosci 2018;12:323. [PMID: 30319362 DOI: 10.3389/fncel.2018.00323] [Cited by in Crossref: 141] [Cited by in F6Publishing: 138] [Article Influence: 35.3] [Reference Citation Analysis]
259 Chen D, Li H, Zhao Q, Song J, Lin C, Yu J. Effect of risperidone treatment on insulin-like growth factor-1 and interleukin-17 in drug naïve first-episode schizophrenia. Psychiatry Res 2021;297:113717. [PMID: 33503523 DOI: 10.1016/j.psychres.2021.113717] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
260 Berger M, Juster RP, Westphal S, Amminger GP, Bogerts B, Schiltz K, Bahn S, Steiner J, Sarnyai Z. Allostatic load is associated with psychotic symptoms and decreases with antipsychotic treatment in patients with schizophrenia and first-episode psychosis. Psychoneuroendocrinology 2018;90:35-42. [PMID: 29427955 DOI: 10.1016/j.psyneuen.2018.02.001] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 7.5] [Reference Citation Analysis]
261 Coryell W, Wilcox H, Evans SJ, Pandey GN, Jones-brando L, Dickerson F, Yolken R. Aggression, impulsivity and inflammatory markers as risk factors for suicidal behavior. Journal of Psychiatric Research 2018;106:38-42. [DOI: 10.1016/j.jpsychires.2018.09.004] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
262 Morgese MG, Schiavone S, Mhillaj E, Bove M, Tucci P, Trabace L. N-3 PUFA diet enrichment prevents amyloid beta-induced depressive-like phenotype. Pharmacol Res 2018;129:526-34. [PMID: 29203442 DOI: 10.1016/j.phrs.2017.11.034] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
263 Han Y, Sun CY, Meng SQ, Tabarak S, Yuan K, Cao L, Yan W, Xu LZ, Deng JH, Zhu WL, Li JL, Lu L, Xue YX, Shi J. Systemic immunization with altered myelin basic protein peptide produces sustained antidepressant-like effects. Mol Psychiatry 2020;25:1260-74. [PMID: 31375779 DOI: 10.1038/s41380-019-0470-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
264 Melo MCA, Garcia RF, de Araújo CFC, Abreu RLC, de Bruin PFC, de Bruin VMS. Clinical significance of neutrophil-lymphocyte and platelet-lymphocyte ratios in bipolar patients: An 18-month prospective study. Psychiatry Research 2019;271:8-14. [DOI: 10.1016/j.psychres.2018.10.077] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 5.7] [Reference Citation Analysis]
265 Yamada Y, Matsumoto M, Iijima K, Sumiyoshi T. Specificity and Continuity of Schizophrenia and Bipolar Disorder: Relation to Biomarkers. Curr Pharm Des 2020;26:191-200. [PMID: 31840595 DOI: 10.2174/1381612825666191216153508] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
266 Miller AH, Haroon E, Felger JC. Therapeutic Implications of Brain-Immune Interactions: Treatment in Translation. Neuropsychopharmacology 2017;42:334-59. [PMID: 27555382 DOI: 10.1038/npp.2016.167] [Cited by in Crossref: 85] [Cited by in F6Publishing: 76] [Article Influence: 14.2] [Reference Citation Analysis]
267 Evrensel A, Ünsalver BÖ, Ceylan ME, Tarhan N. Vaccination and Immunotherapy for Major Depression. Adv Exp Med Biol 2021;1305:503-13. [PMID: 33834415 DOI: 10.1007/978-981-33-6044-0_25] [Reference Citation Analysis]
268 Martínez-Cao C, de la Fuente-Tomás L, García-Fernández A, González-Blanco L, Sáiz PA, Garcia-Portilla MP, Bobes J. Is it possible to stage schizophrenia? A systematic review. Transl Psychiatry 2022;12:197. [PMID: 35545617 DOI: 10.1038/s41398-022-01889-y] [Reference Citation Analysis]
269 Gibson DS, Drain S, Kelly C, Mcgilligan V, Mcclean P, Atkinson SD, Murray E, Mcdowell A, Conway C, Watterson S, Bjourson AJ. Coincidence versus consequence: opportunities in multi-morbidity research and inflammation as a pervasive feature. Expert Review of Precision Medicine and Drug Development 2017;2:147-56. [DOI: 10.1080/23808993.2017.1338920] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
270 Rasmusson AJ, Gallwitz M, Soltanabadi B, Ciuculete DM, Mengel-From J, Christensen K, Nygaard M, Soerensen M, Boström AE, Fredriksson R, Freyhult E, Mwinyi J, Czamara D, Binder EB, Schiöth HB, Cunningham JL. Toll-like receptor 4 methylation grade is linked to depressive symptom severity. Transl Psychiatry 2021;11:371. [PMID: 34226490 DOI: 10.1038/s41398-021-01481-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
271 Goldsmith DR, Haroon E, Miller AH, Strauss GP, Buckley PF, Miller BJ. TNF-α and IL-6 are associated with the deficit syndrome and negative symptoms in patients with chronic schizophrenia. Schizophr Res 2018;199:281-4. [PMID: 29499967 DOI: 10.1016/j.schres.2018.02.048] [Cited by in Crossref: 43] [Cited by in F6Publishing: 45] [Article Influence: 10.8] [Reference Citation Analysis]
272 Ansari Z, Pawar S, Seetharaman R. Neuroinflammation and oxidative stress in schizophrenia: are these opportunities for repurposing? Postgrad Med 2021;:1-13. [PMID: 34766870 DOI: 10.1080/00325481.2021.2006514] [Reference Citation Analysis]
273 Kanchanatawan B, Sirivichayakul S, Ruxrungtham K, Carvalho AF, Geffard M, Ormstad H, Anderson G, Maes M. Deficit, but Not Nondeficit, Schizophrenia Is Characterized by Mucosa-Associated Activation of the Tryptophan Catabolite (TRYCAT) Pathway with Highly Specific Increases in IgA Responses Directed to Picolinic, Xanthurenic, and Quinolinic Acid. Mol Neurobiol 2018;55:1524-36. [PMID: 28181189 DOI: 10.1007/s12035-017-0417-6] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
274 Dmitrzak-Weglarz M, Szczepankiewicz A, Rybakowski J, Kapelski P, Bilska K, Skibinska M, Reszka E, Lesicka M, Jablonska E, Wieczorek E, Bukowska-Olech E, Pawlak J. Transcriptomic profiling as biological markers of depression - A pilot study in unipolar and bipolar women. World J Biol Psychiatry 2021;:1-13. [PMID: 33821765 DOI: 10.1080/15622975.2021.1907715] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
275 Aguilar-Valles A, Haji N, De Gregorio D, Matta-Camacho E, Eslamizade MJ, Popic J, Sharma V, Cao R, Rummel C, Tanti A, Wiebe S, Nuñez N, Comai S, Nadon R, Luheshi G, Mechawar N, Turecki G, Lacaille JC, Gobbi G, Sonenberg N. Translational control of depression-like behavior via phosphorylation of eukaryotic translation initiation factor 4E. Nat Commun 2018;9:2459. [PMID: 29941989 DOI: 10.1038/s41467-018-04883-5] [Cited by in Crossref: 30] [Cited by in F6Publishing: 34] [Article Influence: 7.5] [Reference Citation Analysis]
276 Vasilevska V, Guest PC, Schlaaff K, Incesoy EI, Prüss H, Steiner J. Potential Cross-Links of Inflammation With Schizophreniform and Affective Symptoms: A Review and Outlook on Autoimmune Encephalitis and COVID-19. Front Psychiatry 2021;12:729868. [PMID: 34650454 DOI: 10.3389/fpsyt.2021.729868] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
277 Wu W, Zheng YL, Tian LP, Lai JB, Hu CC, Zhang P, Chen JK, Hu JB, Huang ML, Wei N, Xu WJ, Zhou WH, Lu SJ, Lu J, Qi HL, Wang DD, Zhou XY, Duan JF, Xu Y, Hu SH. Circulating T lymphocyte subsets, cytokines, and immune checkpoint inhibitors in patients with bipolar II or major depression: a preliminary study. Sci Rep 2017;7:40530. [PMID: 28074937 DOI: 10.1038/srep40530] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
278 Melbourne JK, Feiner B, Rosen C, Sharma RP. Targeting the Immune System with Pharmacotherapy in Schizophrenia. Curr Treat Options Psychiatry 2017;4:139-51. [PMID: 28674674 DOI: 10.1007/s40501-017-0114-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
279 Larsen JB, Stunes AK, Vaaler A, Reitan SK. Cytokines in agitated and non-agitated patients admitted to an acute psychiatric department: A cross-sectional study. PLoS One 2019;14:e0222242. [PMID: 31509578 DOI: 10.1371/journal.pone.0222242] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
280 Choi J, Kim J, Min DY, Jung E, Lim Y, Shin SY, Lee YH. Inhibition of TNFα-induced interleukin-6 gene expression by barley (Hordeum vulgare) ethanol extract in BV-2 microglia. Genes Genomics 2019;41:557-66. [PMID: 30796706 DOI: 10.1007/s13258-018-00781-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
281 Roomruangwong C, Noto C, Kanchanatawan B, Anderson G, Kubera M, Carvalho AF, Maes M. The Role of Aberrations in the Immune-Inflammatory Response System (IRS) and the Compensatory Immune-Regulatory Reflex System (CIRS) in Different Phenotypes of Schizophrenia: the IRS-CIRS Theory of Schizophrenia. Mol Neurobiol. 2019;. [PMID: 31473906 DOI: 10.1007/s12035-019-01737-z] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 9.0] [Reference Citation Analysis]
282 Yuan N, Chen Y, Xia Y, Dai J, Liu C. Inflammation-related biomarkers in major psychiatric disorders: a cross-disorder assessment of reproducibility and specificity in 43 meta-analyses. Transl Psychiatry 2019;9:233. [PMID: 31534116 DOI: 10.1038/s41398-019-0570-y] [Cited by in Crossref: 135] [Cited by in F6Publishing: 99] [Article Influence: 45.0] [Reference Citation Analysis]
283 Frydecka D, Krzystek-Korpacka M, Lubeiro A, Stramecki F, Stańczykiewicz B, Beszłej JA, Piotrowski P, Kotowicz K, Szewczuk-Bogusławska M, Pawlak-Adamska E, Misiak B. Profiling inflammatory signatures of schizophrenia: A cross-sectional and meta-analysis study. Brain Behav Immun 2018;71:28-36. [PMID: 29730395 DOI: 10.1016/j.bbi.2018.05.002] [Cited by in Crossref: 48] [Cited by in F6Publishing: 49] [Article Influence: 12.0] [Reference Citation Analysis]
284 Wang AK, Miller BJ. Meta-analysis of Cerebrospinal Fluid Cytokine and Tryptophan Catabolite Alterations in Psychiatric Patients: Comparisons Between Schizophrenia, Bipolar Disorder, and Depression. Schizophr Bull. 2018;44:75-83. [PMID: 28338954 DOI: 10.1093/schbul/sbx035] [Cited by in Crossref: 125] [Cited by in F6Publishing: 120] [Article Influence: 31.3] [Reference Citation Analysis]
285 Clark SL, Chan R, Zhao M, Xie LY, Copeland WE, Aberg KA, van den Oord EJCG. Methylomic Investigation of Problematic Adolescent Cannabis Use and Its Negative Mental Health Consequences. J Am Acad Child Adolesc Psychiatry 2021:S0890-8567(21)00084-8. [PMID: 33631312 DOI: 10.1016/j.jaac.2021.02.008] [Reference Citation Analysis]
286 MacDowell KS, Munarriz-Cuezva E, Meana JJ, Leza JC, Ortega JE. Paliperidone Reversion of Maternal Immune Activation-Induced Changes on Brain Serotonin and Kynurenine Pathways. Front Pharmacol 2021;12:682602. [PMID: 34054556 DOI: 10.3389/fphar.2021.682602] [Reference Citation Analysis]
287 do Sacramento PM, Sales M, Kasahara TM, Monteiro C, Oyamada H, Dias ASO, Lopes L, Castro CT, Rossi ÁD, Milioni LM, Agrawal A, Alvarenga R, Vasconcelos CC, Bento CAM. Major depression favors the expansion of Th17-like cells and decrease the proportion of CD39+Treg cell subsets in response to myelin antigen in multiple sclerosis patients. Cell Mol Life Sci 2022;79:298. [PMID: 35585332 DOI: 10.1007/s00018-022-04315-0] [Reference Citation Analysis]
288 Zhang JC, Yao W, Dong C, Yang C, Ren Q, Ma M, Hashimoto K. Blockade of interleukin-6 receptor in the periphery promotes rapid and sustained antidepressant actions: a possible role of gut-microbiota-brain axis. Transl Psychiatry 2017;7:e1138. [PMID: 28556833 DOI: 10.1038/tp.2017.112] [Cited by in Crossref: 90] [Cited by in F6Publishing: 84] [Article Influence: 18.0] [Reference Citation Analysis]
289 Forbes MP, O'Neil A, Lane M, Agustini B, Myles N, Berk M. Major Depressive Disorder in Older Patients as an Inflammatory Disorder: Implications for the Pharmacological Management of Geriatric Depression. Drugs Aging 2021;38:451-67. [PMID: 33913114 DOI: 10.1007/s40266-021-00858-2] [Reference Citation Analysis]
290 Dai N, Jie H, Duan Y, Xiong P, Xu X, Chen P, Kang M, Li M, Li T, Huang Z, Chen H. Different serum protein factor levels in first-episode drug-naive patients with schizophrenia characterized by positive and negative symptoms. Psychiatry Clin Neurosci 2020;74:472-9. [PMID: 32478952 DOI: 10.1111/pcn.13078] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
291 Sewell MDE, Jiménez-Sánchez L, Shen X, Edmondson-Stait AJ, Green C, Adams MJ, Rifai OM, McIntosh AM, Lyall DM, Whalley HC, Lawrie SM. Associations between major psychiatric disorder polygenic risk scores and blood-based markers in UK biobank. Brain Behav Immun 2021:S0889-1591(21)00233-6. [PMID: 34107350 DOI: 10.1016/j.bbi.2021.06.002] [Reference Citation Analysis]
292 Goldsmith DR, Massa N, Miller BJ, Miller AH, Duncan E. The interaction of lipids and inflammatory markers predict negative symptom severity in patients with schizophrenia. NPJ Schizophr 2021;7:50. [PMID: 34671033 DOI: 10.1038/s41537-021-00179-8] [Reference Citation Analysis]
293 Venugopal D, Shivakumar V, Subbanna M, Kalmady SV, Amaresha AC, Agarwal SM, Narayanaswamy JC, Banerjee M, Debnath M, Venkatasubramanian G. Impact of antipsychotic treatment on methylation status of Interleukin-6 [IL-6] gene in Schizophrenia. Journal of Psychiatric Research 2018;104:88-95. [DOI: 10.1016/j.jpsychires.2018.07.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
294 Shakya PR, Melaku YA, Shivappa N, Hébert JR, Adams RJ, Page AJ, Gill TK. Dietary inflammatory index (DII®) and the risk of depression symptoms in adults. Clin Nutr 2021;40:3631-42. [PMID: 33485704 DOI: 10.1016/j.clnu.2020.12.031] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
295 Wu Y, Tang J, Zhou C, Zhao L, Chen J, Zeng L, Rao C, Shi H, Liao L, Liang Z, Yang Y, Zhou J, Xie P. Quantitative proteomics analysis of the liver reveals immune regulation and lipid metabolism dysregulation in a mouse model of depression. Behav Brain Res 2016;311:330-9. [PMID: 27247144 DOI: 10.1016/j.bbr.2016.05.057] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 4.5] [Reference Citation Analysis]
296 Wu ZW, Yu HH, Wang X, Guan HY, Xiu MH, Zhang XY. Interrelationships Between Oxidative Stress, Cytokines, and Psychotic Symptoms and Executive Functions in Patients With Chronic Schizophrenia. Psychosom Med 2021;83:485-91. [PMID: 34080586 DOI: 10.1097/PSY.0000000000000931] [Reference Citation Analysis]
297 Figueroa-Hall LK, Paulus MP, Savitz J. Toll-Like Receptor Signaling in Depression. Psychoneuroendocrinology 2020;121:104843. [PMID: 32911436 DOI: 10.1016/j.psyneuen.2020.104843] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
298 Solmi M, Suresh Sharma M, Osimo EF, Fornaro M, Bortolato B, Croatto G, Miola A, Vieta E, Pariante CM, Smith L, Fusar-Poli P, Shin JI, Berk M, Carvalho AF. Peripheral levels of C-reactive protein, tumor necrosis factor-α, interleukin-6, and interleukin-1β across the mood spectrum in bipolar disorder: A meta-analysis of mean differences and variability. Brain Behav Immun 2021:S0889-1591(21)00278-6. [PMID: 34332041 DOI: 10.1016/j.bbi.2021.07.014] [Reference Citation Analysis]
299 Grover S, Rani S, Kohat K, Kathiravan S, Patel G, Sahoo S, Mehra A, Singh S, Bhadada S. First episode psychosis following receipt of first dose of COVID-19 vaccine: A case report. Schizophrenia Research 2022;241:70-1. [DOI: 10.1016/j.schres.2022.01.025] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
300 Belbasis L, Köhler CA, Stefanis N, Stubbs B, van Os J, Vieta E, Seeman MV, Arango C, Carvalho AF, Evangelou E. Risk factors and peripheral biomarkers for schizophrenia spectrum disorders: an umbrella review of meta-analyses. Acta Psychiatr Scand 2018;137:88-97. [PMID: 29288491 DOI: 10.1111/acps.12847] [Cited by in Crossref: 78] [Cited by in F6Publishing: 69] [Article Influence: 19.5] [Reference Citation Analysis]
301 Nerurkar L, Siebert S, Mcinnes IB, Cavanagh J. Rheumatoid arthritis and depression: an inflammatory perspective. The Lancet Psychiatry 2019;6:164-73. [DOI: 10.1016/s2215-0366(18)30255-4] [Cited by in Crossref: 96] [Cited by in F6Publishing: 45] [Article Influence: 32.0] [Reference Citation Analysis]
302 Zhang Y, Bi YX, Chen J, Li S, Wu XX, Zhang L, Lin ZJ, Han S, Ding SZ. Association of Peroxiredoxin 1 and brain-derived neurotrophic factor serum levels with depression and anxiety symptoms in patients with irritable bowel syndrome. Gen Hosp Psychiatry 2021;68:59-64. [PMID: 33338736 DOI: 10.1016/j.genhosppsych.2020.11.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
303 Reinfeld S, Cáceda R, Gil R, Strom H, Chacko M. Can new onset psychosis occur after mRNA based COVID-19 vaccine administration? A case report. Psychiatry Res 2021;304:114165. [PMID: 34388513 DOI: 10.1016/j.psychres.2021.114165] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
304 Misiak B, Wójta-Kempa M, Samochowiec J, Schiweck C, Aichholzer M, Reif A, Samochowiec A, Stańczykiewicz B. Peripheral blood inflammatory markers in patients with attention deficit/hyperactivity disorder (ADHD): A systematic review and meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry 2022;118:110581. [PMID: 35660454 DOI: 10.1016/j.pnpbp.2022.110581] [Reference Citation Analysis]
305 Colasanto M, Madigan S, Korczak DJ. Depression and inflammation among children and adolescents: A meta-analysis. Journal of Affective Disorders 2020;277:940-8. [DOI: 10.1016/j.jad.2020.09.025] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
306 Kokkosis AG, Tsirka SE. Neuroimmune Mechanisms and Sex/Gender-Dependent Effects in the Pathophysiology of Mental Disorders. J Pharmacol Exp Ther 2020;375:175-92. [PMID: 32661057 DOI: 10.1124/jpet.120.266163] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
307 Liang JQ, Liao HR, Xu CX, Li XL, Wei ZX, Xie GJ, Cheng Y. Serum Exosome-Derived miR-139-5p as a Potential Biomarker for Major Depressive Disorder. Neuropsychiatr Dis Treat 2020;16:2689-93. [PMID: 33204094 DOI: 10.2147/NDT.S277392] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
308 Maeng SH, Hong H. Inflammation as the Potential Basis in Depression. Int Neurourol J 2019;23:S63-71. [PMID: 31795605 DOI: 10.5213/inj.1938226.113] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
309 Chen MH, Kao ZK, Chang WC, Tu PC, Hsu JW, Huang KL, Su TP, Li CT, Lin WC, Tsai SJ, Bai YM. Increased Proinflammatory Cytokines, Executive Dysfunction, and Reduced Gray Matter Volumes In First-Episode Bipolar Disorder and Major Depressive Disorder. J Affect Disord 2020;274:825-31. [PMID: 32664021 DOI: 10.1016/j.jad.2020.05.158] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
310 Altinoz MA, Ince B, Tek C, Srihari VH, Guloksuz S. The NF-κB signaling pathway: an important therapeutic target in psychiatric disorders. Mol Psychiatry 2018;23:490-1. [DOI: 10.1038/mp.2016.207] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
311 Cardozo PL, de Lima IBQ, Maciel EMA, Silva NC, Dobransky T, Ribeiro FM. Synaptic Elimination in Neurological Disorders. Curr Neuropharmacol 2019;17:1071-95. [PMID: 31161981 DOI: 10.2174/1570159X17666190603170511] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 8.5] [Reference Citation Analysis]
312 Herron JW, Nerurkar L, Cavanagh J. Neuroimmune Biomarkers in Mental Illness. Curr Top Behav Neurosci 2018;40:45-78. [PMID: 29626340 DOI: 10.1007/7854_2018_45] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
313 Li Y, Xie Y, Xu Y, Xian X, Wang R, Cai L, Li G, Li Y. Interleukin-6-white matter network differences explained the susceptibility to depression after stressful life events. J Affect Disord 2022:S0165-0327(22)00234-8. [PMID: 35271870 DOI: 10.1016/j.jad.2022.03.003] [Reference Citation Analysis]
314 Morris G, Stubbs B, Köhler CA, Walder K, Slyepchenko A, Berk M, Carvalho AF. The putative role of oxidative stress and inflammation in the pathophysiology of sleep dysfunction across neuropsychiatric disorders: Focus on chronic fatigue syndrome, bipolar disorder and multiple sclerosis. Sleep Med Rev 2018;41:255-65. [PMID: 29759891 DOI: 10.1016/j.smrv.2018.03.007] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 10.3] [Reference Citation Analysis]
315 Corsi-Zuelli F, Fachim HA, Loureiro CM, Shuhama R, Bertozi G, Joca SRL, Menezes PR, Louzada-Junior P, Del-Ben CM. Prolonged Periods of Social Isolation From Weaning Reduce the Anti-inflammatory Cytokine IL-10 in Blood and Brain. Front Neurosci 2018;12:1011. [PMID: 30686977 DOI: 10.3389/fnins.2018.01011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
316 [DOI: 10.1101/2021.01.08.20248710] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
317 Yang X, Pan A, Gong J, Wen Y, Ye Y, Wu JH, Pan XF, Yang CX. Prospective associations between depressive symptoms and cognitive functions in middle-aged and elderly Chinese adults. J Affect Disord 2020;263:692-7. [PMID: 31744738 DOI: 10.1016/j.jad.2019.11.048] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
318 Dandekar MP, Saxena A, Scaini G, Shin JH, Migut A, Giridharan VV, Zhou Y, Barichello T, Soares JC, Quevedo J, Fenoy AJ. Medial Forebrain Bundle Deep Brain Stimulation Reverses Anhedonic-Like Behavior in a Chronic Model of Depression: Importance of BDNF and Inflammatory Cytokines. Mol Neurobiol 2019;56:4364-80. [PMID: 30317434 DOI: 10.1007/s12035-018-1381-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
319 Mongan D, Ramesar M, Föcking M, Cannon M, Cotter D. Role of inflammation in the pathogenesis of schizophrenia: A review of the evidence, proposed mechanisms and implications for treatment. Early Interv Psychiatry 2020;14:385-97. [PMID: 31368253 DOI: 10.1111/eip.12859] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 6.3] [Reference Citation Analysis]
320 Enrico P, Delvecchio G, Turtulici N, Pigoni A, Villa FM, Perlini C, Rossetti MG, Bellani M, Lasalvia A, Bonetto C, Scocco P, D'Agostino A, Torresani S, Imbesi M, Bellini F, Veronese A, Bocchio-Chiavetto L, Gennarelli M, Balestrieri M, Colombo GI, Finardi A, Ruggeri M, Furlan R, Brambilla P. Classification of Psychoses Based on Immunological Features: A Machine Learning Study in a Large Cohort of First-Episode and Chronic Patients. Schizophr Bull 2021;47:1141-55. [PMID: 33561292 DOI: 10.1093/schbul/sbaa190] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
321 Lee SY, Wang TY, Chen SL, Chang YH, Chen PS, Huang SY, Tzeng NS, Wang LJ, Lee IH, Chen KC, Yang YK, Yang YH, Chen CS, Lu RB. ALDH2 modulated changes in cytokine levels and cognitive function in bipolar disorder: A 12-week follow-up study. Aust N Z J Psychiatry 2018;52:680-9. [PMID: 28778129 DOI: 10.1177/0004867417720517] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
322 Talmon M, Rossi S, Pastore A, Cattaneo CI, Brunelleschi S, Fresu LG. Vortioxetine exerts anti-inflammatory and immunomodulatory effects on human monocytes/macrophages. Br J Pharmacol 2018;175:113-24. [PMID: 29057467 DOI: 10.1111/bph.14074] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 4.6] [Reference Citation Analysis]
323 Köhler CA, Freitas TH, Maes M, de Andrade NQ, Liu CS, Fernandes BS, Stubbs B, Solmi M, Veronese N, Herrmann N, Raison CL, Miller BJ, Lanctôt KL, Carvalho AF. Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies. Acta Psychiatr Scand 2017;135:373-87. [PMID: 28122130 DOI: 10.1111/acps.12698] [Cited by in Crossref: 581] [Cited by in F6Publishing: 518] [Article Influence: 116.2] [Reference Citation Analysis]
324 Costello H, Gould RL, Abrol E, Howard R. Systematic review and meta-analysis of the association between peripheral inflammatory cytokines and generalised anxiety disorder. BMJ Open 2019;9:e027925. [PMID: 31326932 DOI: 10.1136/bmjopen-2018-027925] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 13.0] [Reference Citation Analysis]
325 Lizano P, Lutz O, Xu Y, Rubin LH, Paskowitz L, Lee AM, Eum S, Keedy SK, Hill SK, Reilly JL, Wu B, Tamminga CA, Clementz BA, Pearlson GD, Gershon ES, Keshavan MS, Sweeney JA, Bishop JR. Multivariate relationships between peripheral inflammatory marker subtypes and cognitive and brain structural measures in psychosis. Mol Psychiatry 2021;26:3430-43. [PMID: 33060818 DOI: 10.1038/s41380-020-00914-0] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 10.0] [Reference Citation Analysis]
326 Kucukgoncu S, Kosir U, Zhou E, Sullivan E, Srihari VH, Tek C. Glucose metabolism dysregulation at the onset of mental illness is not limited to first episode psychosis: A systematic review and meta-analysis. Early Interv Psychiatry 2019;13:1021-31. [PMID: 30277314 DOI: 10.1111/eip.12749] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
327 Bigseth TT, Engh JA, Egeland J, Andersen E, Andreassen OA, Bang-Kittilsen G, Falk RS, Holmen TL, Lindberg M, Mordal J, Nielsen J, Steen NE, Ueland T, Vang T, Fredriksen M. Exploring low grade inflammation by soluble urokinase plasminogen activator receptor levels in schizophrenia: a sex-dependent association with depressive symptoms. BMC Psychiatry 2021;21:527. [PMID: 34702245 DOI: 10.1186/s12888-021-03522-6] [Reference Citation Analysis]
328 Lorkiewicz P, Waszkiewicz N. Biomarkers of Post-COVID Depression. J Clin Med 2021;10:4142. [PMID: 34575258 DOI: 10.3390/jcm10184142] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
329 Gong J, Chen G, Chen F, Zhong S, Chen P, Zhong H, Lai S, Tang G, Wang J, Luo Z, Qi Z, Jia Y, Huang L, Wang Y. Association between resting-state functional connectivity of amygdala subregions and peripheral pro-inflammation cytokines levels in bipolar disorder. Brain Imaging Behav 2022. [PMID: 35175549 DOI: 10.1007/s11682-022-00636-7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
330 Goldsmith DR, Haroon E, Miller AH, Addington J, Bearden C, Cadenhead K, Cannon T, Cornblatt B, Mathalon D, McGlashan T, Seidman L, Tsuang M, Woods SW, Walker EF, Perkins DO. Association of baseline inflammatory markers and the development of negative symptoms in individuals at clinical high risk for psychosis. Brain Behav Immun 2019;76:268-74. [PMID: 30496778 DOI: 10.1016/j.bbi.2018.11.315] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 5.8] [Reference Citation Analysis]
331 Wang X, Wang D, Su F, Li C, Chen M. Immune abnormalities and differential gene expression in the hippocampus and peripheral blood of patients with Alzheimer's disease. Ann Transl Med 2022;10:29. [PMID: 35282083 DOI: 10.21037/atm-21-4974] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
332 Gao X, Li Y, Sun Z, Xu H, Ma G, Deng Q, Zhang CX, Li R. Could α-Klotho Unlock the Key Between Depression and Dementia in the Elderly: from Animal to Human Studies. Mol Neurobiol 2021;58:2874-85. [PMID: 33527303 DOI: 10.1007/s12035-021-02313-0] [Reference Citation Analysis]
333 Pinto JV, Moulin TC, Amaral OB. On the transdiagnostic nature of peripheral biomarkers in major psychiatric disorders: A systematic review. Neurosci Biobehav Rev 2017;83:97-108. [PMID: 28986182 DOI: 10.1016/j.neubiorev.2017.10.001] [Cited by in Crossref: 47] [Cited by in F6Publishing: 38] [Article Influence: 9.4] [Reference Citation Analysis]
334 Plank JR, Morgan C, Sundram F, Plank LD, Hoeh N, Ahn S, Muthukumaraswamy S, Lin JC. Brain temperature as an indicator of neuroinflammation induced by typhoid vaccine: Assessment using whole-brain magnetic resonance spectroscopy in a randomised crossover study. Neuroimage Clin 2022;35:103053. [PMID: 35617872 DOI: 10.1016/j.nicl.2022.103053] [Reference Citation Analysis]
335 Kahl KG, Deuschle M, Stubbs B, Schweiger U. Visceral adipose tissue in patients with severe mental illness. Horm Mol Biol Clin Investig 2018;33. [PMID: 29547392 DOI: 10.1515/hmbci-2018-0007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
336 Treadway MT, Admon R, Arulpragasam AR, Mehta M, Douglas S, Vitaliano G, Olson DP, Cooper JA, Pizzagalli DA. Association Between Interleukin-6 and Striatal Prediction-Error Signals Following Acute Stress in Healthy Female Participants. Biol Psychiatry 2017;82:570-7. [PMID: 28506437 DOI: 10.1016/j.biopsych.2017.02.1183] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 8.2] [Reference Citation Analysis]
337 Krefft M, Frydecka D, Zalsman G, Krzystek-Korpacka M, Śmigiel R, Gębura K, Bogunia-Kubik K, Misiak B. A pro-inflammatory phenotype is associated with behavioural traits in children with Prader-Willi syndrome. Eur Child Adolesc Psychiatry 2021;30:899-908. [PMID: 32495042 DOI: 10.1007/s00787-020-01568-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
338 Soczynska JK, Kennedy SH, Alsuwaidan M, Mansur RB, Li M, McAndrews MP, Brietzke E, Woldeyohannes HO, Taylor VH, McIntyre RS. A pilot, open-label, 8-week study evaluating the efficacy, safety and tolerability of adjunctive minocycline for the treatment of bipolar I/II depression. Bipolar Disord 2017;19:198-213. [PMID: 28599348 DOI: 10.1111/bdi.12496] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 7.8] [Reference Citation Analysis]
339 Shen Z, Ni S, Yang W, Sun W, Yang G, Liu G. Redox probes tagged electrochemical aptasensing device for simultaneous detection of multiple cytokines in real time. Sensors and Actuators B: Chemical 2021;336:129747. [DOI: 10.1016/j.snb.2021.129747] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
340 Notter T, Coughlin JM, Gschwind T, Weber-Stadlbauer U, Wang Y, Kassiou M, Vernon AC, Benke D, Pomper MG, Sawa A, Meyer U. Translational evaluation of translocator protein as a marker of neuroinflammation in schizophrenia. Mol Psychiatry 2018;23:323-34. [PMID: 28093569 DOI: 10.1038/mp.2016.248] [Cited by in Crossref: 126] [Cited by in F6Publishing: 114] [Article Influence: 25.2] [Reference Citation Analysis]
341 Jovanovic AM, Mitkovic-Voncina M, Kostic M, Jeremic M, Todorovic J, Popadic D, Tosevski DL, Markovic I. Childhood maltreatment correlates with higher concentration of transforming growth factor beta (TGF-β) in adult patients with major depressive disorder. Psychiatry Res 2021;301:113987. [PMID: 34023675 DOI: 10.1016/j.psychres.2021.113987] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
342 Watts D, Pfaffenseller B, Wollenhaupt-aguiar B, Paul Géa L, Cardoso TDA, Kapczinski F. Agmatine as a potential therapeutic intervention in bipolar depression: the preclinical landscape. Expert Opinion on Therapeutic Targets 2019;23:327-39. [DOI: 10.1080/14728222.2019.1581764] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
343 Sekar S, Grandjean J, Garnell JF, Willems R, Duytschaever H, Seramani S, Su H, Ver Donck L, Bhakoo KK. Neuro-metabolite profiles of rodent models of psychiatric dysfunctions characterised by MR spectroscopy. Neuropharmacology 2019;146:109-16. [PMID: 30472272 DOI: 10.1016/j.neuropharm.2018.11.021] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
344 Solmi F, De Stavola BL, Khandaker GM, Bulik CM, Dalman C, Lewis G. Association between prenatal maternal infection and disordered eating behaviours in adolescence: a UK population-based prospective birth cohort study. Psychol Med 2020;50:927-35. [PMID: 31043182 DOI: 10.1017/S0033291719000795] [Reference Citation Analysis]
345 Young KD, Drevets WC, Dantzer R, Teague TK, Bodurka J, Savitz J. Kynurenine pathway metabolites are associated with hippocampal activity during autobiographical memory recall in patients with depression. Brain Behav Immun 2016;56:335-42. [PMID: 27091600 DOI: 10.1016/j.bbi.2016.04.007] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 6.3] [Reference Citation Analysis]
346 Delgado I, Huet L, Dexpert S, Beau C, Forestier D, Ledaguenel P, Aubert A, Sauvant J, Aouizerate B, Magne E, Capuron L. Depressive symptoms in obesity: Relative contribution of low-grade inflammation and metabolic health. Psychoneuroendocrinology 2018;91:55-61. [DOI: 10.1016/j.psyneuen.2018.02.030] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 6.8] [Reference Citation Analysis]
347 Beurel E, Toups M, Nemeroff CB. The Bidirectional Relationship of Depression and Inflammation: Double Trouble. Neuron 2020;107:234-56. [PMID: 32553197 DOI: 10.1016/j.neuron.2020.06.002] [Cited by in Crossref: 46] [Cited by in F6Publishing: 52] [Article Influence: 23.0] [Reference Citation Analysis]
348 López-Cruz L, Salamone JD, Correa M. Caffeine and Selective Adenosine Receptor Antagonists as New Therapeutic Tools for the Motivational Symptoms of Depression. Front Pharmacol 2018;9:526. [PMID: 29910727 DOI: 10.3389/fphar.2018.00526] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 9.8] [Reference Citation Analysis]
349 Wang X, Li Y, Wu L, Xiao S, Ji Y, Tan Y, Jiang C, Zhang G. Dysregulation of the gut-brain-skin axis and key overlapping inflammatory and immune mechanisms of psoriasis and depression. Biomed Pharmacother 2021;137:111065. [PMID: 33540138 DOI: 10.1016/j.biopha.2020.111065] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
350 Delacrétaz A, Zdralovic A, Vandenberghe F, Saigi-morgui N, Glatard A, Quteineh L, Gholam-rezaee M, Raffoul W, Applegate LA, Jafari P, Gamma F, von Gunten A, Conus P, Eap CB. Association of variants in SH2B1 and RABEP1 with worsening of low-density lipoprotein and glucose parameters in patients treated with psychotropic drugs. Gene 2017;628:8-15. [DOI: 10.1016/j.gene.2017.07.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
351 Nobis A, Zalewski D, Waszkiewicz N. Peripheral Markers of Depression. J Clin Med 2020;9:E3793. [PMID: 33255237 DOI: 10.3390/jcm9123793] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
352 Maples-Keller JL, Yasinski C, Stojek M, Ravi M, Watkins LE, Patton SC, Rothbaum AO, Unongo M, Dunlop BW, Rauch SAM, Michopoulos V, Rothbaum BO. The relations between C-reactive protein and trauma exposure, PTSD and depression symptoms, and PTSD psychotherapy treatment response in treatment seeking veterans and service members. Brain Behav Immun 2022;101:84-92. [PMID: 34990746 DOI: 10.1016/j.bbi.2021.12.025] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
353 Toft H, Neupane SP, Bramness JG, Tilden T, Wampold BE, Lien L. The effect of trauma and alcohol on the relationship between level of cytokines and depression among patients entering psychiatric treatment. BMC Psychiatry 2018;18:95. [PMID: 29631540 DOI: 10.1186/s12888-018-1677-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
354 Jeppesen R, Benros ME. Autoimmune Diseases and Psychotic Disorders. Front Psychiatry 2019;10:131. [PMID: 30949074 DOI: 10.3389/fpsyt.2019.00131] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 10.7] [Reference Citation Analysis]
355 Jiang X, Guo Y, Jia L, Zhu Y, Sun Q, Kong L, Wu F, Tang Y. Altered Levels of Plasma Inflammatory Cytokines and White Matter Integrity in Bipolar Disorder Patients With Suicide Attempts. Front Psychiatry 2022;13:861881. [DOI: 10.3389/fpsyt.2022.861881] [Reference Citation Analysis]
356 Miller BJ, Parker CB, Rapaport MH, Buckley PF, McCall WV. Insomnia and suicidal ideation in nonaffective psychosis. Sleep 2019;42. [PMID: 30407600 DOI: 10.1093/sleep/zsy215] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
357 Okamoto N, Natsuyama T, Igata R, Konishi Y, Tesen H, Ikenouchi A, Yoshimura R. Associations Between the Kynurenine Pathway, Proinflammatory Cytokines, and Brain-Derived Neurotrophic Factor in Hospitalized Patients With Chronic Schizophrenia: A Preliminary Study. Front Psychiatry 2021;12:696059. [PMID: 34393855 DOI: 10.3389/fpsyt.2021.696059] [Reference Citation Analysis]
358 Teixeira AL, Gama CS, Rocha NP, Teixeira MM. Revisiting the Role of Eotaxin-1/CCL11 in Psychiatric Disorders. Front Psychiatry 2018;9:241. [PMID: 29962972 DOI: 10.3389/fpsyt.2018.00241] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 6.5] [Reference Citation Analysis]
359 Shmarina GV, Orlova MD, Ershova ES, Jestkova EM, Martynov AV, Veiko NN, Konkova MS, Dolgikh OA, Filev AD, Kostyuk SV. NRF2 and HMOX1 Gene Expression against the Background of Systemic Oxidative Stress in Patients with Acute Psychosis. Russ J Genet 2020;56:96-102. [DOI: 10.1134/s102279542001010x] [Cited by in Crossref: 4] [Article Influence: 2.0] [Reference Citation Analysis]
360 Sørensen NV, Orlovska-waast S, Jeppesen R, Klein-petersen AW, Christensen RH, Benros ME. Neuroinflammatory biomarkers in the cerebrospinal fluid from 106 patients with recent onset depression compared to 106 individually matched healthy controls. Biological Psychiatry 2022. [DOI: 10.1016/j.biopsych.2022.04.002] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
361 Zhu F, Zhang L, Liu F, Wu R, Guo W, Ou J, Zhang X, Zhao J. Altered Serum Tumor Necrosis Factor and Interleukin-1β in First-Episode Drug-Naive and Chronic Schizophrenia. Front Neurosci 2018;12:296. [PMID: 29867314 DOI: 10.3389/fnins.2018.00296] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
362 Çakici N, Bot M, Lamers F, Janssen T, van der Spek PJ, de Haan L, Bahn S, Penninx BW, van Beveren NJ. Increased serum levels of leptin and insulin in both schizophrenia and major depressive disorder: A cross-disorder proteomics analysis. European Neuropsychopharmacology 2019;29:835-46. [DOI: 10.1016/j.euroneuro.2019.05.010] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
363 Watson D, Levin-Aspenson HF, Waszczuk MA, Conway CC, Dalgleish T, Dretsch MN, Eaton NR, Forbes MK, Forbush KT, Hobbs KA, Michelini G, Nelson BD, Sellbom M, Slade T, South SC, Sunderland M, Waldman I, Witthöft M, Wright AGC, Kotov R, Krueger RF; HiTOP Utility Workgroup. Validity and utility of Hierarchical Taxonomy of Psychopathology (HiTOP): III. Emotional dysfunction superspectrum. World Psychiatry 2022;21:26-54. [PMID: 35015357 DOI: 10.1002/wps.20943] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 10.0] [Reference Citation Analysis]
364 Cuperfain AB, Kennedy JL, Gonçalves VF. Overlapping mechanisms linking insulin resistance with cognition and neuroprogression in bipolar disorder. Neurosci Biobehav Rev 2020;111:125-34. [PMID: 31978440 DOI: 10.1016/j.neubiorev.2020.01.022] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
365 Sethi R, Gómez-Coronado N, Walker AJ, Robertson OD, Agustini B, Berk M, Dodd S. Neurobiology and Therapeutic Potential of Cyclooxygenase-2 (COX-2) Inhibitors for Inflammation in Neuropsychiatric Disorders. Front Psychiatry 2019;10:605. [PMID: 31551825 DOI: 10.3389/fpsyt.2019.00605] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 7.3] [Reference Citation Analysis]
366 Suda K, Matsuda K. How Microbes Affect Depression: Underlying Mechanisms via the Gut-Brain Axis and the Modulating Role of Probiotics. Int J Mol Sci 2022;23:1172. [PMID: 35163104 DOI: 10.3390/ijms23031172] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
367 Khandaker GM, Zammit S, Burgess S, Lewis G, Jones PB. Association between a functional interleukin 6 receptor genetic variant and risk of depression and psychosis in a population-based birth cohort. Brain Behav Immun 2018;69:264-72. [PMID: 29197507 DOI: 10.1016/j.bbi.2017.11.020] [Cited by in Crossref: 51] [Cited by in F6Publishing: 47] [Article Influence: 10.2] [Reference Citation Analysis]
368 Dawidowski B, Grelecki G, Biłgorajski A, Podwalski P, Misiak B, Samochowiec J. Effect of Antipsychotic Treatment on Neutrophil-to-Lymphocyte Ratio during Hospitalization for Acute Psychosis in the Course of Schizophrenia-A Cross-Sectional Retrospective Study. J Clin Med 2021;11:232. [PMID: 35011972 DOI: 10.3390/jcm11010232] [Reference Citation Analysis]
369 Yoshimura R, Katsuki A, Atake K, Hori H, Igata R, Konishi Y. Influence of fluvoxamine on plasma interleukin-6 or clinical improvement in patients with major depressive disorder. Neuropsychiatr Dis Treat 2017;13:437-41. [PMID: 28243095 DOI: 10.2147/NDT.S123121] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
370 Murphy CE, Kondo Y, Walker AK, Rothmond DA, Matsumoto M, Shannon Weickert C. Regional, cellular and species difference of two key neuroinflammatory genes implicated in schizophrenia. Brain, Behavior, and Immunity 2020;88:826-39. [DOI: 10.1016/j.bbi.2020.05.055] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
371 Haroon E, Miller AH, Sanacora G. Inflammation, Glutamate, and Glia: A Trio of Trouble in Mood Disorders. Neuropsychopharmacology 2017;42:193-215. [PMID: 27629368 DOI: 10.1038/npp.2016.199] [Cited by in Crossref: 200] [Cited by in F6Publishing: 179] [Article Influence: 33.3] [Reference Citation Analysis]
372 North HF, Weissleder C, Fullerton JM, Sager R, Webster MJ, Weickert CS. A schizophrenia subgroup with elevated inflammation displays reduced microglia, increased peripheral immune cell and altered neurogenesis marker gene expression in the subependymal zone. Transl Psychiatry 2021;11:635. [PMID: 34911938 DOI: 10.1038/s41398-021-01742-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
373 Okamoto N, Watanabe K, Ngyuyen L, Ikenouchi A, Kishi T, Iwata N, Kakeda S, Korogi Y, Yoshimura R. Association of Serum Kynurenine Levels and Neural Networks in Patients with First-Episode, Drug-Naïve Major Depression: A Source-Based Morphometry Study. Neuropsychiatr Dis Treat 2020;16:2569-77. [PMID: 33154644 DOI: 10.2147/NDT.S279622] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
374 Ohnuma T, Nishimon S, Takeda M, Sannohe T, Katsuta N, Arai H. Carbonyl Stress and Microinflammation-Related Molecules as Potential Biomarkers in Schizophrenia. Front Psychiatry 2018;9:82. [PMID: 29593588 DOI: 10.3389/fpsyt.2018.00082] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
375 Nikiphorou E, Lempp H, Kohrt BA. Treatment failure in inflammatory arthritis: time to think about syndemics? Rheumatology 2019;58:1526-33. [DOI: 10.1093/rheumatology/kez222] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
376 Benros ME. High-quality large-scale longitudinal studies with detailed multimodal immunological phenotyping are warranted to disentangle the involvement of the immune system in psychosis. Acta Psychiatr Scand 2022;146:3-5. [PMID: 35714064 DOI: 10.1111/acps.13458] [Reference Citation Analysis]
377 Moschny N, Hefner G, Grohmann R, Eckermann G, Maier HB, Seifert J, Heck J, Francis F, Bleich S, Toto S, Meissner C. Therapeutic Drug Monitoring of Second- and Third-Generation Antipsychotic Drugs-Influence of Smoking Behavior and Inflammation on Pharmacokinetics. Pharmaceuticals (Basel) 2021;14:514. [PMID: 34071813 DOI: 10.3390/ph14060514] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
378 Cohen-Woods S, Fisher HL, Ahmetspahic D, Douroudis K, Stacey D, Hosang GM, Korszun A, Owen M, Craddock N, Arolt V, Dannlowski U, Breen G, Craig IW, Farmer A, Baune BT, Lewis CM, Uher R, McGuffin P. Interaction between childhood maltreatment on immunogenetic risk in depression: Discovery and replication in clinical case-control samples. Brain Behav Immun 2018;67:203-10. [PMID: 28867280 DOI: 10.1016/j.bbi.2017.08.023] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 4.4] [Reference Citation Analysis]
379 Firth J, Veronese N, Cotter J, Shivappa N, Hebert JR, Ee C, Smith L, Stubbs B, Jackson SE, Sarris J. What Is the Role of Dietary Inflammation in Severe Mental Illness? A Review of Observational and Experimental Findings. Front Psychiatry 2019;10:350. [PMID: 31156486 DOI: 10.3389/fpsyt.2019.00350] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 8.3] [Reference Citation Analysis]
380 Mohite S, Salem H, Cordeiro T, Tannous J, Mwangi B, Selvaraj S, Soares JC, Sanches M, Teixeira AL. Correlations between peripheral levels of inflammatory mediators and frontolimbic structures in bipolar disorder: an exploratory analysis. CNS Spectr 2021;:1-6. [PMID: 34121653 DOI: 10.1017/S1092852921000596] [Reference Citation Analysis]
381 Sørensen NV, Orlovska-waast S, Jeppesen R, Christensen RH, Benros ME. Neuroimmunological investigations of cerebrospinal fluid in patients with recent onset depression – a study protocol. BMC Psychiatry 2022;22. [DOI: 10.1186/s12888-021-03633-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
382 Tamouza R, Meyer U, Foiselle M, Richard JR, Lu CL, Boukouaci W, Le Corvoisier P, Barrau C, Lucas A, Perron H, Leboyer M. Identification of inflammatory subgroups of schizophrenia and bipolar disorder patients with HERV-W ENV antigenemia by unsupervised cluster analysis. Transl Psychiatry 2021;11:377. [PMID: 34230451 DOI: 10.1038/s41398-021-01499-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
383 González-Blanco L, García-Portilla MP, García-Álvarez L, de la Fuente-Tomás L, Iglesias García C, Sáiz PA, Rodríguez-González S, Coto-Montes A, Bobes J. Can interleukin-2 and interleukin-1β be specific biomarkers of negative symptoms in schizophrenia? Rev Psiquiatr Salud Ment (Engl Ed) 2019;12:9-16. [PMID: 29724678 DOI: 10.1016/j.rpsm.2018.03.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
384 Corsi-Zuelli F, Deakin B. Impaired regulatory T cell control of astroglial overdrive and microglial pruning in schizophrenia. Neurosci Biobehav Rev 2021;125:637-53. [PMID: 33713699 DOI: 10.1016/j.neubiorev.2021.03.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
385 Miller BJ, McCall WV, McEvoy JP, Lu XY. Insomnia and inflammation in phase 1 of the clinical antipsychotic trials of intervention effectiveness study. Psychiatry Res 2021;305:114195. [PMID: 34481199 DOI: 10.1016/j.psychres.2021.114195] [Reference Citation Analysis]
386 Xu Y, Zhou Z, Pan J, Huang H. Associations Between Asthma and Polycystic Ovary Syndrome: Current Perspectives. Front Endocrinol 2022;13:936948. [DOI: 10.3389/fendo.2022.936948] [Reference Citation Analysis]
387 Cho SH, Lim JE, Lee J, Lee JS, Jeong HG, Lee MS, Ko YH, Han C, Ham BJ, Han KM. Association between high-sensitivity C-reactive protein levels and depression: Moderation by age, sex, obesity, and aerobic physical activity. J Affect Disord 2021;291:375-83. [PMID: 34091325 DOI: 10.1016/j.jad.2021.05.040] [Reference Citation Analysis]
388 Ľupták M, Michaličková D, Fišar Z, Kitzlerová E, Hroudová J. Novel approaches in schizophrenia-from risk factors and hypotheses to novel drug targets. World J Psychiatr 2021; 11(7): 277-296 [PMID: 34327122 DOI: 10.5498/wjp.v11.i7.277] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
389 Roohi E, Jaafari N, Hashemian F. On inflammatory hypothesis of depression: what is the role of IL-6 in the middle of the chaos? J Neuroinflammation 2021;18:45. [PMID: 33593388 DOI: 10.1186/s12974-021-02100-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
390 Elliesen R, Walther A. Commentary: Physical Functional Capacity and C-Reactive Protein in Schizophrenia. Front Psychiatry 2018;9:7. [PMID: 29434554 DOI: 10.3389/fpsyt.2018.00007] [Reference Citation Analysis]
391 Kovács MÁ, Tényi T, Kugyelka R, Prenek L, Hau L, Magyar ÉE, Herold R, Balogh P, Simon D. Elevated Osteopontin and Interferon Gamma Serum Levels and Increased Neutrophil-to-Lymphocyte Ratio Are Associated With the Severity of Symptoms in Schizophrenia. Front Psychiatry 2019;10:996. [PMID: 32038330 DOI: 10.3389/fpsyt.2019.00996] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
392 Khandaker GM, Zuber V, Rees JMB, Carvalho L, Mason AM, Foley CN, Gkatzionis A, Jones PB, Burgess S. Shared mechanisms between coronary heart disease and depression: findings from a large UK general population-based cohort. Mol Psychiatry 2020;25:1477-86. [PMID: 30886334 DOI: 10.1038/s41380-019-0395-3] [Cited by in Crossref: 80] [Cited by in F6Publishing: 68] [Article Influence: 26.7] [Reference Citation Analysis]
393 Tseng PT, Chen YW, Tu KY, Wang HY, Chung W, Wu CK, Hsu SP, Kuo HC, Lin PY. State-dependent increase in the levels of neurotrophin-3 and neurotrophin-4/5 in patients with bipolar disorder: A meta-analysis. J Psychiatr Res 2016;79:86-92. [PMID: 27214525 DOI: 10.1016/j.jpsychires.2016.05.009] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
394 Sorri A, Järventausta K, Kampman O, Lehtimäki K, Björkqvist M, Tuohimaa K, Hämäläinen M, Moilanen E, Leinonen E. Low tumor necrosis factor-α levels predict symptom reduction during electroconvulsive therapy in major depressive disorder. Brain Behav 2018;8:e00933. [PMID: 29670819 DOI: 10.1002/brb3.933] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
395 Bugge E, Wynn R, Mollnes TE, Reitan SK, Lapid MI, Grønli OK. Changes in cytokines during treatment of elderly, hospitalized psychiatric patients - a naturalistic study. Psychoneuroendocrinology 2019;108:135-9. [PMID: 31276906 DOI: 10.1016/j.psyneuen.2019.06.014] [Reference Citation Analysis]
396 Wu Y, Li Y, Jia Y, Wei C, Xu H, Guo R, Li Y, Jia J, Qi X, Gao X. Imbalance in amino acid and purine metabolisms at the hypothalamus in inflammation-associated depression by GC-MS. Mol Biosyst 2017;13:2715-28. [PMID: 29160327 DOI: 10.1039/c7mb00494j] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
397 Zhou H, Wang J, Zhang Y, Shao F, Wang W. The Role of Microglial CX3CR1 in Schizophrenia-Related Behaviors Induced by Social Isolation. Front Integr Neurosci 2020;14:551676. [PMID: 33013335 DOI: 10.3389/fnint.2020.551676] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
398 Attwood MM, Jonsson J, Rask-Andersen M, Schiöth HB. Soluble ligands as drug targets. Nat Rev Drug Discov 2020;19:695-710. [PMID: 32873970 DOI: 10.1038/s41573-020-0078-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
399 Rukavishnikov GV, Kasyanov ED, Zhilyaeva TV, Mazo GE. [Schizophrenia and cardiometabolic disorders]. Zh Nevrol Psikhiatr Im S S Korsakova 2021;121:132-8. [PMID: 34283543 DOI: 10.17116/jnevro2021121061132] [Reference Citation Analysis]
400 Khandaker GM, Dantzer R, Jones PB. Immunopsychiatry: important facts. Psychol Med 2017;47:2229-37. [PMID: 28418288 DOI: 10.1017/S0033291717000745] [Cited by in Crossref: 77] [Cited by in F6Publishing: 43] [Article Influence: 15.4] [Reference Citation Analysis]
401 Boukezzi S, Costi S, Shin LM, Kim-Schulze S, Cathomas F, Collins A, Russo SJ, Morris LS, Murrough JW. Exaggerated amygdala response to threat and association with immune hyperactivity in depression. Brain Behav Immun 2022;104:205-12. [PMID: 35636614 DOI: 10.1016/j.bbi.2022.05.015] [Reference Citation Analysis]
402 Cha HY, Yang SJ, Kim SW. Higher Dietary Inflammation in Patients with Schizophrenia: A Case-Control Study in Korea. Nutrients 2021;13:2033. [PMID: 34199231 DOI: 10.3390/nu13062033] [Reference Citation Analysis]
403 Ogłodek EA. The role of PON-1, GR, IL-18, and OxLDL in depression with and without posttraumatic stress disorder. Pharmacological Reports 2017;69:837-45. [DOI: 10.1016/j.pharep.2017.03.015] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
404 Sigitova E, Fišar Z, Hroudová J, Cikánková T, Raboch J. Biological hypotheses and biomarkers of bipolar disorder. Psychiatry Clin Neurosci 2017;71:77-103. [PMID: 27800654 DOI: 10.1111/pcn.12476] [Cited by in Crossref: 93] [Cited by in F6Publishing: 77] [Article Influence: 18.6] [Reference Citation Analysis]
405 Walther A, Penz M, Ijacic D, Rice TR. Bipolar Spectrum Disorders in Male Youth: The Interplay between Symptom Severity, Inflammation, Steroid Secretion, and Body Composition. Front Psychiatry 2017;8:207. [PMID: 29093685 DOI: 10.3389/fpsyt.2017.00207] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
406 Brown GM, McIntyre RS, Rosenblat J, Hardeland R. Depressive disorders: Processes leading to neurogeneration and potential novel treatments. Prog Neuropsychopharmacol Biol Psychiatry 2018;80:189-204. [PMID: 28433459 DOI: 10.1016/j.pnpbp.2017.04.023] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 5.6] [Reference Citation Analysis]
407 Corsi-Zuelli F, Deakin B, de Lima MHF, Qureshi O, Barnes NM, Upthegrove R, Louzada-Junior P, Del-Ben CM. T regulatory cells as a potential therapeutic target in psychosis? Current challenges and future perspectives. Brain Behav Immun Health 2021;17:100330. [PMID: 34661175 DOI: 10.1016/j.bbih.2021.100330] [Reference Citation Analysis]
408 Husain MI, Strawbridge R, Stokes PR, Young AH. Anti-inflammatory treatments for mood disorders: Systematic review and meta-analysis. J Psychopharmacol 2017;31:1137-48. [PMID: 28858537 DOI: 10.1177/0269881117725711] [Cited by in Crossref: 58] [Cited by in F6Publishing: 47] [Article Influence: 11.6] [Reference Citation Analysis]
409 Lisitsyna TA, Veltishchev DY, Lila AM, Nasonov EL. Interleukin 6 as a pathogenic factor mediating clinical manifestations and a therapeutic target for rheumatic diseases and depressive disorders. Naučno-praktičeskaâ revmatologiâ 2019;57:318-27. [DOI: 10.14412/1995-4484-2019-318-327] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
410 Morris G, Sominsky L, Walder KR, Berk M, Marx W, Carvalho AF, Bortolasci CC, Maes M, Puri BK. Inflammation and Nitro-oxidative Stress as Drivers of Endocannabinoid System Aberrations in Mood Disorders and Schizophrenia. Mol Neurobiol 2022. [PMID: 35347586 DOI: 10.1007/s12035-022-02800-y] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
411 Khandaker GM. Early-Life Biomarkers for Psychosis Risk in Young People: Another Nail in the Coffin for Cartesian Dualism. Biol Psychiatry 2019;86:2-3. [PMID: 31221245 DOI: 10.1016/j.biopsych.2019.05.009] [Reference Citation Analysis]
412 Misiak B, Bartoli F, Stramecki F, Samochowiec J, Lis M, Kasznia J, Jarosz K, Stańczykiewicz B. Appetite regulating hormones in first-episode psychosis: A systematic review and meta-analysis. Neurosci Biobehav Rev 2019;102:362-70. [PMID: 31121198 DOI: 10.1016/j.neubiorev.2019.05.018] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
413 Dean B, Lam LQ, Scarr E, Duce JA. Cortical biometals: Changed levels in suicide and with mood disorders. Journal of Affective Disorders 2019;243:539-44. [DOI: 10.1016/j.jad.2018.09.026] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
414 Xu B, Moradi M, Kuplicki R, Stewart JL, McKinney B, Sen S, Paulus MP. Machine Learning Analysis of Electronic Nose in a Transdiagnostic Community Sample With a Streamlined Data Collection Approach: No Links Between Volatile Organic Compounds and Psychiatric Symptoms. Front Psychiatry 2020;11:503248. [PMID: 33192639 DOI: 10.3389/fpsyt.2020.503248] [Reference Citation Analysis]
415 Miyata S, Ishino Y, Shimizu S, Tohyama M. Involvement of inflammatory responses in the brain to the onset of major depressive disorder due to stress exposure. Front Aging Neurosci 2022;14:934346. [DOI: 10.3389/fnagi.2022.934346] [Reference Citation Analysis]
416 Purves-Tyson TD, Robinson K, Brown AM, Boerrigter D, Cai HQ, Weissleder C, Owens SJ, Rothmond DA, Shannon Weickert C. Increased Macrophages and C1qA, C3, C4 Transcripts in the Midbrain of People With Schizophrenia. Front Immunol 2020;11:2002. [PMID: 33133060 DOI: 10.3389/fimmu.2020.02002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
417 Thylur DS, Goldsmith DR. Brick by Brick: Building a Transdiagnostic Understanding of Inflammation in Psychiatry. Harv Rev Psychiatry 2022;30:40-53. [PMID: 34995034 DOI: 10.1097/HRP.0000000000000326] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
418 Lee SY, Wang TY, Chen SL, Chang YH, Chen PS, Huang SY, Tzeng NS, Wang LJ, Lee IH, Chen KC, Yang YK, Hong JS, Lu RB. Combination of dextromethorphan and memantine in treating bipolar spectrum disorder: a 12-week double-blind randomized clinical trial. Int J Bipolar Disord 2020;8:11. [PMID: 32115672 DOI: 10.1186/s40345-019-0174-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
419 Postolache TT, Medoff DR, Brown CH, Fang LJ, Upadhyaya SK, Lowry CA, Miller M, Kreyenbuhl JA. Lipophilic vs. hydrophilic statins and psychiatric hospitalizations and emergency room visits in US Veterans with schizophrenia and bipolar disorder. Pteridines 2021;32:48-69. [PMID: 34887622 DOI: 10.1515/pteridines-2020-0028] [Reference Citation Analysis]
420 Lin C, Chen K, Yu J, Feng W, Fu W, Yang F, Zhang X, Chen D. Relationship between TNF-α levels and psychiatric symptoms in first-episode drug-naïve patients with schizophrenia before and after risperidone treatment and in chronic patients. BMC Psychiatry 2021;21:561. [PMID: 34763685 DOI: 10.1186/s12888-021-03569-5] [Reference Citation Analysis]
421 Kim SY, Chanyang M, Oh DJ, Choi HG. Association between depression and rheumatoid arthritis: two longitudinal follow-up studies using a national sample cohort. Rheumatology 2020;59:1889-97. [DOI: 10.1093/rheumatology/kez559] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
422 Pan S, Tan Y, Yao S, Zhao X, Xiong J. Serum high-sensitivity C-reactive protein: A delicate sentinel elevated in drug-free acutely agitated patients with schizophrenia. Psychiatry Res 2016;246:89-94. [PMID: 27669496 DOI: 10.1016/j.psychres.2016.09.033] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
423 Hahad O, Daiber A, Michal M, Kuntic M, Lieb K, Beutel M, Münzel T. Smoking and Neuropsychiatric Disease-Associations and Underlying Mechanisms. Int J Mol Sci 2021;22:7272. [PMID: 34298890 DOI: 10.3390/ijms22147272] [Reference Citation Analysis]
424 Smesny S, Milleit B, Schaefer MR, Hesse J, Schlögelhofer M, Langbein K, Hipler UC, Berger M, Cotter DR, Sauer H, McGorry PD, Amminger GP. Effects of omega-3 PUFA on immune markers in adolescent individuals at ultra-high risk for psychosis - Results of the randomized controlled Vienna omega-3 study. Schizophr Res 2017;188:110-7. [PMID: 28126360 DOI: 10.1016/j.schres.2017.01.026] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
425 Jiang Y, Liu Y, Gao M, Xue M, Wang Z, Liang H. Nicotinamide riboside alleviates alcohol-induced depression-like behaviours in C57BL/6J mice by altering the intestinal microbiota associated with microglial activation and BDNF expression. Food Funct 2020;11:378-91. [PMID: 31820774 DOI: 10.1039/c9fo01780a] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
426 Nelson LH, Saulsbery AI, Lenz KM. Small cells with big implications: Microglia and sex differences in brain development, plasticity and behavioral health. Prog Neurobiol 2019;176:103-19. [PMID: 30193820 DOI: 10.1016/j.pneurobio.2018.09.002] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
427 Chang M, Womer FY, Edmiston EK, Bai C, Zhou Q, Jiang X, Wei S, Wei Y, Ye Y, Huang H, He Y, Xu K, Tang Y, Wang F. Neurobiological Commonalities and Distinctions Among Three Major Psychiatric Diagnostic Categories: A Structural MRI Study. Schizophr Bull 2018;44:65-74. [PMID: 29036668 DOI: 10.1093/schbul/sbx028] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 9.0] [Reference Citation Analysis]
428 Hylén U, McGlinchey A, Orešič M, Bejerot S, Humble MB, Särndahl E, Hyötyläinen T, Eklund D. Potential Transdiagnostic Lipid Mediators of Inflammatory Activity in Individuals With Serious Mental Illness. Front Psychiatry 2021;12:778325. [PMID: 34899431 DOI: 10.3389/fpsyt.2021.778325] [Reference Citation Analysis]
429 Iglesias-González M, Boigues M, Sanagustin D, Giralt-López M, Cuevas-Esteban J, Martínez-Cáceres E, Díez-Quevedo C. Association of serum interleukin-6 and C-reactive protein with depressive and adjustment disorders in COVID-19 inpatients. Brain Behav Immun Health 2022;19:100405. [PMID: 34927104 DOI: 10.1016/j.bbih.2021.100405] [Reference Citation Analysis]
430 Müller N, Krause D, Barth R, Myint AM, Weidinger E, Stettinger W, Zill P, Drexhage H, Schwarz MJ. Childhood Adversity and Current Stress are related to Pro- and Anti-inflammatory Cytokines in Major Depression. J Affect Disord 2019;253:270-6. [PMID: 31063941 DOI: 10.1016/j.jad.2019.04.088] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 9.0] [Reference Citation Analysis]
431 Hughes HK, Ashwood P. Overlapping evidence of innate immune dysfunction in psychotic and affective disorders. Brain Behav Immun Health 2020;2:100038. [PMID: 34589829 DOI: 10.1016/j.bbih.2020.100038] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
432 Mucher P, Batmyagmar D, Perkmann T, Repl M, Radakovics A, Ponocny-Seliger E, Lukas I, Fritzer-Szekeres M, Lehrner J, Knogler T, Tscholakoff D, Fondi M, Wagner OF, Winker R, Haslacher H. Basal myokine levels are associated with quality of life and depressed mood in older adults. Psychophysiology 2021;58:e13799. [PMID: 33655551 DOI: 10.1111/psyp.13799] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
433 Jeon S, Kim SH, Shin SY, Lee YH. Clozapine reduces Toll-like receptor 4/NF-κB-mediated inflammatory responses through inhibition of calcium/calmodulin-dependent Akt activation in microglia. Prog Neuropsychopharmacol Biol Psychiatry 2018;81:477-87. [PMID: 28431901 DOI: 10.1016/j.pnpbp.2017.04.012] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
434 Satyanarayanan SK, Shih Y, Chien Y, Huang S, Gałecki P, Kasper S, Chang JP, Su K. Anti-Oxidative Effects of Melatonin Receptor Agonist and Omega-3 Polyunsaturated Fatty Acids in Neuronal SH-SY5Y Cells: Deciphering Synergic Effects on Anti-Depressant Mechanisms. Mol Neurobiol 2018;55:7271-84. [DOI: 10.1007/s12035-018-0899-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
435 Zhang JC, Yao W, Ren Q, Yang C, Dong C, Ma M, Wu J, Hashimoto K. Depression-like phenotype by deletion of α7 nicotinic acetylcholine receptor: Role of BDNF-TrkB in nucleus accumbens. Sci Rep 2016;6:36705. [PMID: 27821848 DOI: 10.1038/srep36705] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
436 Türközer HB, Lizano P, Adhan I, Ivleva EI, Lutz O, Zeng V, Zeng A, Raymond N, Bannai D, Lee A, Bishop JR, Clementz BA, Pearlson GD, Sweeney JA, Gershon E, Keshavan MS, Tamminga CA. Regional and Sex-specific Alterations in the Visual Cortex of Individuals with Psychosis Spectrum Disorders. Biological Psychiatry 2022. [DOI: 10.1016/j.biopsych.2022.03.023] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
437 Tzur Bitan D, Berzin D, Cohen A. Hidradenitis suppurativa and schizophrenia: a nationwide cohort study. J Eur Acad Dermatol Venereol 2019;34:574-9. [DOI: 10.1111/jdv.15997] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
438 Tolkien K, Bradburn S, Murgatroyd C. An anti-inflammatory diet as a potential intervention for depressive disorders: A systematic review and meta-analysis. Clin Nutr 2019;38:2045-52. [PMID: 30502975 DOI: 10.1016/j.clnu.2018.11.007] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 8.8] [Reference Citation Analysis]
439 Jeong SH, Kim YS. Challenges in Prescribing Clozapine in the Era of COVID-19: A Review Focused on Immunological Implications. Clin Psychopharmacol Neurosci 2021;19:411-22. [PMID: 34294611 DOI: 10.9758/cpn.2021.19.3.411] [Reference Citation Analysis]
440 Buchmann A, Ritter C, Müller ST, Haynes M, Ghisleni C, Tuura R, Hasler G. Associations between Heart Rate Variability, Peripheral Inflammatory Markers and Major Depressive Disorder. J Affect Disord 2022:S0165-0327(22)00166-5. [PMID: 35196535 DOI: 10.1016/j.jad.2022.02.017] [Reference Citation Analysis]
441 Munkholm K, Vinberg M, Pedersen BK, Poulsen HE, Ekstrøm CT, Kessing LV. A multisystem composite biomarker as a preliminary diagnostic test in bipolar disorder. Acta Psychiatr Scand 2019;139:227-36. [PMID: 30383306 DOI: 10.1111/acps.12983] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
442 Alvarez-Mon MA, Gómez AM, Orozco A, Lahera G, Sosa MD, Diaz D, Auba E, Albillos A, Monserrat J, Alvarez-Mon M. Abnormal Distribution and Function of Circulating Monocytes and Enhanced Bacterial Translocation in Major Depressive Disorder. Front Psychiatry 2019;10:812. [PMID: 31803077 DOI: 10.3389/fpsyt.2019.00812] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
443 Łoś K, Kulikowska J, Waszkiewicz N. First-Time Psychotic Symptoms in a Patient After COVID-19 Infection-A Case Report. Front Psychiatry 2021;12:726059. [PMID: 34721104 DOI: 10.3389/fpsyt.2021.726059] [Reference Citation Analysis]
444 Millett CE, Burdick KE, Kubicki MR. The Effects of Peripheral Inflammation on the Brain-A Neuroimaging Perspective. Harv Rev Psychiatry 2022;30:54-8. [PMID: 34995035 DOI: 10.1097/HRP.0000000000000323] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
445 Vichaya EG, Gross PS, Estrada DJ, Cole SW, Grossberg AJ, Evans SE, Tuvim MJ, Dickey BF, Dantzer R. Lipocalin-2 is dispensable in inflammation-induced sickness and depression-like behavior. Psychopharmacology (Berl) 2019;236:2975-82. [PMID: 30806746 DOI: 10.1007/s00213-019-05190-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
446 Tabatabaeizadeh S, Abdizadeh MF, Meshkat Z, Khodashenas E, Darroudi S, Fazeli M, Ferns GA, Avan A, Ghayour-mobarhan M. There is an association between serum high-sensitivity C-reactive protein (hs-CRP) concentrations and depression score in adolescent girls. Psychoneuroendocrinology 2018;88:102-4. [DOI: 10.1016/j.psyneuen.2017.11.014] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
447 Munkholm K, Jacoby AS, Lenskjold T, Bruunsgaard H, Vinberg M, Kessing LV. Leukocytes in peripheral blood in patients with bipolar disorder - Trait and state alterations and association with levels of cytokines and C-reactive protein. Psychiatry Res 2018;261:383-90. [PMID: 29353768 DOI: 10.1016/j.psychres.2018.01.022] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
448 Lin Y, Peng Y, Zhu C, Su Y, Shi Y, Lin Z, Chen J, Cui D. Pretreatment Serum MCP-1 Level Predicts Response to Risperidone in Schizophrenia. Shanghai Arch Psychiatry 2017;29:287-94. [PMID: 29276352 DOI: 10.11919/j.issn.1002-0829.217093] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
449 Alloy LB, Nusslock R. Future Directions for Understanding Adolescent Bipolar Spectrum Disorders: A Reward Hypersensitivity Perspective. J Clin Child Adolesc Psychol 2019;48:669-83. [PMID: 30908092 DOI: 10.1080/15374416.2019.1567347] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
450 Toritsuka M, Makinodan M, Yamauchi T, Yamashita Y, Ikawa D, Komori T, Kimoto S, Hamano-Iwasa K, Matsuzaki H, Kishimoto T. Altered gene expression in lymphoblastoid cell lines after subculture. In Vitro Cell Dev Biol Anim 2018;54:523-7. [PMID: 29948745 DOI: 10.1007/s11626-018-0267-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
451 Osimo EF, Stochl J, Zammit S, Lewis G, Jones PB, Khandaker GM. Longitudinal population subgroups of CRP and risk of depression in the ALSPAC birth cohort. Compr Psychiatry 2020;96:152143. [PMID: 31707310 DOI: 10.1016/j.comppsych.2019.152143] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
452 Chase KA, Melbourne JK, Rosen C, McCarthy-Jones S, Jones N, Feiner BM, Sharma RP. Traumagenics: At the intersect of childhood trauma, immunity and psychosis. Psychiatry Res 2019;273:369-77. [PMID: 30682559 DOI: 10.1016/j.psychres.2018.12.097] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
453 Harb H, González-de-la-vara M, Thalheimer L, Klein U, Renz H, Rose M, Kruse J, Potaczek D, Peters E. Assessment of Brain Derived Neurotrophic Factor in hair to study stress responses: A pilot investigation. Psychoneuroendocrinology 2017;86:134-43. [DOI: 10.1016/j.psyneuen.2017.09.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
454 Osimo EF, Cardinal RN, Jones PB, Khandaker GM. Prevalence and correlates of low-grade systemic inflammation in adult psychiatric inpatients: An electronic health record-based study. Psychoneuroendocrinology. 2018;91:226-234. [PMID: 29544672 DOI: 10.1016/j.psyneuen.2018.02.031] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 9.3] [Reference Citation Analysis]
455 Bulut NS, Yorguner N, Çarkaxhiu Bulut G. The severity of inflammation in major neuropsychiatric disorders: comparison of neutrophil-lymphocyte and platelet-lymphocyte ratios between schizophrenia, bipolar mania, bipolar depression, major depressive disorder, and obsessive compulsive disorder. Nord J Psychiatry 2021;:1-9. [PMID: 34319861 DOI: 10.1080/08039488.2021.1919201] [Reference Citation Analysis]
456 Gerritsen C, Iyengar Y, DaSilva T, Koppel A, Rusjan P, Bagby RM, Mizrahi R. Personality traits in psychosis and psychosis risk linked to TSPO expression: a neuroimmune marker. Personal Neurosci 2020;3:e14. [PMID: 33354652 DOI: 10.1017/pen.2020.14] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
457 Mørch RH, Dieset I, Færden A, Reponen EJ, Hope S, Hoseth EZ, Gardsjord ES, Aas M, Iversen T, Joa I, Morken G, Agartz I, Melle I, Aukrust P, Djurovic S, Ueland T, Andreassen OA. Inflammatory markers are altered in severe mental disorders independent of comorbid cardiometabolic disease risk factors. Psychol Med 2019;49:1749-57. [PMID: 30688187 DOI: 10.1017/S0033291718004142] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 7.3] [Reference Citation Analysis]
458 Robertson OD, Coronado NG, Sethi R, Berk M, Dodd S. Putative neuroprotective pharmacotherapies to target the staged progression of mental illness. Early Interv Psychiatry 2019;13:1032-49. [PMID: 30690898 DOI: 10.1111/eip.12775] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 5.7] [Reference Citation Analysis]
459 Guo JY, Lesh TA, Niendam TA, Ragland JD, Tully LM, Carter CS. Brain free water alterations in first-episode psychosis: a longitudinal analysis of diagnosis, course of illness, and medication effects. Psychol Med 2021;51:1001-10. [PMID: 31910929 DOI: 10.1017/S0033291719003969] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
460 Morris G, Berk M, Walder K, O'Neil A, Maes M, Puri BK. The lipid paradox in neuroprogressive disorders: Causes and consequences. Neurosci Biobehav Rev 2021;128:35-57. [PMID: 34118292 DOI: 10.1016/j.neubiorev.2021.06.017] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
461 Misiak B, Frydecka D, Stanczykiewicz B, Samochowiec J. Editorial: Peripheral Markers of Immune Response in Major Psychiatric Disorders: Where Are We Now and Where Do We Want to Be? Front Psychiatry 2019;10:5. [PMID: 30723427 DOI: 10.3389/fpsyt.2019.00005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
462 Chen X, Yao T, Cai J, Fu X, Li H, Wu J. Systemic inflammatory regulators and 7 major psychiatric disorders: A two-sample Mendelian randomization study. Prog Neuropsychopharmacol Biol Psychiatry 2022;:110534. [PMID: 35150783 DOI: 10.1016/j.pnpbp.2022.110534] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
463 Kasahara T, Kato T. What Can Mitochondrial DNA Analysis Tell Us About Mood Disorders? Biological Psychiatry 2018;83:731-8. [DOI: 10.1016/j.biopsych.2017.09.010] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 4.8] [Reference Citation Analysis]
464 Bora E. Peripheral inflammatory and neurotrophic biomarkers of cognitive impairment in schizophrenia: a meta-analysis. Psychol Med 2019;49:1971-9. [PMID: 31284882 DOI: 10.1017/S0033291719001685] [Cited by in Crossref: 49] [Cited by in F6Publishing: 39] [Article Influence: 16.3] [Reference Citation Analysis]
465 Purves-Tyson TD, Weber-Stadlbauer U, Richetto J, Rothmond DA, Labouesse MA, Polesel M, Robinson K, Shannon Weickert C, Meyer U. Increased levels of midbrain immune-related transcripts in schizophrenia and in murine offspring after maternal immune activation. Mol Psychiatry 2021;26:849-63. [PMID: 31168068 DOI: 10.1038/s41380-019-0434-0] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 12.3] [Reference Citation Analysis]
466 Garrosa-Jiménez J, Sánchez Carro Y, Ovejero-Benito MC, Del Sastre E, García AG, López MG, López-García P, Cano-Abad MF. Intracellular calcium and inflammatory markers, mediated by purinergic stimulation, are differentially regulated in monocytes of patients with major depressive disorder. Neurosci Lett 2021;765:136275. [PMID: 34606909 DOI: 10.1016/j.neulet.2021.136275] [Reference Citation Analysis]
467 Lee SY, Wang TY, Lu RB, Wang LJ, Chang CH, Chiang YC, Pan CC, Tsai KW. Plasma BDNF and Cytokines Correlated with Protein Biomarkers for Bipolar II Disorder. J Pers Med 2021;11:1282. [PMID: 34945756 DOI: 10.3390/jpm11121282] [Reference Citation Analysis]
468 Andreou D, Jørgensen KN, Wortinger LA, Engen K, Vaskinn A, Ueland T, Yolken RH, Andreassen OA, Agartz I. Cytomegalovirus infection and IQ in patients with severe mental illness and healthy individuals. Psychiatry Res 2021;300:113929. [PMID: 33866186 DOI: 10.1016/j.psychres.2021.113929] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
469 Sandberg AA, Steen VM, Torsvik A. Is Elevated Neutrophil Count and Neutrophil-to-Lymphocyte Ratio a Cause or Consequence of Schizophrenia?-A Scoping Review. Front Psychiatry 2021;12:728990. [PMID: 34603107 DOI: 10.3389/fpsyt.2021.728990] [Reference Citation Analysis]
470 Barnes TR, Drake R, Paton C, Cooper SJ, Deakin B, Ferrier IN, Gregory CJ, Haddad PM, Howes OD, Jones I, Joyce EM, Lewis S, Lingford-hughes A, Maccabe JH, Owens DC, Patel MX, Sinclair JM, Stone JM, Talbot PS, Upthegrove R, Wieck A, Yung AR. Evidence-based guidelines for the pharmacological treatment of schizophrenia: Updated recommendations from the British Association for Psychopharmacology. J Psychopharmacol 2020;34:3-78. [DOI: 10.1177/0269881119889296] [Cited by in Crossref: 47] [Cited by in F6Publishing: 39] [Article Influence: 15.7] [Reference Citation Analysis]
471 Zeni-Graiff M, Rizzo LB, Mansur RB, Maurya PK, Sethi S, Cunha GR, Asevedo E, Pan P, Zugman A, Yamagata AS, Higuchi C, Bressan RA, Gadelha A, Brietzke E. Peripheral immuno-inflammatory abnormalities in ultra-high risk of developing psychosis. Schizophr Res 2016;176:191-5. [PMID: 27424266 DOI: 10.1016/j.schres.2016.06.031] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 5.3] [Reference Citation Analysis]
472 Adjibade M, Andreeva VA, Lemogne C, Touvier M, Shivappa N, Hébert JR, Wirth MD, Hercberg S, Galan P, Julia C, Assmann KE, Kesse-Guyot E. The Inflammatory Potential of the Diet Is Associated with Depressive Symptoms in Different Subgroups of the General Population. J Nutr 2017;147:879-87. [PMID: 28356432 DOI: 10.3945/jn.116.245167] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 5.6] [Reference Citation Analysis]
473 Edberg D, Hoppensteadt D, Walborn A, Fareed J, Sinacore J, Halaris A. Plasma C-reactive protein levels in bipolar depression during cyclooxygenase-2 inhibitor combination treatment. Journal of Psychiatric Research 2018;102:1-7. [DOI: 10.1016/j.jpsychires.2018.02.004] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 5.8] [Reference Citation Analysis]
474 Wagh VV, Vyas P, Agrawal S, Pachpor TA, Paralikar V, Khare SP. Peripheral Blood-Based Gene Expression Studies in Schizophrenia: A Systematic Review. Front Genet 2021;12:736483. [PMID: 34721526 DOI: 10.3389/fgene.2021.736483] [Reference Citation Analysis]
475 Miller BJ, Buckley PF. Monoclonal antibody immunotherapy in psychiatric disorders. Lancet Psychiatry 2017;4:13-5. [PMID: 28012468 DOI: 10.1016/S2215-0366(16)30366-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 2.4] [Reference Citation Analysis]
476 Manoliu A, Bosch OG, Brakowski J, Brühl AB, Seifritz E. The potential impact of biochemical mediators on telomere attrition in major depressive disorder and implications for future study designs: A narrative review. Journal of Affective Disorders 2018;225:630-46. [DOI: 10.1016/j.jad.2017.08.022] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
477 Minarini A, Ferrari S, Galletti M, Giambalvo N, Perrone D, Rioli G, Galeazzi GM. N-acetylcysteine in the treatment of psychiatric disorders: current status and future prospects. Expert Opin Drug Metab Toxicol 2017;13:279-92. [PMID: 27766914 DOI: 10.1080/17425255.2017.1251580] [Cited by in Crossref: 64] [Cited by in F6Publishing: 55] [Article Influence: 10.7] [Reference Citation Analysis]
478 Leite Dantas R, Freff J, Ambrée O, Beins EC, Forstner AJ, Dannlowski U, Baune BT, Scheu S, Alferink J. Dendritic Cells: Neglected Modulators of Peripheral Immune Responses and Neuroinflammation in Mood Disorders? Cells 2021;10:941. [PMID: 33921690 DOI: 10.3390/cells10040941] [Reference Citation Analysis]
479 Müller N. Inflammation in Schizophrenia: Pathogenetic Aspects and Therapeutic Considerations. Schizophr Bull 2018;44:973-82. [PMID: 29648618 DOI: 10.1093/schbul/sby024] [Cited by in Crossref: 145] [Cited by in F6Publishing: 132] [Article Influence: 48.3] [Reference Citation Analysis]
480 Radhakrishnan R, Kaser M, Guloksuz S. The Link Between the Immune System, Environment, and Psychosis. Schizophr Bull 2017;43:693-7. [PMID: 28969353 DOI: 10.1093/schbul/sbx057] [Cited by in Crossref: 40] [Cited by in F6Publishing: 33] [Article Influence: 10.0] [Reference Citation Analysis]
481 Steiner J, Prüss H, Köhler S, Frodl T, Hasan A, Falkai P. Autoimmune encephalitis with psychosis: Warning signs, step-by-step diagnostics and treatment. The World Journal of Biological Psychiatry 2020;21:241-54. [DOI: 10.1080/15622975.2018.1555376] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 11.7] [Reference Citation Analysis]
482 Khandaker GM, Stochl J, Zammit S, Lewis G, Dantzer R, Jones PB. Association between circulating levels of C-reactive protein and positive and negative symptoms of psychosis in adolescents in a general population birth cohort. J Psychiatr Res 2020:S0022-3956(20)31087-6. [PMID: 33229033 DOI: 10.1016/j.jpsychires.2020.11.028] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
483 Melbourne JK, Pang Y, Park MR, Sudhalkar N, Rosen C, Sharma RP. Treatment with the antipsychotic risperidone is associated with increased M1-like JAK-STAT1 signature gene expression in PBMCs from participants with psychosis and THP-1 monocytes and macrophages. Int Immunopharmacol 2020;79:106093. [PMID: 31863919 DOI: 10.1016/j.intimp.2019.106093] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
484 Miller BJ, Buckley PF, Mcevoy JP. Inflammation, substance use, psychopathology, and cognition in phase 1 of the clinical antipsychotic trials of intervention effectiveness study. Schizophrenia Research 2018;195:275-82. [DOI: 10.1016/j.schres.2017.08.027] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
485 Mao R, Zhang C, Chen J, Zhao G, Zhou R, Wang F, Xu J, Yang T, Su Y, Huang J, Wu Z, Cao L, Wang Y, Hu Y, Yuan C, Yi Z, Hong W, Wang Z, Peng D, Fang Y. Different levels of pro- and anti-inflammatory cytokines in patients with unipolar and bipolar depression. J Affect Disord 2018;237:65-72. [PMID: 29778935 DOI: 10.1016/j.jad.2018.04.115] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 7.3] [Reference Citation Analysis]
486 Liu JY, Chen HY, Lin JJ, Lu MK, Tan HP, Jang FL, Lin SH. Alterations of plasma cytokine biomarkers for identifying age at onset of schizophrenia with neurological soft signs. Int J Med Sci 2020;17:255-62. [PMID: 32038109 DOI: 10.7150/ijms.38891] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
487 Orhan F, Schwieler L, Fatouros-Bergman H, Malmqvist A, Cervenka S, Collste K, Flyckt L, Farde L, Sellgren CM, Piehl F, Engberg G, Erhardt S; Karolinska Schizophrenia Project (KaSP) Consortium. Increased number of monocytes and plasma levels of MCP-1 and YKL-40 in first-episode psychosis. Acta Psychiatr Scand 2018;138:432-40. [PMID: 30132802 DOI: 10.1111/acps.12944] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
488 Luís JP, Simões CJV, Brito RMM. The Therapeutic Prospects of Targeting IL-1R1 for the Modulation of Neuroinflammation in Central Nervous System Disorders. Int J Mol Sci 2022;23:1731. [PMID: 35163653 DOI: 10.3390/ijms23031731] [Reference Citation Analysis]
489 Leighton SP, Nerurkar L, Krishnadas R, Johnman C, Graham GJ, Cavanagh J. Chemokines in depression in health and in inflammatory illness: a systematic review and meta-analysis. Mol Psychiatry. 2018;23:48-58. [PMID: 29133955 DOI: 10.1038/mp.2017.205] [Cited by in Crossref: 123] [Cited by in F6Publishing: 105] [Article Influence: 24.6] [Reference Citation Analysis]
490 Yui S, Sasayama D, Yamaguchi M, Washizuka S. Altered levels of salivary cytokines in patients with major depressive disorder. Clinical Neurology and Neurosurgery 2022;221:107390. [DOI: 10.1016/j.clineuro.2022.107390] [Reference Citation Analysis]
491 Sakrajda K, Szczepankiewicz A. Inflammation-Related Changes in Mood Disorders and the Immunomodulatory Role of Lithium. Int J Mol Sci 2021;22:1532. [PMID: 33546417 DOI: 10.3390/ijms22041532] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
492 Himmerich H, Patsalos O, Lichtblau N, Ibrahim MAA, Dalton B. Cytokine Research in Depression: Principles, Challenges, and Open Questions. Front Psychiatry 2019;10:30. [PMID: 30792669 DOI: 10.3389/fpsyt.2019.00030] [Cited by in Crossref: 61] [Cited by in F6Publishing: 53] [Article Influence: 20.3] [Reference Citation Analysis]
493 Miola A, Dal Porto V, Meda N, Perini G, Solmi M, Sambataro F. Secondary Mania induced by TNF-α inhibitors: A systematic review. Psychiatry Clin Neurosci 2021. [PMID: 34590391 DOI: 10.1111/pcn.13302] [Reference Citation Analysis]
494 Calarge CA, Devaraj S, Shulman RJ. Gut permeability and depressive symptom severity in unmedicated adolescents. Journal of Affective Disorders 2019;246:586-94. [DOI: 10.1016/j.jad.2018.12.077] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 6.3] [Reference Citation Analysis]
495 Osimo EF, Pillinger T, Rodriguez IM, Khandaker GM, Pariante CM, Howes OD. Inflammatory markers in depression: A meta-analysis of mean differences and variability in 5,166 patients and 5,083 controls. Brain Behav Immun 2020;87:901-9. [PMID: 32113908 DOI: 10.1016/j.bbi.2020.02.010] [Cited by in Crossref: 54] [Cited by in F6Publishing: 52] [Article Influence: 27.0] [Reference Citation Analysis]
496 Gay F, Romeo B, Martelli C, Benyamina A, Hamdani N. Cytokines changes associated with electroconvulsive therapy in patients with treatment-resistant depression: a Meta-analysis. Psychiatry Res 2021;297:113735. [PMID: 33497973 DOI: 10.1016/j.psychres.2021.113735] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
497 Dinakaran D, Sreeraj VS, Venkatasubramanian G. Role of Curcumin in the Management of Schizophrenia: A Narrative Review. Indian Journal of Psychological Medicine 2022;44:107-13. [DOI: 10.1177/02537176211033331] [Reference Citation Analysis]
498 Bigseth TT, Fredriksen M, Egeland J, Andersen E, Andreassen OA, Bang-Kittilsen G, Falk RS, Holmen TL, Martinsen EW, Mordal J, Nielsen J, Steen NE, Ueland T, Vang T, Engh JA. Elevated levels of soluble urokinase plasminogen activator receptor as a low-grade inflammation marker in schizophrenia: A case-control study. Schizophr Res 2021;228:190-2. [PMID: 33450603 DOI: 10.1016/j.schres.2020.11.051] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
499 Jiang C, Yin H, Liu A, Liu Q, Ma H, Geng Q. Dietary inflammatory index and depression risk in patients with chronic diseases and comorbidity. J Affect Disord 2022:S0165-0327(22)00007-6. [PMID: 34990633 DOI: 10.1016/j.jad.2022.01.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
500 Tanaka M, Tóth F, Polyák H, Szabó Á, Mándi Y, Vécsei L. Immune Influencers in Action: Metabolites and Enzymes of the Tryptophan-Kynurenine Metabolic Pathway. Biomedicines 2021;9:734. [PMID: 34202246 DOI: 10.3390/biomedicines9070734] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
501 Müller N. The Role of Intercellular Adhesion Molecule-1 in the Pathogenesis of Psychiatric Disorders. Front Pharmacol 2019;10:1251. [PMID: 31824303 DOI: 10.3389/fphar.2019.01251] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 9.3] [Reference Citation Analysis]
502 Mueller FS, Scarborough J, Schalbetter SM, Richetto J, Kim E, Couch A, Yee Y, Lerch JP, Vernon AC, Weber-Stadlbauer U, Meyer U. Behavioral, neuroanatomical, and molecular correlates of resilience and susceptibility to maternal immune activation. Mol Psychiatry 2021;26:396-410. [PMID: 33230204 DOI: 10.1038/s41380-020-00952-8] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 20.0] [Reference Citation Analysis]
503 Vonder Haar C, Ferland JN, Kaur S, Riparip LK, Rosi S, Winstanley CA. Cocaine self-administration is increased after frontal traumatic brain injury and associated with neuroinflammation. Eur J Neurosci 2019;50:2134-45. [PMID: 30118561 DOI: 10.1111/ejn.14123] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
504 Ramirez K, Fornaguera-Trías J, Sheridan JF. Stress-Induced Microglia Activation and Monocyte Trafficking to the Brain Underlie the Development of Anxiety and Depression. Curr Top Behav Neurosci 2017;31:155-72. [PMID: 27352390 DOI: 10.1007/7854_2016_25] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 7.0] [Reference Citation Analysis]
505 Trovão N, Prata J, VonDoellinger O, Santos S, Barbosa M, Coelho R. Peripheral Biomarkers for First-Episode Psychosis-Opportunities from the Neuroinflammatory Hypothesis of Schizophrenia. Psychiatry Investig 2019;16:177-84. [PMID: 30836740 DOI: 10.30773/pi.2018.12.19.1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
506 Hoshikawa T, Okamoto N, Natsuyama T, Fujii R, Ikenouchi A, Honma Y, Harada M, Yoshimura R. Associations of Serum Cytokines, Growth Factors, and High-Sensitivity C-Reactive Protein Levels in Patients with Major Depression with and without Type 2 Diabetes Mellitus: An Explanatory Investigation. NDT 2022;Volume 18:173-86. [DOI: 10.2147/ndt.s350121] [Reference Citation Analysis]
507 Liu SH, Du Y, Chen L, Cheng Y. Glial Cell Abnormalities in Major Psychiatric Diseases: A Systematic Review of Postmortem Brain Studies. Mol Neurobiol 2022. [PMID: 35013935 DOI: 10.1007/s12035-021-02672-8] [Reference Citation Analysis]
508 Lizano P, Lutz O, Ling G, Lee AM, Eum S, Bishop JR, Kelly S, Pasternak O, Clementz B, Pearlson G, Sweeney JA, Gershon E, Tamminga C, Keshavan M. Association of Choroid Plexus Enlargement With Cognitive, Inflammatory, and Structural Phenotypes Across the Psychosis Spectrum. Am J Psychiatry 2019;176:564-72. [PMID: 31164007 DOI: 10.1176/appi.ajp.2019.18070825] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
509 Severance EG, Yolken RH. Tracking a dysregulated gut-brain axis with biomarkers of the microbiome. Biomarkers in Neuropsychiatry 2020;2:100009. [DOI: 10.1016/j.bionps.2019.100009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
510 Sudhalkar N, Rosen C, Melbourne JK, Park MR, Chase KA, Sharma RP. Long Non-Coding RNAs Associated with Heterochromatin Function in Immune Cells in Psychosis. Noncoding RNA 2018;4:E43. [PMID: 30567388 DOI: 10.3390/ncrna4040043] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
511 Allen AP, Curran EA, Duggan Á, Cryan JF, Chorcoráin AN, Dinan TG, Molloy DW, Kearney PM, Clarke G. A systematic review of the psychobiological burden of informal caregiving for patients with dementia: Focus on cognitive and biological markers of chronic stress. Neurosci Biobehav Rev 2017;73:123-64. [PMID: 27986469 DOI: 10.1016/j.neubiorev.2016.12.006] [Cited by in Crossref: 97] [Cited by in F6Publishing: 86] [Article Influence: 16.2] [Reference Citation Analysis]
512 Groh A, Jahn K, Walter M, Heck J, Lichtinghagen R, Janke E, Westhoff MLS, Deest M, Frieling H, Bleich S, Kahl K, Heberlein A. TNF-α Increase in a Cohort of Depressive Patients. Dis Markers 2021;2021:8897421. [PMID: 34257748 DOI: 10.1155/2021/8897421] [Reference Citation Analysis]
513 Misiak B, Bartoli F, Carrà G, Stańczykiewicz B, Gładka A, Frydecka D, Samochowiec J, Jarosz K, Hadryś T, Miller BJ. Immune-inflammatory markers and psychosis risk: A systematic review and meta-analysis. Psychoneuroendocrinology 2021;127:105200. [PMID: 33740587 DOI: 10.1016/j.psyneuen.2021.105200] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
514 Inanli I, Aydin M, Çaliskan AM, Eren I. Neutrophil/lymphocyte ratio, monocyte/lymphocyte ratio, and mean platelet volume as systemic inflammatory markers in different states of bipolar disorder. Nordic Journal of Psychiatry 2019;73:372-9. [DOI: 10.1080/08039488.2019.1640789] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
515 Çakici N, Sutterland AL, Penninx BWJH, de Haan L, van Beveren NJM. Changes in peripheral blood compounds following psychopharmacological treatment in drug-naïve first-episode patients with either schizophrenia or major depressive disorder: a meta-analysis. Psychol Med 2021;51:538-49. [PMID: 33653423 DOI: 10.1017/S0033291721000155] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
516 Kale A, Basu D, Sahoo S, Minz RW. Immune-mediated inflammatory markers in acute and transient psychotic disorders-comparison with schizophrenia: An exploratory comparative study. Early Interv Psychiatry 2022. [PMID: 35699508 DOI: 10.1111/eip.13319] [Reference Citation Analysis]
517 Gao Y, Li Y, Li S, Liang X, Ren Z, Yang X, Zhang B, Hu Y, Yang X. Systematic discovery of signaling pathways linking immune activation to schizophrenia. iScience 2021;24:103209. [PMID: 34746692 DOI: 10.1016/j.isci.2021.103209] [Reference Citation Analysis]
518 Quidé Y, Bortolasci CC, Spolding B, Kidnapillai S, Watkeys OJ, Cohen-Woods S, Berk M, Carr VJ, Walder K, Green MJ. Association between childhood trauma exposure and pro-inflammatory cytokines in schizophrenia and bipolar-I disorder. Psychol Med 2019;49:2736-44. [PMID: 30560764 DOI: 10.1017/S0033291718003690] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
519 Mizuki Y, Sakamoto S, Okahisa Y, Yada Y, Hashimoto N, Takaki M, Yamada N. Mechanisms Underlying the Comorbidity of Schizophrenia and Type 2 Diabetes Mellitus. Int J Neuropsychopharmacol 2021;24:367-82. [PMID: 33315097 DOI: 10.1093/ijnp/pyaa097] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
520 Goetz RL, Miller BJ. Total and Differential White Blood Cell Counts, Cocaine, and Marijuana Use in Patients With Schizophrenia. J Nerv Ment Dis 2019;207:633-6. [DOI: 10.1097/nmd.0000000000001019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
521 Mirzavandi F, Babaie S, Rahimpour S, Razmpoosh E, Talenezhad N, Aghaei Zarch SM, Mozaffari-khosravi H. The effect of high dose of intramuscular vitamin D supplement injections on depression in patients with type 2 diabetes and vitamin D deficiency: A randomized controlled clinical trial. Obesity Medicine 2020;17:100192. [DOI: 10.1016/j.obmed.2020.100192] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
522 de Souza DV, Pappis L, Bandeira TT, Sangoi GG, Fontana T, Rissi VB, Sagrillo MR, Duarte MM, Duarte T, Bodenstein DF, Andreazza AC, Cruz IBMD, Ribeiro EE, Antoniazzi A, Ourique AF, Machado AK. Açaí (Euterpe oleracea Mart.) presents anti-neuroinflammatory capacity in LPS-activated microglia cells. Nutr Neurosci 2020;:1-12. [PMID: 33170113 DOI: 10.1080/1028415X.2020.1842044] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
523 Halaris A, Sohl E, Whitham EA. Treatment-Resistant Depression Revisited: A Glimmer of Hope. J Pers Med 2021;11:155. [PMID: 33672126 DOI: 10.3390/jpm11020155] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
524 Sales MC, Kasahara TM, Sacramento PM, Rossi ÁD, Cafasso MOSD, Oyamada HAA, Hygino J, Alvim F, Andrade RM, Cristina Vasconcelos C, Bento CAM. Selective serotonin reuptake inhibitor attenuates the hyperresponsiveness of TLR2+ and TLR4+ Th17/Tc17-like cells in multiple sclerosis patients with major depression. Immunology 2021;162:290-305. [PMID: 33112414 DOI: 10.1111/imm.13281] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
525 Pollak TA, Drndarski S, Stone JM, David AS, McGuire P, Abbott NJ. The blood-brain barrier in psychosis. Lancet Psychiatry. 2018;5:79-92. [PMID: 28781208 DOI: 10.1016/s2215-0366(17)30293-6] [Cited by in Crossref: 92] [Cited by in F6Publishing: 52] [Article Influence: 18.4] [Reference Citation Analysis]
526 Dunleavy C, Elsworthy RJ, Upthegrove R, Wood SJ, Aldred S. Inflammation in first-episode psychosis: The contribution of inflammatory biomarkers to the emergence of negative symptoms, a systematic review and meta-analysis. Acta Psychiatr Scand 2022. [PMID: 35202480 DOI: 10.1111/acps.13416] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
527 Karageorgiou V, Milas GP, Michopoulos I. Neutrophil-to-lymphocyte ratio in schizophrenia: A systematic review and meta-analysis. Schizophrenia Research 2019;206:4-12. [DOI: 10.1016/j.schres.2018.12.017] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 6.7] [Reference Citation Analysis]
528 Kappelmann N, Khandaker GM, Dal H, Stochl J, Kosidou K, Jones PB, Dalman C, Karlsson H. Systemic inflammation and intelligence in early adulthood and subsequent risk of schizophrenia and other non-affective psychoses: a longitudinal cohort and co-relative study. Psychol Med 2019;49:295-302. [PMID: 29622048 DOI: 10.1017/S0033291718000831] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
529 Zuzarte P, Scola G, Duong A, Kostiw K, Figueira ML, Costa-vitali A. NT-proBNP is a potential mediator between reduced ejection fraction and depression in patients with heart failure. Journal of Psychiatric Research 2018;104:8-15. [DOI: 10.1016/j.jpsychires.2018.06.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
530 MacCormack JK, Gaudier-Diaz MM, Armstrong-Carter EL, Arevalo JMG, Meltzer-Brody S, Sloan EK, Cole SW, Muscatell KA. Beta-adrenergic blockade blunts inflammatory and antiviral/antibody gene expression responses to acute psychosocial stress. Neuropsychopharmacology 2021;46:756-62. [PMID: 33452438 DOI: 10.1038/s41386-020-00897-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
531 Appleton KM, Voyias PD, Sallis HM, Dawson S, Ness AR, Churchill R, Perry R. Omega-3 fatty acids for depression in adults. Cochrane Database Syst Rev 2021;11:CD004692. [PMID: 34817851 DOI: 10.1002/14651858.CD004692.pub5] [Reference Citation Analysis]
532 Li Z, Zhang T, Xu L, Wei Y, Tang Y, Hu Q, Liu X, Li X, Davis J, Smith R, Jin H, Wang J. Decreasing risk of psychosis by sulforaphane study protocol for a randomized, double-blind, placebo-controlled, clinical multi-centre trial. Early Interv Psychiatry 2021;15:585-94. [PMID: 32436318 DOI: 10.1111/eip.12988] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
533 Tseng H, Chang HH, Wei S, Lu T, Hsieh Y, Yang YK, Chen PS. Peripheral inflammation is associated with dysfunctional corticostriatal circuitry and executive dysfunction in bipolar disorder patients. Brain, Behavior, and Immunity 2021;91:695-702. [DOI: 10.1016/j.bbi.2020.09.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
534 Duan J, Wei Y, Womer FY, Zhang X, Chang M, Zhu Y, Liu Z, Li C, Yin Z, Zhang R, Sun J, Wang P, Wang S, Jiang X, Wei S, Zhang Y, Tang Y, Wang F. Neurobiological substrates of major psychiatry disorders: transdiagnostic associations between white matter abnormalities, neuregulin 1 and clinical manifestation. J Psychiatry Neurosci 2021;46:E506-15. [PMID: 34467747 DOI: 10.1503/jpn.200166] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
535 Jonker I, Rosmalen JGM, Schoevers RA. Childhood life events, immune activation and the development of mood and anxiety disorders: the TRAILS study. Transl Psychiatry 2017;7:e1112. [PMID: 28463238 DOI: 10.1038/tp.2017.62] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 4.8] [Reference Citation Analysis]
536 Pekala M, Doliwa M, Kalita K. Impact of maternal immune activation on dendritic spine development. Dev Neurobiol 2021;81:524-45. [PMID: 33382515 DOI: 10.1002/dneu.22804] [Reference Citation Analysis]
537 Morrens M, Overloop C, Coppens V, Loots E, Van Den Noortgate M, Vandenameele S, Leboyer M, De Picker L. The relationship between immune and cognitive dysfunction in mood and psychotic disorder: a systematic review and a meta-analysis. Mol Psychiatry 2022. [PMID: 35484245 DOI: 10.1038/s41380-022-01582-y] [Reference Citation Analysis]
538 Ramesh R, Sundaresh A, Rajkumar RP, Negi VS, Vijayalakshmi MA, Krishnamoorthy R, Tamouza R, Leboyer M, Kamalanathan AS. DNA hydrolysing IgG catalytic antibodies: an emerging link between psychoses and autoimmunity. NPJ Schizophr 2021;7:13. [PMID: 33637732 DOI: 10.1038/s41537-021-00143-6] [Reference Citation Analysis]
539 Han K, Tae W, Kim A, Kang Y, Kang W, Kang J, Kim Y, Kim B, Seong JY, Ham B. Serum FAM19A5 levels: A novel biomarker for neuroinflammation and neurodegeneration in major depressive disorder. Brain, Behavior, and Immunity 2020;87:852-9. [DOI: 10.1016/j.bbi.2020.03.021] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
540 Tang G, Chen P, Chen G, Zhong S, Gong J, Zhong H, Ye T, Chen F, Wang J, Luo Z, Qi Z, Jia Y, Wang Y, Huang L. Inflammation is correlated with abnormal functional connectivity in unmedicated bipolar depression: an independent component analysis study of resting-state fMRI. Psychol Med 2021;:1-11. [PMID: 33602352 DOI: 10.1017/S003329172100009X] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
541 Liu S, Qiao Y, Wu Y, Shen Y, Ke C. The longitudinal relation between depressive symptoms and change in self-rated health: A nationwide cohort study. J Psychiatr Res 2021;136:217-23. [PMID: 33618063 DOI: 10.1016/j.jpsychires.2021.02.039] [Reference Citation Analysis]
542 Osimo EF, Baxter LJ, Lewis G, Jones PB, Khandaker GM. Prevalence of low-grade inflammation in depression: a systematic review and meta-analysis of CRP levels. Psychol Med 2019;49:1958-70. [PMID: 31258105 DOI: 10.1017/S0033291719001454] [Cited by in Crossref: 204] [Cited by in F6Publishing: 119] [Article Influence: 68.0] [Reference Citation Analysis]
543 Singh D, Guest PC, Dobrowolny H, Vasilevska V, Meyer-Lotz G, Bernstein HG, Borucki K, Neyazi A, Bogerts B, Jacobs R, Steiner J. Changes in leukocytes and CRP in different stages of major depression. J Neuroinflammation 2022;19:74. [PMID: 35379263 DOI: 10.1186/s12974-022-02429-7] [Reference Citation Analysis]
544 Andreou D, Jørgensen KN, Nerland S, Ueland T, Vaskinn A, Haukvik UK, Yolken RH, Andreassen OA, Agartz I. Herpes simplex virus 1 infection on grey matter and general intelligence in severe mental illness. Transl Psychiatry 2022;12:276. [PMID: 35821107 DOI: 10.1038/s41398-022-02044-3] [Reference Citation Analysis]
545 Ceskova E. Pharmacological strategies for the management of comorbid depression and schizophrenia. Expert Opinion on Pharmacotherapy 2020;21:459-65. [DOI: 10.1080/14656566.2020.1717466] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
546 Zhang J, Luo W, Huang P, Peng L, Huang Q. Maternal C-reactive protein and cytokine levels during pregnancy and the risk of selected neuropsychiatric disorders in offspring: A systematic review and meta-analysis. Journal of Psychiatric Research 2018;105:86-94. [DOI: 10.1016/j.jpsychires.2018.09.002] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
547 Li X, Shi X, Tan Y, Yu Y, Tang C, Xu G, Zhang X, Liao H, Mai X, Chen W, Luo X, Xu C, Xie G, Liang J. Metabolic indexes of obesity in patients with common mental disorders in stable stage. BMC Psychiatry 2022;22:91. [PMID: 35130845 DOI: 10.1186/s12888-022-03752-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
548 Orlovska-Waast S, Köhler-Forsberg O, Brix SW, Nordentoft M, Kondziella D, Krogh J, Benros ME. Cerebrospinal fluid markers of inflammation and infections in schizophrenia and affective disorders: a systematic review and meta-analysis. Mol Psychiatry 2019;24:869-87. [PMID: 30116031 DOI: 10.1038/s41380-018-0220-4] [Cited by in Crossref: 94] [Cited by in F6Publishing: 80] [Article Influence: 23.5] [Reference Citation Analysis]
549 Feng R, Womer FY, Edmiston EK, Chen Y, Wang Y, Chang M, Yin Z, Wei Y, Duan J, Ren S, Li C, Liu Z, Jiang X, Wei S, Li S, Zhang X, Zuo XN, Tang Y, Wang F. Antipsychotic Effects on Cortical Morphology in Schizophrenia and Bipolar Disorders. Front Neurosci 2020;14:579139. [PMID: 33362453 DOI: 10.3389/fnins.2020.579139] [Reference Citation Analysis]
550 Shvartsur R, Agam G, Shnaider A, Uzzan S, Nassar A, Jabarin A, Abu-Freha N, Meir K, Azab AN. Safety and Efficacy of Combined Low-Dose Lithium and Low-Dose Aspirin: A Pharmacological and Behavioral Proof-of-Concept Study in Rats. Pharmaceutics 2021;13:1827. [PMID: 34834241 DOI: 10.3390/pharmaceutics13111827] [Reference Citation Analysis]
551 Pu X, Li J, Ma X, Yang S, Wang L. The functional polymorphisms linked with interleukin-1β gene expression are associated with bipolar disorder. Psychiatr Genet 2021;31:72-8. [PMID: 33707400 DOI: 10.1097/YPG.0000000000000272] [Reference Citation Analysis]
552 Di Biase MA, Zalesky A, Cetin-Karayumak S, Rathi Y, Lv J, Boerrigter D, North H, Tooney P, Pantelis C, Pasternak O, Shannon Weickert C, Cropley VL. Large-Scale Evidence for an Association Between Peripheral Inflammation and White Matter Free Water in Schizophrenia and Healthy Individuals. Schizophr Bull 2021;47:542-51. [PMID: 33085749 DOI: 10.1093/schbul/sbaa134] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
553 Zhang C, Wu Z, Zhao G, Wang F, Fang Y. Identification of IL6 as a susceptibility gene for major depressive disorder. Sci Rep 2016;6:31264. [PMID: 27502736 DOI: 10.1038/srep31264] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 4.5] [Reference Citation Analysis]
554 Lin CY, Chang FW, Yang JJ, Chang CH, Yeh CL, Lei WT, Huang CF, Liu JM, Hsu RJ. Increased risk of bipolar disorder in patients with scabies: A nationwide population-based matched-cohort study. Psychiatry Res 2017;257:14-20. [PMID: 28709117 DOI: 10.1016/j.psychres.2017.07.013] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
555 Klawonn AM, Fritz M, Castany S, Pignatelli M, Canal C, Similä F, Tejeda HA, Levinsson J, Jaarola M, Jakobsson J, Hidalgo J, Heilig M, Bonci A, Engblom D. Microglial activation elicits a negative affective state through prostaglandin-mediated modulation of striatal neurons. Immunity 2021;54:225-234.e6. [PMID: 33476547 DOI: 10.1016/j.immuni.2020.12.016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
556 Watson CJ, Thomas RH, Solomon T, Michael BD, Nicholson TR, Pollak TA. COVID-19 and psychosis risk: Real or delusional concern? Neurosci Lett 2021;741:135491. [PMID: 33220366 DOI: 10.1016/j.neulet.2020.135491] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
557 Balestrieri E, Matteucci C, Cipriani C, Grelli S, Ricceri L, Calamandrei G, Vallebona PS. Endogenous Retroviruses Activity as a Molecular Signature of Neurodevelopmental Disorders. Int J Mol Sci 2019;20:E6050. [PMID: 31801288 DOI: 10.3390/ijms20236050] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
558 Kheirouri S, Alizadeh M. Dietary Inflammatory Potential and the Risk of Incident Depression in Adults: A Systematic Review. Adv Nutr 2019;10:9-18. [PMID: 30615107 DOI: 10.1093/advances/nmy100] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
559 Pinto JV, Passos IC, Gomes F, Reckziegel R, Kapczinski F, Mwangi B, Kauer-Sant'Anna M. Peripheral biomarker signatures of bipolar disorder and schizophrenia: A machine learning approach. Schizophr Res 2017;188:182-4. [PMID: 28110815 DOI: 10.1016/j.schres.2017.01.018] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 2.6] [Reference Citation Analysis]
560 Laumet G, Edralin JD, Chiang AC, Dantzer R, Heijnen CJ, Kavelaars A. Resolution of inflammation-induced depression requires T lymphocytes and endogenous brain interleukin-10 signaling. Neuropsychopharmacology 2018;43:2597-605. [PMID: 30054585 DOI: 10.1038/s41386-018-0154-1] [Cited by in Crossref: 51] [Cited by in F6Publishing: 45] [Article Influence: 12.8] [Reference Citation Analysis]
561 Rosenblat JD. Targeting the immune system in the treatment of bipolar disorder. Psychopharmacology (Berl) 2019;236:2909-21. [PMID: 30756134 DOI: 10.1007/s00213-019-5175-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 5.7] [Reference Citation Analysis]
562 de la Garza AL, Garza-Cuellar MA, Silva-Hernandez IA, Cardenas-Perez RE, Reyes-Castro LA, Zambrano E, Gonzalez-Hernandez B, Garza-Ocañas L, Fuentes-Mera L, Camacho A. Maternal Flavonoids Intake Reverts Depression-Like Behaviour in Rat Female Offspring. Nutrients 2019;11:E572. [PMID: 30866491 DOI: 10.3390/nu11030572] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
563 Green C, Shen X, Stevenson AJ, Conole ELS, Harris MA, Barbu MC, Hawkins EL, Adams MJ, Hillary RF, Lawrie SM, Evans KL, Walker RM, Morris SW, Porteous DJ, Wardlaw JM, Steele JD, Waiter GD, Sandu AL, Campbell A, Marioni RE, Cox SR, Cavanagh J, McIntosh AM, Whalley HC. Structural brain correlates of serum and epigenetic markers of inflammation in major depressive disorder. Brain Behav Immun 2021;92:39-48. [PMID: 33221487 DOI: 10.1016/j.bbi.2020.11.024] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
564 Seidel M, Ehrlich S, Breithaupt L, Welch E, Wiklund C, Hübel C, Thornton LM, Savva A, Fundin BT, Pege J, Billger A, Abbaspour A, Schaefer M, Boehm I, Zvrskovec J, Rosager EV, Hasselbalch KC, Leppä V, Sjögren M, Nergårdh R, Feusner JD, Ghaderi A, Bulik CM. Study protocol of comprehensive risk evaluation for anorexia nervosa in twins (CREAT): a study of discordant monozygotic twins with anorexia nervosa. BMC Psychiatry 2020;20:507. [PMID: 33054774 DOI: 10.1186/s12888-020-02903-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
565 Sabe M, Pillinger T, Kaiser S, Chen C, Taipale H, Tanskanen A, Tiihonen J, Leucht S, Correll CU, Solmi M. Half a century of research on antipsychotics and schizophrenia: A scientometric study of hotspots, nodes, bursts, and trends. Neurosci Biobehav Rev 2022;136:104608. [PMID: 35303594 DOI: 10.1016/j.neubiorev.2022.104608] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
566 Cai HQ, Weickert TW, Catts VS, Balzan R, Galletly C, Liu D, O'Donnell M, Shannon Weickert C. Altered levels of immune cell adhesion molecules are associated with memory impairment in schizophrenia and healthy controls. Brain Behav Immun 2020;89:200-8. [PMID: 32540151 DOI: 10.1016/j.bbi.2020.06.017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
567 Chestnykh DA, Amato D, Kornhuber J, Müller CP. Pharmacotherapy of schizophrenia: Mechanisms of antipsychotic accumulation, therapeutic action and failure. Behav Brain Res 2021;403:113144. [PMID: 33515642 DOI: 10.1016/j.bbr.2021.113144] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
568 Chen L, Zheng WH, Du Y, Li XS, Yu Y, Wang H, Cheng Y. Altered Peripheral Immune Profiles in First-Episode, Drug-Free Patients With Schizophrenia: Response to Antipsychotic Medications. Front Med (Lausanne) 2021;8:757655. [PMID: 34901070 DOI: 10.3389/fmed.2021.757655] [Reference Citation Analysis]
569 Zhou Y, Wang C, Lan X, Li H, Chao Z, Ning Y. Plasma inflammatory cytokines and treatment-resistant depression with comorbid pain: improvement by ketamine. J Neuroinflammation 2021;18:200. [PMID: 34526064 DOI: 10.1186/s12974-021-02245-5] [Reference Citation Analysis]
570 Niu Z, Yang L, Wu X, Zhu Y, Chen J, Fang Y. The Relationship Between Neuroimmunity and Bipolar Disorder: Mechanism and Translational Application. Neurosci Bull 2019;35:595-607. [PMID: 31214924 DOI: 10.1007/s12264-019-00403-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
571 Renna ME, O'Toole MS, Spaeth PE, Lekander M, Mennin DS. The association between anxiety, traumatic stress, and obsessive-compulsive disorders and chronic inflammation: A systematic review and meta-analysis. Depress Anxiety 2018;35:1081-94. [PMID: 30199144 DOI: 10.1002/da.22790] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 10.5] [Reference Citation Analysis]
572 Kuwano N, Kato TA, Mitsuhashi M, Sato-Kasai M, Shimokawa N, Hayakawa K, Ohgidani M, Sagata N, Kubo H, Sakurai T, Kanba S. Neuron-related blood inflammatory markers as an objective evaluation tool for major depressive disorder: An exploratory pilot case-control study. J Affect Disord 2018;240:88-98. [PMID: 30059939 DOI: 10.1016/j.jad.2018.07.040] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
573 Lin Y, Peng Y, He S, Xu J, Shi Y, Su Y, Zhu C, Zhang X, Zhou R, Cui D. Serum IL-1ra, a novel biomarker predicting olanzapine-induced hypercholesterolemia and hyperleptinemia in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2018;84:71-78. [PMID: 29410009 DOI: 10.1016/j.pnpbp.2018.01.020] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
574 Moradi E, Marttinen M, Häkkinen T, Hiltunen M, Nykter M. Supervised pathway analysis of blood gene expression profiles in Alzheimer's disease. Neurobiol Aging 2019;84:98-108. [PMID: 31522136 DOI: 10.1016/j.neurobiolaging.2019.07.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
575 Khandaker GM, Oltean BP, Kaser M, Dibben CRM, Ramana R, Jadon DR, Dantzer R, Coles AJ, Lewis G, Jones PB. Protocol for the insight study: a randomised controlled trial of single-dose tocilizumab in patients with depression and low-grade inflammation. BMJ Open 2018;8:e025333. [PMID: 30244217 DOI: 10.1136/bmjopen-2018-025333] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 7.0] [Reference Citation Analysis]
576 Al-Dujaili AH, Mousa RF, Al-Hakeim HK, Maes M. High Mobility Group Protein 1 and Dickkopf-Related Protein 1 in Schizophrenia and Treatment-Resistant Schizophrenia: Associations With Interleukin-6, Symptom Domains, and Neurocognitive Impairments. Schizophr Bull 2021;47:530-41. [PMID: 32971537 DOI: 10.1093/schbul/sbaa136] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
577 Branchi I, Poggini S, Capuron L, Benedetti F, Poletti S, Tamouza R, Drexhage HA, Penninx BWJH, Pariante CM; European College of Neuropsychopharmacology (ECNP) ImmunoNeuroPsychiatry Thematic Working Group and Marion Leboyer. Brain-immune crosstalk in the treatment of major depressive disorder. Eur Neuropsychopharmacol 2021;45:89-107. [PMID: 33386229 DOI: 10.1016/j.euroneuro.2020.11.016] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
578 Dalkner N, Reininghaus E, Schwalsberger K, Rieger A, Hamm C, Pilz R, Lenger M, Queissner R, Falzberger VS, Platzer M, Fellendorf FT, Birner A, Bengesser SA, Weiss EM, McIntyre RS, Mangge H, Reininghaus B. C-Reactive Protein as a Possible Predictor of Trail-Making Performance in Individuals with Psychiatric Disorders. Nutrients 2020;12:E3019. [PMID: 33023087 DOI: 10.3390/nu12103019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
579 Fanelli G, Benedetti F, Wang S, Lee S, Jun T, Masand PS, Patkar AA, Han C, Serretti A, Pae C, Fabbri C. Reduced CXCL1/GRO chemokine plasma levels are a possible biomarker of elderly depression. Journal of Affective Disorders 2019;249:410-7. [DOI: 10.1016/j.jad.2019.02.042] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
580 Duong A, Jeong H, El Sabbagh DES, Andreazza AC. Systemic inflammatory biomarkers in DSM-5 defined disorders and COVID-19: Evidence from published meta-analyses. Biological Psychiatry Global Open Science 2022. [DOI: 10.1016/j.bpsgos.2022.01.006] [Reference Citation Analysis]
581 Werner MCF, Wirgenes KV, Shadrin AA, Lunding SH, Rødevand L, Hjell G, Ormerod MB, Haram M, Agartz I, Djurovic S, Melle I, Aukrust P, Ueland T, Andreassen OA, Steen NE. Limited association between infections, autoimmune disease and genetic risk and immune activation in severe mental disorders. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2022. [DOI: 10.1016/j.pnpbp.2022.110511] [Reference Citation Analysis]
582 Weissleder C, North HF, Shannon Weickert C. Important unanswered questions about adult neurogenesis in schizophrenia. Curr Opin Psychiatry 2019;32:170-8. [PMID: 30762701 DOI: 10.1097/YCO.0000000000000501] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
583 Lazary J, Eszlari N, Juhasz G, Bagdy G. A functional variant of CB2 receptor gene interacts with childhood trauma and FAAH gene on anxious and depressive phenotypes. J Affect Disord 2019;257:716-22. [PMID: 31382124 DOI: 10.1016/j.jad.2019.07.083] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
584 Kim E, Zhao Z, Rzasa JR, Glassman M, Bentley WE, Chen S, Kelly DL, Payne GF. Association of acute psychosocial stress with oxidative stress: Evidence from serum analysis. Redox Biol 2021;47:102138. [PMID: 34555595 DOI: 10.1016/j.redox.2021.102138] [Reference Citation Analysis]
585 Yasrebi SO, Momtazmanesh S, Moghaddam HS, Shahmansouri N, Mehrpooya M, Arbabi M, Ghazizadeh-Hashemi F, Akhondzadeh S. Pentoxifylline for treatment of major depression after percutaneous coronary intervention or coronary artery bypass grafting: A randomized, double-blind, placebo-controlled trial. J Psychosom Res 2021;150:110635. [PMID: 34627009 DOI: 10.1016/j.jpsychores.2021.110635] [Reference Citation Analysis]
586 Eltokhi A, Sommer IE. A Reciprocal Link Between Gut Microbiota, Inflammation and Depression: A Place for Probiotics? Front Neurosci 2022;16:852506. [PMID: 35546876 DOI: 10.3389/fnins.2022.852506] [Reference Citation Analysis]
587 Chu AL, Stochl J, Lewis G, Zammit S, Jones PB, Khandaker GM. Longitudinal association between inflammatory markers and specific symptoms of depression in a prospective birth cohort. Brain Behav Immun 2019;76:74-81. [PMID: 30414442 DOI: 10.1016/j.bbi.2018.11.007] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 9.8] [Reference Citation Analysis]
588 Teixeira AL, Salem H, Frey BN, Barbosa IG, Machado-Vieira R. Update on bipolar disorder biomarker candidates. Expert Rev Mol Diagn 2016;16:1209-20. [PMID: 27737600 DOI: 10.1080/14737159.2016.1248413] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 4.2] [Reference Citation Analysis]
589 Kahl KG, Fraccarollo D, Winter L, Bauersachs J, Westhoff-Bleck M. Increased epicardial adipose tissue in young adults with congenital heart disease comorbid with major depressive disorder. J Affect Disord 2019;257:678-83. [PMID: 31377604 DOI: 10.1016/j.jad.2019.07.070] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
590 Lee K, Abraham S, Cleaver R. A systematic review of licensed weight-loss medications in treating antipsychotic-induced weight gain and obesity in schizophrenia and psychosis. Gen Hosp Psychiatry 2022;78:58-67. [PMID: 35863294 DOI: 10.1016/j.genhosppsych.2022.07.006] [Reference Citation Analysis]
591 Huang MH, Chen MH, Hsu JW, Huang KL, Tsai SJ, Su TP, Bai YM. Inflammation, cognitive dysfunction, and suicidal ideation among patients with major depression. CNS Spectr 2021;:1-25. [PMID: 34423759 DOI: 10.1017/S1092852921000729] [Reference Citation Analysis]
592 Bauer ME, Teixeira AL. Inflammation in psychiatric disorders: what comes first? Ann N Y Acad Sci 2019;1437:57-67. [PMID: 29752710 DOI: 10.1111/nyas.13712] [Cited by in Crossref: 115] [Cited by in F6Publishing: 103] [Article Influence: 28.8] [Reference Citation Analysis]
593 Laskaris L, Mancuso S, Shannon Weickert C, Zalesky A, Chana G, Wannan C, Bousman C, Baune BT, McGorry P, Pantelis C, Cropley VL. Brain morphology is differentially impacted by peripheral cytokines in schizophrenia-spectrum disorder. Brain Behav Immun 2021;95:299-309. [PMID: 33838248 DOI: 10.1016/j.bbi.2021.04.002] [Reference Citation Analysis]
594 Felger JC. Imaging the Role of Inflammation in Mood and Anxiety-related Disorders.Curr Neuropharmacol. 2018;16:533-558. [PMID: 29173175 DOI: 10.2174/1570159X15666171123201142] [Cited by in Crossref: 88] [Cited by in F6Publishing: 55] [Article Influence: 22.0] [Reference Citation Analysis]
595 Ushakov VL, Malashenkova IK, Kostyuk GP, Zakharova NV, Krynskiy SA, Kartashov SI, Ogurtsov DP, Bravve LV, Kaydan MA, Hailov NA, Chekulaeva EI, Didkovsky NA. [The relationship between inflammation, cognitive disorders and neuroimaging data in schizophrenia]. Zh Nevrol Psikhiatr Im S S Korsakova 2020;120:70-8. [PMID: 33340301 DOI: 10.17116/jnevro202012011170] [Reference Citation Analysis]
596 Rosenblat JD, McIntyre RS. Bipolar Disorder and Immune Dysfunction: Epidemiological Findings, Proposed Pathophysiology and Clinical Implications. Brain Sci 2017;7:E144. [PMID: 29084144 DOI: 10.3390/brainsci7110144] [Cited by in Crossref: 74] [Cited by in F6Publishing: 64] [Article Influence: 14.8] [Reference Citation Analysis]
597 Costi S, Morris LS, Collins A, Fernandez NF, Patel M, Xie H, Kim-Schulze S, Stern ER, Collins KA, Cathomas F, Parides MK, Whitton AE, Pizzagalli DA, Russo SJ, Murrough JW. Peripheral immune cell reactivity and neural response to reward in patients with depression and anhedonia. Transl Psychiatry 2021;11:565. [PMID: 34741019 DOI: 10.1038/s41398-021-01668-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
598 Takemori Y, Sasayama D, Toida Y, Kotagiri M, Sugiyama N, Yamaguchi M, Washizuka S, Honda H. Possible utilization of salivary IFN-γ/IL-4 ratio as a marker of chronic stress in healthy individuals. Neuropsychopharmacol Rep 2021;41:65-72. [PMID: 33465301 DOI: 10.1002/npr2.12157] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
599 Carboni L, McCarthy DJ, Delafont B, Filosi M, Ivanchenko E, Ratti E, Learned SM, Alexander R, Domenici E. Biomarkers for response in major depression: comparing paroxetine and venlafaxine from two randomised placebo-controlled clinical studies. Transl Psychiatry 2019;9:182. [PMID: 31375659 DOI: 10.1038/s41398-019-0521-7] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 11.3] [Reference Citation Analysis]
600 Gao Y, Fan Y, Yang Z, Ma Q, Zhao B, He X, Gao F, Qian L, Wang W, Chen C, Chen Y, Gao C, Ma X, Zhu F. Systems biological assessment of altered cytokine responses to bacteria and fungi reveals impaired immune functionality in schizophrenia. Mol Psychiatry 2021. [PMID: 34728799 DOI: 10.1038/s41380-021-01362-0] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
601 Kogan S, Ospina LH, Kimhy D. Inflammation in individuals with schizophrenia - Implications for neurocognition and daily function. Brain Behav Immun 2018;74:296-9. [PMID: 30218782 DOI: 10.1016/j.bbi.2018.09.016] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
602 Reiter A, Bengesser SA, Hauschild AC, Birkl-Töglhofer AM, Fellendorf FT, Platzer M, Färber T, Seidl M, Mendel LM, Unterweger R, Lenger M, Mörkl S, Dalkner N, Birner A, Queissner R, Hamm C, Maget A, Pilz R, Kohlhammer-Dohr A, Wagner-Skacel J, Kreuzer K, Schöggl H, Amberger-Otti D, Lahousen T, Leitner-Afschar B, Haybäck J, Kapfhammer HP, Reininghaus E. Interleukin-6 Gene Expression Changes after a 4-Week Intake of a Multispecies Probiotic in Major Depressive Disorder-Preliminary Results of the PROVIT Study. Nutrients 2020;12:E2575. [PMID: 32858844 DOI: 10.3390/nu12092575] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
603 Yang C, Wardenaar KJ, Bosker FJ, Li J, Schoevers RA. Inflammatory markers and treatment outcome in treatment resistant depression: A systematic review. J Affect Disord 2019;257:640-9. [PMID: 31357161 DOI: 10.1016/j.jad.2019.07.045] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 8.7] [Reference Citation Analysis]
604 You MJ, Bang M, Park HS, Yang B, Jang KB, Yoo J, Hwang DY, Kim M, Kim B, Lee SH, Kwon MS. Human umbilical cord-derived mesenchymal stem cells alleviate schizophrenia-relevant behaviors in amphetamine-sensitized mice by inhibiting neuroinflammation. Transl Psychiatry. 2020;10:123. [PMID: 32341334 DOI: 10.1038/s41398-020-0802-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
605 Pillinger T, D'Ambrosio E, McCutcheon R, Howes OD. Is psychosis a multisystem disorder? A meta-review of central nervous system, immune, cardiometabolic, and endocrine alterations in first-episode psychosis and perspective on potential models. Mol Psychiatry 2019;24:776-94. [PMID: 29743584 DOI: 10.1038/s41380-018-0058-9] [Cited by in Crossref: 63] [Cited by in F6Publishing: 50] [Article Influence: 15.8] [Reference Citation Analysis]
606 Runge K, Fiebich BL, Kuzior H, Saliba SW, Yousif NM, Meixensberger S, Nickel K, Denzel D, Schiele MA, Maier SJ, Berger B, Dersch R, Domschke K, Tebartz van Elst L, Endres D. An observational study investigating cytokine levels in the cerebrospinal fluid of patients with schizophrenia spectrum disorders. Schizophr Res 2021;231:205-13. [PMID: 33887648 DOI: 10.1016/j.schres.2021.03.022] [Reference Citation Analysis]
607 Hoang D, Xu Y, Lutz O, Bannai D, Zeng V, Bishop JR, Keshavan M, Lizano P. Inflammatory Subtypes in Antipsychotic-Naïve First-Episode Schizophrenia are Associated with Altered Brain Morphology and Topological Organization. Brain Behav Immun 2021;100:297-308. [PMID: 34875344 DOI: 10.1016/j.bbi.2021.11.019] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
608 Abdoli A, Taghipour A, Pirestani M, Mofazzal Jahromi MA, Roustazadeh A, Mir H, Ardakani HM, Kenarkoohi A, Falahi S, Karimi M. Infections, inflammation, and risk of neuropsychiatric disorders: the neglected role of "co-infection". Heliyon 2020;6:e05645. [PMID: 33319101 DOI: 10.1016/j.heliyon.2020.e05645] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
609 Kalkman HO, Hersberger M, Walitza S, Berger GE. Disentangling the Molecular Mechanisms of the Antidepressant Activity of Omega-3 Polyunsaturated Fatty Acid: A Comprehensive Review of the Literature. Int J Mol Sci 2021;22:4393. [PMID: 33922396 DOI: 10.3390/ijms22094393] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
610 Upthegrove R, Khandaker GM. Cytokines, Oxidative Stress and Cellular Markers of Inflammation in Schizophrenia. Curr Top Behav Neurosci 2020;44:49-66. [PMID: 31115797 DOI: 10.1007/7854_2018_88] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 14.5] [Reference Citation Analysis]
611 Orlovska-Waast S, Petersen LV, Gasse C, Nordentoft M, Mortensen PB, Kondziella D, Benros ME. Cerebrospinal fluid test results and associations with subsequent mental disorders, neurological diseases, and CNS infections: A population-based cohort study. Brain Behav Immun 2021;98:210-8. [PMID: 34390802 DOI: 10.1016/j.bbi.2021.08.006] [Reference Citation Analysis]
612 Flux MC, Lowry CA. Finding intestinal fortitude: Integrating the microbiome into a holistic view of depression mechanisms, treatment, and resilience. Neurobiol Dis 2020;135:104578. [PMID: 31454550 DOI: 10.1016/j.nbd.2019.104578] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
613 Gao Q, Song H, Wang XT, Liang Y, Xi YJ, Gao Y, Guo QJ, LeBaron T, Luo YX, Li SC, Yin X, Shi HS, Ma YX. Molecular hydrogen increases resilience to stress in mice. Sci Rep 2017;7:9625. [PMID: 28852144 DOI: 10.1038/s41598-017-10362-6] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
614 Gallego JA, Blanco EA, Husain-Krautter S, Madeline Fagen E, Moreno-Merino P, Del Ojo-Jiménez JA, Ahmed A, Rothstein TL, Lencz T, Malhotra AK. Cytokines in cerebrospinal fluid of patients with schizophrenia spectrum disorders: New data and an updated meta-analysis. Schizophr Res 2018;202:64-71. [PMID: 30025760 DOI: 10.1016/j.schres.2018.07.019] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 10.0] [Reference Citation Analysis]
615 Perry BI, Upthegrove R, Kappelmann N, Jones PB, Burgess S, Khandaker GM. Associations of immunological proteins/traits with schizophrenia, major depression and bipolar disorder: A bi-directional two-sample mendelian randomization study. Brain Behav Immun 2021:S0889-1591(21)00273-7. [PMID: 34280516 DOI: 10.1016/j.bbi.2021.07.009] [Reference Citation Analysis]
616 Yang X, Zhao H, Liu X, Xie Q, Zhou X, Deng Q, Wang G. The Relationship Between Serum Cytokine Levels and the Degree of Psychosis and Cognitive Impairment in Patients With Methamphetamine-Associated Psychosis in Chinese Patients. Front Psychiatry 2020;11:594766. [PMID: 33362607 DOI: 10.3389/fpsyt.2020.594766] [Reference Citation Analysis]
617 Marcinowicz P, Więdłocha M, Zborowska N, Dębowska W, Podwalski P, Misiak B, Tyburski E, Szulc A. A Meta-Analysis of the Influence of Antipsychotics on Cytokines Levels in First Episode Psychosis. J Clin Med 2021;10:2488. [PMID: 34199832 DOI: 10.3390/jcm10112488] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
618 Korostynski M, Hoinkis D, Piechota M, Golda S, Pera J, Slowik A, Dziedzic T. Toll-like receptor 4-mediated cytokine synthesis and post-stroke depressive symptoms. Transl Psychiatry 2021;11:246. [PMID: 33903586 DOI: 10.1038/s41398-021-01359-x] [Reference Citation Analysis]
619 Fraguas D, Díaz-Caneja CM, Ayora M, Hernández-Álvarez F, Rodríguez-Quiroga A, Recio S, Leza JC, Arango C. Oxidative Stress and Inflammation in First-Episode Psychosis: A Systematic Review and Meta-analysis. Schizophr Bull 2019;45:742-51. [PMID: 30169868 DOI: 10.1093/schbul/sby125] [Cited by in Crossref: 50] [Cited by in F6Publishing: 46] [Article Influence: 25.0] [Reference Citation Analysis]
620 Maj C, Tosato S, Zanardini R, Lasalvia A, Favaro A, Leuci E, De Girolamo G, Ruggeri M, Gennarelli M, Bocchio‐chiavetto L; the GET‐UP GROUP. Correlations between immune and metabolic serum markers and schizophrenia/bipolar disorder polygenic risk score in first‐episode psychosis. Early Intervention in Psychiatry 2020;14:507-11. [DOI: 10.1111/eip.12906] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
621 Miller BJ, Herzig KH, Jokelainen J, Karhu T, Keinänen-Kiukaanniemi S, Järvelin MR, Veijola J, Viinamäki H, Päivikki Tanskanen, Jääskeläinen E, Isohanni M, Timonen M. Inflammation, hippocampal volume, and cognition in schizophrenia: results from the Northern Finland Birth Cohort 1966. Eur Arch Psychiatry Clin Neurosci 2021;271:609-22. [PMID: 32382794 DOI: 10.1007/s00406-020-01134-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
622 Wang Y, Wei Y, Edmiston EK, Womer FY, Zhang X, Duan J, Zhu Y, Zhang R, Yin Z, Zhang Y, Jiang X, Wei S, Liu Z, Zhang Y, Tang Y, Wang F. Altered structural connectivity and cytokine levels in Schizophrenia and Genetic high-risk individuals: Associations with disease states and vulnerability. Schizophr Res 2020;223:158-65. [PMID: 32684357 DOI: 10.1016/j.schres.2020.05.044] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
623 Morris G, Puri BK, Olive L, Carvalho A, Berk M, Walder K, Gustad LT, Maes M. Endothelial dysfunction in neuroprogressive disorders-causes and suggested treatments. BMC Med 2020;18:305. [PMID: 33070778 DOI: 10.1186/s12916-020-01749-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
624 Walther A, Mackens-Kiani A, Eder J, Herbig M, Herold C, Kirschbaum C, Guck J, Wittwer LD, Beesdo-Baum K, Kräter M. Depressive disorders are associated with increased peripheral blood cell deformability: a cross-sectional case-control study (Mood-Morph). Transl Psychiatry 2022;12:150. [PMID: 35396373 DOI: 10.1038/s41398-022-01911-3] [Reference Citation Analysis]
625 Romeo B, Lestra V, Martelli C, Benyamina A, Hamdani N. Cannabis Cessation, Inflammatory Markers and Schizophrenia. J Dual Diagn 2022;:1-9. [PMID: 34985404 DOI: 10.1080/15504263.2021.2013697] [Reference Citation Analysis]
626 Perry BI, Zammit S, Jones PB, Khandaker GM. Childhood inflammatory markers and risks for psychosis and depression at age 24: Examination of temporality and specificity of association in a population-based prospective birth cohort. Schizophr Res 2021;230:69-76. [PMID: 33684738 DOI: 10.1016/j.schres.2021.02.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
627 Malashenkova IK, Krynskiy SA, Ogurtsov DP, Hailov NA, Zakharova NV, Bravve LV, Kaydan MA, Chekulaeva EI, Andreyuk DS, Ushakov VL, Didkovsky NA, Kostyuk GP. Immunoinflammatory Profile in Patients with Episodic and Continuous Paranoid Schizophrenia. Consortium Psychiatricum 2021;2:19-31. [DOI: 10.17816/cp66] [Reference Citation Analysis]
628 Ślusarczyk J, Trojan E, Wydra K, Głombik K, Chamera K, Kucharczyk M, Budziszewska B, Kubera M, Lasoń W, Filip M, Basta-Kaim A. Beneficial impact of intracerebroventricular fractalkine administration on behavioral and biochemical changes induced by prenatal stress in adult rats: Possible role of NLRP3 inflammasome pathway. Biochem Pharmacol 2016;113:45-56. [PMID: 27206338 DOI: 10.1016/j.bcp.2016.05.008] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.5] [Reference Citation Analysis]
629 Savitz J, Harrison NA. Interoception and Inflammation in Psychiatric Disorders.Biol Psychiatry Cogn Neurosci Neuroimaging. 2018;3:514-524. [PMID: 29884282 DOI: 10.1016/j.bpsc.2017.12.011] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
630 Huang TL, Lo LH, Shiea J, Su H. Rapid and simple analysis of disease-associated biomarkers of Taiwanese patients with schizophrenia using matrix-assisted laser desorption ionization mass spectrometry. Clin Chim Acta 2017;473:75-81. [PMID: 28807542 DOI: 10.1016/j.cca.2017.08.011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
631 Ning H, Du Y, Zhao Y, Liu Q, Li X, Zhang H, Jiang D, Feng H. Longitudinal impact of metabolic syndrome and depressive symptoms on subsequent functional disability among middle-aged and older adults in China. J Affect Disord 2022;296:216-23. [PMID: 34614438 DOI: 10.1016/j.jad.2021.09.061] [Reference Citation Analysis]
632 Barron H, Hafizi S, Andreazza AC, Mizrahi R. Neuroinflammation and Oxidative Stress in Psychosis and Psychosis Risk. Int J Mol Sci 2017;18:E651. [PMID: 28304340 DOI: 10.3390/ijms18030651] [Cited by in Crossref: 72] [Cited by in F6Publishing: 66] [Article Influence: 14.4] [Reference Citation Analysis]
633 Chen MH, Hsu JW, Huang KL, Tsai SJ, Tu PC, Bai YM. Inflammatory cytokines in and cognitive function of adolescents with first-episode schizophrenia, bipolar disorder, or major depressive disorder. CNS Spectr 2021;:1-8. [PMID: 34664544 DOI: 10.1017/S1092852921000857] [Reference Citation Analysis]
634 Fond G, Sunhary de Verville PL, Richieri R, Etchecopar-Etchart D, Korchia T, Faugere M, Godin O, Schürhoff F, Berna F, Aouizerate B, Capdevielle D, Chereau I, Clauss-Kobayashi J, Coulon N, Dorey JM, Dubertret C, Dubreucq J, Mallet J, Misdrahi D, Passerieux C, Pignon B, Rey R, Urbach M, Leboyer M; FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) Group. Redefining peripheral inflammation signature in schizophrenia based on the real-world FACE-SZ cohort. Prog Neuropsychopharmacol Biol Psychiatry 2021;111:110335. [PMID: 33933539 DOI: 10.1016/j.pnpbp.2021.110335] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
635 Mucci F, Marazziti D, Della Vecchia A, Baroni S, Morana P, Carpita B, Mangiapane P, Morana F, Morana B, Dell'Osso L. State-of-the-Art: Inflammatory and Metabolic Markers in Mood Disorders. Life (Basel) 2020;10:E82. [PMID: 32517269 DOI: 10.3390/life10060082] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
636 Miller BJ, Goldsmith DR. Evaluating the Hypothesis That Schizophrenia Is an Inflammatory Disorder. Focus (Am Psychiatr Publ) 2020;18:391-401. [PMID: 33343251 DOI: 10.1176/appi.focus.20200015] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
637 Melbourne JK, Rosen C, Chase KA, Feiner B, Sharma RP. Monocyte Transcriptional Profiling Highlights a Shift in Immune Signatures Over the Course of Illness in Schizophrenia. Front Psychiatry 2021;12:649494. [PMID: 34054608 DOI: 10.3389/fpsyt.2021.649494] [Reference Citation Analysis]
638 Steiner J, Prüß H, Köhler S, Hasan A, Falkai P. [Autoimmune encephalitis with psychotic symptoms : Diagnostics, warning signs and practical approach]. Nervenarzt 2018;89:530-8. [PMID: 29523913 DOI: 10.1007/s00115-018-0499-z] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
639 Barbosa IG, Ferreira RDA, Rocha NP, Mol GC, da Mata Chiaccjio Leite F, Bauer IE, Teixeira AL. Predictors of cognitive performance in bipolar disorder: The role of educational degree and inflammatory markers. Journal of Psychiatric Research 2018;106:31-7. [DOI: 10.1016/j.jpsychires.2018.09.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
640 Stein F, Meller T, Brosch K, Schmitt S, Ringwald K, Pfarr JK, Meinert S, Thiel K, Lemke H, Waltemate L, Grotegerd D, Opel N, Jansen A, Nenadić I, Dannlowski U, Krug A, Kircher T. Psychopathological Syndromes Across Affective and Psychotic Disorders Correlate With Gray Matter Volumes. Schizophr Bull 2021:sbab037. [PMID: 33860786 DOI: 10.1093/schbul/sbab037] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
641 Andreou D, Jørgensen KN, Nerland S, Engen K, Yolken RH, Andreassen OA, Agartz I. Cytomegalovirus infection associated with smaller dentate gyrus in men with severe mental illness. Brain Behav Immun 2021;96:54-62. [PMID: 34010712 DOI: 10.1016/j.bbi.2021.05.009] [Reference Citation Analysis]
642 Culmsee C, Michels S, Scheu S, Arolt V, Dannlowski U, Alferink J. Mitochondria, Microglia, and the Immune System-How Are They Linked in Affective Disorders? Front Psychiatry 2018;9:739. [PMID: 30687139 DOI: 10.3389/fpsyt.2018.00739] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 10.3] [Reference Citation Analysis]
643 Bustan Y, Drapisz A, Ben Dor DH, Avrahami M, Schwartz-Lifshitz M, Weizman A, Barzilay R. Elevated neutrophil to lymphocyte ratio in non-affective psychotic adolescent inpatients: Evidence for early association between inflammation and psychosis. Psychiatry Res 2018;262:149-53. [PMID: 29448179 DOI: 10.1016/j.psychres.2018.02.002] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 5.8] [Reference Citation Analysis]
644 Jin K, Lu J, Yu Z, Shen Z, Li H, Mou T, Xu Y, Huang M. Linking peripheral IL-6, IL-1β and hypocretin-1 with cognitive impairment from major depression. J Affect Disord 2020;277:204-11. [PMID: 32829196 DOI: 10.1016/j.jad.2020.08.024] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
645 Sowa-Kućma M, Styczeń K, Siwek M, Misztak P, Nowak RJ, Dudek D, Rybakowski JK, Nowak G, Maes M. Lipid Peroxidation and Immune Biomarkers Are Associated with Major Depression and Its Phenotypes, Including Treatment-Resistant Depression and Melancholia. Neurotox Res 2018;33:448-60. [PMID: 29103192 DOI: 10.1007/s12640-017-9835-5] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 5.4] [Reference Citation Analysis]
646 Petrova D, Catena A, Rodríguez-Barranco M, Redondo-Sánchez D, Bayo-Lozano E, Garcia-Retamero R, Jiménez-Moleón JJ, Sánchez MJ. Physical Comorbidities and Depression in Recent and Long-Term Adult Cancer Survivors: NHANES 2007-2018. Cancers (Basel) 2021;13:3368. [PMID: 34282756 DOI: 10.3390/cancers13133368] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
647 Corsi-zuelli F, Loureiro CM, Shuhama R, Fachim HA, Menezes PR, Louzada-junior P, Mondelli V, Del-ben CM. Cytokine profile in first-episode psychosis, unaffected siblings and community-based controls: the effects of familial liability and childhood maltreatment. Psychol Med 2020;50:1139-47. [DOI: 10.1017/s0033291719001016] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 6.7] [Reference Citation Analysis]
648 Noto MN, Maes M, Nunes SOV, Ota VK, Rossaneis AC, Verri WA Jr, Cordeiro Q, Belangero SI, Gadelha A, Bressan RA, Noto C. Activation of the immune-inflammatory response system and the compensatory immune-regulatory system in antipsychotic naive first episode psychosis. Eur Neuropsychopharmacol 2019;29:416-31. [PMID: 30594344 DOI: 10.1016/j.euroneuro.2018.12.008] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 7.0] [Reference Citation Analysis]
649 Yeh TC, Chu HT, Tsai CK, Chang HA, Yang FC, Huang SY, Liang CS. Distinct Inflammation Biomarkers in Healthy Individuals and Patients with Schizophrenia: A Reliability Testing of Multiplex Cytokine Immunoassay by Bland-Altman Analysis. Psychiatry Investig 2019;16:607-14. [PMID: 31352771 DOI: 10.30773/pi.2019.04.14] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
650 Belzeaux R, Lefebvre MN, Lazzari A, Le Carpentier T, Consoloni JL, Zendjidjian X, Abbar M, Courtet P, Naudin J, Boucraut J, Gressens P, Glaichenhaus N, Ibrahim EC. How to: Measuring blood cytokines in biological psychiatry using commercially available multiplex immunoassays. Psychoneuroendocrinology 2017;75:72-82. [PMID: 27810706 DOI: 10.1016/j.psyneuen.2016.10.010] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
651 Kogan S, Ospina LH, Mittal VA, Kimhy D. The impact of inflammation on neurocognition and risk for psychosis: a critical review. Eur Arch Psychiatry Clin Neurosci 2020;270:793-802. [PMID: 31620871 DOI: 10.1007/s00406-019-01073-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
652 Kelly KM, Smith JA, Mezuk B. Depression and interleukin-6 signaling: A Mendelian Randomization study. Brain Behav Immun 2021;95:106-14. [PMID: 33631287 DOI: 10.1016/j.bbi.2021.02.019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
653 Engler H, Brendt P, Wischermann J, Wegner A, Röhling R, Schoemberg T, Meyer U, Gold R, Peters J, Benson S, Schedlowski M. Selective increase of cerebrospinal fluid IL-6 during experimental systemic inflammation in humans: association with depressive symptoms. Mol Psychiatry 2017;22:1448-54. [PMID: 28138158 DOI: 10.1038/mp.2016.264] [Cited by in Crossref: 65] [Cited by in F6Publishing: 60] [Article Influence: 13.0] [Reference Citation Analysis]
654 Xiu MH, Wang DM, Du XD, Chen N, Tan SP, Tan YL, Yang FD, Cho RY, Zhang XY. Interaction of BDNF and cytokines in executive dysfunction in patients with chronic schizophrenia. Psychoneuroendocrinology 2019;108:110-7. [DOI: 10.1016/j.psyneuen.2019.06.006] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
655 Turner A, McGrath JJ, Dean OM, Dodd S, Baker A, Cotton SM, Scott JG, Kavanagh BE, Ashton MM, Walker AJ, Brown E, Berk M. Protocol and Rationale: A 24-week Double-blind, Randomized, Placebo Controlled Trial of the Efficacy of Adjunctive Garcinia mangostanaLinn. (Mangosteen) Pericarp for Schizophrenia. Clin Psychopharmacol Neurosci 2019;17:297-307. [PMID: 30905130 DOI: 10.9758/cpn.2019.17.2.297] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
656 Baune BT, Sampson E, Louise J, Hori H, Schubert KO, Clark SR, Mills NT, Fourrier C. No evidence for clinical efficacy of adjunctive celecoxib with vortioxetine in the treatment of depression: A 6-week double-blind placebo controlled randomized trial. Eur Neuropsychopharmacol 2021;53:34-46. [PMID: 34375789 DOI: 10.1016/j.euroneuro.2021.07.092] [Reference Citation Analysis]
657 Kroken RA, Sommer IE, Steen VM, Dieset I, Johnsen E. Constructing the Immune Signature of Schizophrenia for Clinical Use and Research; An Integrative Review Translating Descriptives Into Diagnostics. Front Psychiatry. 2018;9:753. [PMID: 30766494 DOI: 10.3389/fpsyt.2018.00753] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 9.3] [Reference Citation Analysis]
658 de Melo LGP, Nunes SOV, Anderson G, Vargas HO, Barbosa DS, Galecki P, Carvalho AF, Maes M. Shared metabolic and immune-inflammatory, oxidative and nitrosative stress pathways in the metabolic syndrome and mood disorders. Prog Neuropsychopharmacol Biol Psychiatry 2017;78:34-50. [PMID: 28438472 DOI: 10.1016/j.pnpbp.2017.04.027] [Cited by in Crossref: 84] [Cited by in F6Publishing: 76] [Article Influence: 16.8] [Reference Citation Analysis]
659 Łoś K, Waszkiewicz N. Biological Markers in Anxiety Disorders. J Clin Med 2021;10:1744. [PMID: 33920547 DOI: 10.3390/jcm10081744] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
660 Kanchanatawan B, Sirivichayakul S, Carvalho AF, Anderson G, Galecki P, Maes M. Depressive, anxiety and hypomanic symptoms in schizophrenia may be driven by tryptophan catabolite (TRYCAT) patterning of IgA and IgM responses directed to TRYCATs. Prog Neuropsychopharmacol Biol Psychiatry 2018;80:205-16. [PMID: 28690204 DOI: 10.1016/j.pnpbp.2017.06.033] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
661 Bordoni L, Petracci I, Calleja-Agius J, Lalor JG, Gabbianelli R. NURR1 Alterations in Perinatal Stress: A First Step towards Late-Onset Diseases? A Narrative Review. Biomedicines 2020;8:E584. [PMID: 33302583 DOI: 10.3390/biomedicines8120584] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
662 King S, Holleran L, Mothersill D, Patlola S, Rokita K, McManus R, Keynon M, McDonald C, Hallahan B, Corvin A, Morris D, Kelly J, McKernan D, Donohoe G. Early Life Adversity, Functional Connectivity And Cognitive Performance In Schizophrenia: The Mediating Role Of IL-6. Brain Behav Immun 2021:S0889-1591(21)00247-6. [PMID: 34242739 DOI: 10.1016/j.bbi.2021.06.016] [Reference Citation Analysis]
663 Meikle CKS, Creeden JF, McCullumsmith C, Worth RG. SSRIs: Applications in inflammatory lung disease and implications for COVID-19. Neuropsychopharmacol Rep 2021;41:325-35. [PMID: 34254465 DOI: 10.1002/npr2.12194] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
664 North HF, Bruggemann J, Cropley V, Swaminathan V, Sundram S, Lenroot R, Pereira AM, Zalesky A, Bousman C, Pantelis C, Weickert TW, Shannon Weickert C. Increased peripheral inflammation in schizophrenia is associated with worse cognitive performance and related cortical thickness reductions. Eur Arch Psychiatry Clin Neurosci 2021;271:595-607. [PMID: 33760971 DOI: 10.1007/s00406-021-01237-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 12.0] [Reference Citation Analysis]
665 Huang MH, Chan YE, Chen MH, Hsu JW, Huang KL, Li CT, Tsai SJ, Bai YM, Su TP. Pro-inflammatory cytokines and cognitive dysfunction among patients with bipolar disorder and major depression. Psychiatry Clin Neurosci 2022. [PMID: 35674415 DOI: 10.1111/pcn.13433] [Reference Citation Analysis]
666 Erazo R. Depresión e inflamación: ¿Una relación más allá del azar? Revista Médica Clínica Las Condes 2020;31:188-96. [DOI: 10.1016/j.rmclc.2020.02.006] [Reference Citation Analysis]
667 Basson AR, Lam M, Cominelli F. Complementary and Alternative Medicine Strategies for Therapeutic Gut Microbiota Modulation in Inflammatory Bowel Disease and their Next-Generation Approaches. Gastroenterol Clin North Am. 2017;46:689-729. [PMID: 29173517 DOI: 10.1016/j.gtc.2017.08.002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
668 Bishop JR, Zhang L, Lizano P. Inflammation Subtypes and Translating Inflammation-Related Genetic Findings in Schizophrenia and Related Psychoses: A Perspective on Pathways for Treatment Stratification and Novel Therapies. Harv Rev Psychiatry 2022;30:59-70. [PMID: 34995036 DOI: 10.1097/HRP.0000000000000321] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 9.0] [Reference Citation Analysis]
669 May AC, Burrows K, Figueroa-Hall LK, Kirlic N, White EJ, Smith R, Ekhtiari H, Paulus MP, Savitz J, Stewart JL; T1000 Investigators. Sex differences in circulating inflammatory mediators as a function of substance use disorder. Drug Alcohol Depend 2021;221:108610. [PMID: 33631550 DOI: 10.1016/j.drugalcdep.2021.108610] [Reference Citation Analysis]
670 Kalkman HO. Novel Treatment Targets Based on Insights in the Etiology of Depression: Role of IL-6 Trans-Signaling and Stress-Induced Elevation of Glutamate and ATP. Pharmaceuticals (Basel) 2019;12:E113. [PMID: 31362361 DOI: 10.3390/ph12030113] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
671 Goldsmith DR, Crooks CL, Walker EF, Cotes RO. An Update on Promising Biomarkers in Schizophrenia. Focus (Am Psychiatr Publ) 2018;16:153-63. [PMID: 31975910 DOI: 10.1176/appi.focus.20170046] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
672 Corsi-Zuelli FMDG, Brognara F, Quirino GFDS, Hiroki CH, Fais RS, Del-Ben CM, Ulloa L, Salgado HC, Kanashiro A, Loureiro CM. Neuroimmune Interactions in Schizophrenia: Focus on Vagus Nerve Stimulation and Activation of the Alpha-7 Nicotinic Acetylcholine Receptor. Front Immunol 2017;8:618. [PMID: 28620379 DOI: 10.3389/fimmu.2017.00618] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
673 Osimo EF, Baxter L, Stochl J, Perry BI, Metcalf SA, Kunutsor SK, Laukkanen JA, Wium-Andersen MK, Jones PB, Khandaker GM. Longitudinal association between CRP levels and risk of psychosis: a meta-analysis of population-based cohort studies. NPJ Schizophr 2021;7:31. [PMID: 34050185 DOI: 10.1038/s41537-021-00161-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
674 Strzelecki D, Urban-kowalczyk M, Wysokiński A. Serum levels of TNF-alpha in patients with chronic schizophrenia during treatment augmentation with sarcosine (results of the PULSAR study). Psychiatry Research 2018;268:447-53. [DOI: 10.1016/j.psychres.2018.08.002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
675 Doney E, Cadoret A, Dion-Albert L, Lebel M, Menard C. Inflammation-driven brain and gut barrier dysfunction in stress and mood disorders. Eur J Neurosci 2021. [PMID: 33876886 DOI: 10.1111/ejn.15239] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
676 Belem da Silva CT, Hoffmann MS, Sant Anna RT, Wehrmeister FC, Gonçalves H, Oliveira IO, Oliveira PD, Vargas da Silva AM, Kieling C, Manfro GG, Menezes AMB. Early Emotional Symptoms Predicting Carotid Atherosclerosis in Youth: Results From a Birth Cohort in Latin America. J Am Heart Assoc 2019;8:e011011. [PMID: 30651035 DOI: 10.1161/JAHA.118.011011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
677 Giménez-Orenga K, Oltra E. Human Endogenous Retrovirus as Therapeutic Targets in Neurologic Disease. Pharmaceuticals (Basel) 2021;14:495. [PMID: 34073730 DOI: 10.3390/ph14060495] [Reference Citation Analysis]
678 Gibson CL, Bassir Nia A, Spriggs SA, DeFrancisco D, Swift A, Perkel C, Zhong X, Mazumdar M, Fernandez N, Patel M, Kim-Schulze S, Hurd YL. Cannabinoid use in psychotic patients impacts inflammatory levels and their association with psychosis severity. Psychiatry Res 2020;293:113380. [PMID: 32818918 DOI: 10.1016/j.psychres.2020.113380] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
679 Kim YK, Kim OY, Song J. Alleviation of Depression by Glucagon-Like Peptide 1 Through the Regulation of Neuroinflammation, Neurotransmitters, Neurogenesis, and Synaptic Function. Front Pharmacol 2020;11:1270. [PMID: 32922295 DOI: 10.3389/fphar.2020.01270] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
680 Kopczynska M, Zelek W, Touchard S, Gaughran F, Di Forti M, Mondelli V, Murray R, O'Donovan MC, Morgan BP. Complement system biomarkers in first episode psychosis. Schizophr Res 2019;204:16-22. [PMID: 29279246 DOI: 10.1016/j.schres.2017.12.012] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 5.0] [Reference Citation Analysis]
681 Stein F, Lemmer G, Schmitt S, Brosch K, Meller T, Fischer E, Kraus C, Lenhard L, Köhnlein B, Murata H, Bäcker A, Müller M, Franz M, Förster K, Meinert S, Enneking V, Koch K, Grotegerd D, Nagels A, Nenadić I, Dannlowski U, Kircher T, Krug A. Factor analyses of multidimensional symptoms in a large group of patients with major depressive disorder, bipolar disorder, schizoaffective disorder and schizophrenia. Schizophr Res 2020;218:38-47. [PMID: 32192794 DOI: 10.1016/j.schres.2020.03.011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
682 Keinänen J, Suvisaari J, Reinikainen J, Kieseppä T, Lindgren M, Mäntylä T, Rikandi E, Sundvall J, Torniainen-holm M, Mantere O. Low-grade inflammation in first-episode psychosis is determined by increased waist circumference. Psychiatry Research 2018;270:547-53. [DOI: 10.1016/j.psychres.2018.10.022] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
683 Tamminga CA, Clementz BA, Pearlson G, Keshavan M, Gershon ES, Ivleva EI, McDowell J, Meda SA, Keedy S, Calhoun VD, Lizano P, Bishop JR, Hudgens-Haney M, Alliey-Rodriguez N, Asif H, Gibbons R. Biotyping in psychosis: using multiple computational approaches with one data set. Neuropsychopharmacology 2021;46:143-55. [PMID: 32979849 DOI: 10.1038/s41386-020-00849-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
684 Wang L, Wang R, Liu L, Qiao D, Baldwin DS, Hou R. Effects of SSRIs on peripheral inflammatory markers in patients with major depressive disorder: A systematic review and meta-analysis. Brain, Behavior, and Immunity 2019;79:24-38. [DOI: 10.1016/j.bbi.2019.02.021] [Cited by in Crossref: 53] [Cited by in F6Publishing: 48] [Article Influence: 17.7] [Reference Citation Analysis]
685 Goldsmith DR, Rapaport MH. Inflammation and Negative Symptoms of Schizophrenia: Implications for Reward Processing and Motivational Deficits. Front Psychiatry 2020;11:46. [PMID: 32153436 DOI: 10.3389/fpsyt.2020.00046] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
686 Luo Y, Ullah R, Wang J, Du Y, Huang S, Meng L, Gao Y, Gong M, Galaj E, Yin X, Shi H. Exogenous Carbon Monoxide Produces Rapid Antidepressant- and Anxiolytic-Like Effects. Front Pharmacol 2021;12:757417. [PMID: 34867375 DOI: 10.3389/fphar.2021.757417] [Reference Citation Analysis]
687 Dion-Albert L, Bandeira Binder L, Daigle B, Hong-Minh A, Lebel M, Menard C. Sex differences in the blood-brain barrier: implications for mental health. Front Neuroendocrinol 2022;:100989. [PMID: 35271863 DOI: 10.1016/j.yfrne.2022.100989] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
688 Lavoie S, Allott K, Amminger P, Bartholomeusz C, Berger M, Breakspear M, Henders AK, Lee R, Lin A, Mcgorry P, Rice S, Schmaal L, Wood SJ. Harmonised collection of data in youth mental health: Towards large datasets. Aust N Z J Psychiatry 2020;54:46-56. [DOI: 10.1177/0004867419844322] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
689 Breton E, Fotso Soh J, Booij L. Immunoinflammatory processes: Overlapping mechanisms between obesity and eating disorders? Neurosci Biobehav Rev 2022;138:104688. [PMID: 35594735 DOI: 10.1016/j.neubiorev.2022.104688] [Reference Citation Analysis]
690 Koga N, Ogura J, Yoshida F, Hattori K, Hori H, Aizawa E, Ishida I, Kunugi H. Altered polyunsaturated fatty acid levels in relation to proinflammatory cytokines, fatty acid desaturase genotype, and diet in bipolar disorder. Transl Psychiatry 2019;9:208. [PMID: 31455761 DOI: 10.1038/s41398-019-0536-0] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
691 Hubbard DB, Miller BJ. Meta-analysis of blood cortisol levels in individuals with first-episode psychosis. Psychoneuroendocrinology 2019;104:269-75. [PMID: 30909008 DOI: 10.1016/j.psyneuen.2019.03.014] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
692 Tsai SY, Chung KH, Chen PH. Levels of interleukin-6 and high-sensitivity C-reactive protein reflecting mania severity in bipolar disorder. Bipolar Disord 2017;19:708-9. [PMID: 29268004 DOI: 10.1111/bdi.12570] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
693 Hjell G, Szabo A, Mørch-johnsen L, Holst R, Tesli N, Bell C, Fischer-vieler T, Werner MCF, Lunding SH, Ormerod MBEG, Johansen IT, Dieset I, Djurovic S, Melle I, Ueland T, Andreassen OA, Steen NE, Haukvik UK. Interleukin-18 signaling system links to agitation in severe mental disorders. Psychoneuroendocrinology 2022. [DOI: 10.1016/j.psyneuen.2022.105721] [Reference Citation Analysis]
694 Jeppesen R, Orlovska-Waast S, Vindegaard Sørensen N, Christensen RHB, Benros ME. Immunological investigations of the cerebrospinal fluid in patients with recent onset psychotic disorders: A study protocol. PLoS One 2021;16:e0257946. [PMID: 34587214 DOI: 10.1371/journal.pone.0257946] [Reference Citation Analysis]
695 Balanzá-Martínez V, Shansis FM, Tatay-Manteiga A, López-García P. Diet and Neurocognition in Mood Disorders - An Overview of the Overlooked. Curr Pharm Des 2020;26:2353-62. [PMID: 32188376 DOI: 10.2174/1381612826666200318152530] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
696 Chen Q, Wei Z, Wang L, Xu X, Wei Z, Zheng P, Cao K, Zhang Z, Chen K, Liang Q. Dry Eye Disease in Patients With Schizophrenia: A Case-Control Study. Front Med (Lausanne) 2022;9:831337. [PMID: 35223927 DOI: 10.3389/fmed.2022.831337] [Reference Citation Analysis]
697 Ma J, Zhang Y, Huang Z, Liu X, Lv L, Li Y. Relationship Between Curative Effect and Serum Inflammatory Factors Level in Male Patients With First-Episode Schizophrenia Treated With Olanzapine. Front Psychiatry 2021;12:782289. [PMID: 34955927 DOI: 10.3389/fpsyt.2021.782289] [Reference Citation Analysis]
698 Konefal SC, Stellwagen D. Tumour necrosis factor-mediated homeostatic synaptic plasticity in behavioural models: testing a role in maternal immune activation. Philos Trans R Soc Lond B Biol Sci 2017;372:20160160. [PMID: 28093554 DOI: 10.1098/rstb.2016.0160] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
699 Just D, Månberg A, Mitsios N, Stockmeier CA, Rajkowska G, Uhlén M, Mulder J, Feuk L, Cunningham JL, Nilsson P, Carlström EL. Exploring autoantibody signatures in brain tissue from patients with severe mental illness. Transl Psychiatry 2020;10:401. [PMID: 33208725 DOI: 10.1038/s41398-020-01079-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
700 Jansma J, van Essen R, Haarman BC, Chatziioannou AC, Borkent J, Ioannou M, van Hemert S, Sommer IE, El Aidy S. Metabolic phenotyping reveals a potential link between elevated faecal amino acids, diet and symptom severity in individuals with severe mental illness. Journal of Psychiatric Research 2022;151:507-15. [DOI: 10.1016/j.jpsychires.2022.05.011] [Reference Citation Analysis]
701 Moisan MP, Foury A, Dexpert S, Cole SW, Beau C, Forestier D, Ledaguenel P, Magne E, Capuron L. Transcriptomic signaling pathways involved in a naturalistic model of inflammation-related depression and its remission. Transl Psychiatry 2021;11:203. [PMID: 33824279 DOI: 10.1038/s41398-021-01323-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
702 De Picker LJ, Morrens M, Chance SA, Boche D. Microglia and Brain Plasticity in Acute Psychosis and Schizophrenia Illness Course: A Meta-Review. Front Psychiatry 2017;8:238. [PMID: 29201010 DOI: 10.3389/fpsyt.2017.00238] [Cited by in Crossref: 64] [Cited by in F6Publishing: 57] [Article Influence: 12.8] [Reference Citation Analysis]
703 Mongan D, Healy C, Jones HJ, Zammit S, Cannon M, Cotter DR. Plasma polyunsaturated fatty acids and mental disorders in adolescence and early adulthood: cross-sectional and longitudinal associations in a general population cohort. Transl Psychiatry 2021;11:321. [PMID: 34059620 DOI: 10.1038/s41398-021-01425-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
704 Howes OD, McCutcheon R. Inflammation and the neural diathesis-stress hypothesis of schizophrenia: a reconceptualization. Transl Psychiatry 2017;7:e1024. [PMID: 28170004 DOI: 10.1038/tp.2016.278] [Cited by in Crossref: 130] [Cited by in F6Publishing: 108] [Article Influence: 26.0] [Reference Citation Analysis]
705 Dieset I, Mørch RH, Hope S, Hoseth EZ, Reponen EJ, Gran JM, Aas M, Michelsen AE, Reichborn-Kjennerud T, Nesvåg R, Agartz I, Melle I, Aukrust P, Djurovic S, Ueland T, Andreassen OA. An association between YKL-40 and type 2 diabetes in psychotic disorders. Acta Psychiatr Scand 2019;139:37-45. [PMID: 30328100 DOI: 10.1111/acps.12971] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
706 Puangsri P, Ninla-Aesong P. Potential usefulness of complete blood count parameters and inflammatory ratios as simple biomarkers of depression and suicide risk in drug-naive, adolescents with major depressive disorder. Psychiatry Res 2021;305:114216. [PMID: 34571404 DOI: 10.1016/j.psychres.2021.114216] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
707 Abautret-Daly Á, Dempsey E, Parra-Blanco A, Medina C, Harkin A. Gut-brain actions underlying comorbid anxiety and depression associated with inflammatory bowel disease. Acta Neuropsychiatr 2018;30:275-96. [PMID: 28270247 DOI: 10.1017/neu.2017.3] [Cited by in Crossref: 79] [Cited by in F6Publishing: 67] [Article Influence: 19.8] [Reference Citation Analysis]
708 Essali N, Goldsmith DR, Carbone L, Miller BJ. Psychosis as an adverse effect of monoclonal antibody immunotherapy. Brain Behav Immun 2019;81:646-9. [PMID: 31170448 DOI: 10.1016/j.bbi.2019.06.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
709 Huang YJ, Tsai SY, Chung KH, Chen PH, Huang SH, Kuo CJ. State-dependent alterations of lipid profiles in patients with bipolar disorder. Int J Psychiatry Med 2018;53:273-81. [PMID: 29280686 DOI: 10.1177/0091217417749786] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]